id	sid	tid	token	lemma	pos
dpc-4515	1	1	dermatology	dermatology	NOUN
dpc-4515	1	2	:	:	PUNCT
dpc-4515	1	3	practical	practical	ADJ
dpc-4515	1	4	and	and	CCONJ
dpc-4515	1	5	conceptual	conceptual	ADJ
dpc-4515	1	6	original	original	ADJ
dpc-4515	1	7	article	article	NOUN
dpc-4515	1	8	|	|	ADV
dpc-4515	1	9	dermatol	dermatol	ADJ
dpc-4515	1	10	pract	pract	NOUN
dpc-4515	1	11	concept	concept	NOUN
dpc-4515	1	12	.	.	PUNCT
dpc-4515	2	1	2024;14(4):e2024265	2024;14(4):e2024265	NUM
dpc-4515	2	2	1	1	NUM
dpc-4515	2	3	pyoderma	pyoderma	NOUN
dpc-4515	2	4	gangrenosum	gangrenosum	NOUN
dpc-4515	2	5	:	:	PUNCT
dpc-4515	2	6	a	a	DET
dpc-4515	2	7	retrospective	retrospective	ADJ
dpc-4515	2	8	case	case	NOUN
dpc-4515	2	9	series	series	NOUN
dpc-4515	2	10	of	of	ADP
dpc-4515	2	11	44	44	NUM
dpc-4515	2	12	patients	patient	NOUN
dpc-4515	2	13	federico	federico	PROPN
dpc-4515	2	14	bardazzi1	bardazzi1	PROPN
dpc-4515	2	15	,	,	PUNCT
dpc-4515	2	16	lorenzo	lorenzo	PROPN
dpc-4515	2	17	maltoni1,2	maltoni1,2	PROPN
dpc-4515	2	18	,	,	PUNCT
dpc-4515	2	19	giacomo	giacomo	PROPN
dpc-4515	2	20	clarizio1,2	clarizio1,2	PROPN
dpc-4515	2	21	,	,	PUNCT
dpc-4515	2	22	maria	maria	PROPN
dpc-4515	2	23	francesca	francesca	PROPN
dpc-4515	2	24	baracca1,2	baracca1,2	PROPN
dpc-4515	2	25	,	,	PUNCT
dpc-4515	2	26	camilla	camilla	PROPN
dpc-4515	2	27	loi1,2	loi1,2	PROPN
dpc-4515	2	28	,	,	PUNCT
dpc-4515	2	29	michela	michela	PROPN
dpc-4515	2	30	starace1,2	starace1,2	PROPN
dpc-4515	2	31	,	,	PUNCT
dpc-4515	2	32	yuri	yuri	PROPN
dpc-4515	2	33	merli1,2	merli1,2	PROPN
dpc-4515	2	34	,	,	PUNCT
dpc-4515	2	35	cosimo	cosimo	PROPN
dpc-4515	2	36	misciali1	misciali1	PROPN
dpc-4515	2	37	1	1	NUM
dpc-4515	2	38	dermatology	dermatology	NOUN
dpc-4515	2	39	unit	unit	NOUN
dpc-4515	2	40	,	,	PUNCT
dpc-4515	2	41	irccs	irccs	PROPN
dpc-4515	2	42	azienda	azienda	PROPN
dpc-4515	2	43	ospedaliero	ospedaliero	PROPN
dpc-4515	2	44	-	-	PUNCT
dpc-4515	2	45	universitaria	universitaria	PROPN
dpc-4515	2	46	di	di	PROPN
dpc-4515	2	47	bologna	bologna	PROPN
dpc-4515	2	48	,	,	PUNCT
dpc-4515	2	49	bologna	bologna	PROPN
dpc-4515	2	50	,	,	PUNCT
dpc-4515	2	51	italy	italy	PROPN
dpc-4515	2	52	2	2	NUM
dpc-4515	2	53	department	department	NOUN
dpc-4515	2	54	of	of	ADP
dpc-4515	2	55	medical	medical	ADJ
dpc-4515	2	56	and	and	CCONJ
dpc-4515	2	57	surgical	surgical	ADJ
dpc-4515	2	58	sciences	science	NOUN
dpc-4515	2	59	,	,	PUNCT
dpc-4515	2	60	alma	alma	NOUN
dpc-4515	2	61	mater	mater	PROPN
dpc-4515	2	62	studiorum	studiorum	PROPN
dpc-4515	2	63	university	university	PROPN
dpc-4515	2	64	of	of	ADP
dpc-4515	2	65	bologna	bologna	PROPN
dpc-4515	2	66	,	,	PUNCT
dpc-4515	2	67	italy	italy	PROPN
dpc-4515	2	68	key	key	ADJ
dpc-4515	2	69	words	word	NOUN
dpc-4515	2	70	:	:	PUNCT
dpc-4515	2	71	pyoderma	pyoderma	NOUN
dpc-4515	2	72	gangrenosum	gangrenosum	NOUN
dpc-4515	2	73	,	,	PUNCT
dpc-4515	2	74	neutrophilic	neutrophilic	ADJ
dpc-4515	2	75	dermatosis	dermatosis	NOUN
dpc-4515	2	76	,	,	PUNCT
dpc-4515	2	77	biological	biological	ADJ
dpc-4515	2	78	therapy	therapy	NOUN
dpc-4515	2	79	citation	citation	NOUN
dpc-4515	2	80	:	:	PUNCT
dpc-4515	2	81	bardazzi	bardazzi	PROPN
dpc-4515	2	82	f	f	PROPN
dpc-4515	2	83	,	,	PUNCT
dpc-4515	2	84	maltoni	maltoni	PROPN
dpc-4515	2	85	l	l	NOUN
dpc-4515	2	86	,	,	PUNCT
dpc-4515	2	87	clarizio	clarizio	VERB
dpc-4515	2	88	g	g	NOUN
dpc-4515	2	89	,	,	PUNCT
dpc-4515	2	90	et	et	PROPN
dpc-4515	2	91	al	al	PROPN
dpc-4515	2	92	.	.	PUNCT
dpc-4515	2	93	pyoderma	pyoderma	PROPN
dpc-4515	2	94	gangrenosum	gangrenosum	NOUN
dpc-4515	2	95	:	:	PUNCT
dpc-4515	2	96	a	a	DET
dpc-4515	2	97	retrospective	retrospective	ADJ
dpc-4515	2	98	case	case	NOUN
dpc-4515	2	99	series	series	NOUN
dpc-4515	2	100	of	of	ADP
dpc-4515	2	101	44	44	NUM
dpc-4515	2	102	patients	patient	NOUN
dpc-4515	2	103	.	.	PUNCT
dpc-4515	3	1	dermatol	dermatol	NOUN
dpc-4515	3	2	pract	pract	PROPN
dpc-4515	3	3	concept	concept	NOUN
dpc-4515	3	4	.	.	PUNCT
dpc-4515	4	1	2024;14(4):e2024265	2024;14(4):e2024265	X
dpc-4515	4	2	.	.	PUNCT
dpc-4515	4	3	doi	doi	NOUN
dpc-4515	4	4	:	:	PUNCT
dpc-4515	4	5	https://doi.org/10.5826/dpc.1404a265	https://doi.org/10.5826/dpc.1404a265	NOUN
dpc-4515	4	6	accepted	accept	VERB
dpc-4515	4	7	:	:	PUNCT
dpc-4515	4	8	july	july	PROPN
dpc-4515	4	9	7	7	NUM
dpc-4515	4	10	,	,	PUNCT
dpc-4515	4	11	2024	2024	NUM
dpc-4515	4	12	;	;	PUNCT
dpc-4515	4	13	published	publish	VERB
dpc-4515	4	14	:	:	PUNCT
dpc-4515	4	15	october	october	PROPN
dpc-4515	4	16	2024	2024	NUM
dpc-4515	5	1	copyright	copyright	NOUN
dpc-4515	5	2	:	:	PUNCT
dpc-4515	5	3	©	©	PROPN
dpc-4515	5	4	2024	2024	NUM
dpc-4515	5	5	bardazzi	bardazzi	NOUN
dpc-4515	5	6	et	et	PROPN
dpc-4515	5	7	al	al	PROPN
dpc-4515	5	8	.	.	PUNCT
dpc-4515	6	1	this	this	PRON
dpc-4515	6	2	is	be	AUX
dpc-4515	6	3	an	an	DET
dpc-4515	6	4	open	open	ADJ
dpc-4515	6	5	-	-	PUNCT
dpc-4515	6	6	access	access	NOUN
dpc-4515	6	7	article	article	NOUN
dpc-4515	6	8	distributed	distribute	VERB
dpc-4515	6	9	under	under	ADP
dpc-4515	6	10	the	the	DET
dpc-4515	6	11	terms	term	NOUN
dpc-4515	6	12	of	of	ADP
dpc-4515	6	13	the	the	DET
dpc-4515	6	14	creative	creative	ADJ
dpc-4515	6	15	commons	common	NOUN
dpc-4515	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4515	6	17	license	license	NOUN
dpc-4515	6	18	(	(	PUNCT
dpc-4515	6	19	by	by	ADP
dpc-4515	6	20	-	-	PUNCT
dpc-4515	6	21	nc-4.0	nc-4.0	NOUN
dpc-4515	6	22	)	)	PUNCT
dpc-4515	6	23	,	,	PUNCT
dpc-4515	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4515	6	25	,	,	PUNCT
dpc-4515	6	26	which	which	PRON
dpc-4515	6	27	permits	permit	VERB
dpc-4515	6	28	unrestricted	unrestricted	ADJ
dpc-4515	6	29	noncommercial	noncommercial	ADJ
dpc-4515	6	30	use	use	NOUN
dpc-4515	6	31	,	,	PUNCT
dpc-4515	6	32	distribution	distribution	NOUN
dpc-4515	6	33	,	,	PUNCT
dpc-4515	6	34	and	and	CCONJ
dpc-4515	6	35	reproduction	reproduction	NOUN
dpc-4515	6	36	in	in	ADP
dpc-4515	6	37	any	any	DET
dpc-4515	6	38	medium	medium	NOUN
dpc-4515	6	39	,	,	PUNCT
dpc-4515	6	40	provided	provide	VERB
dpc-4515	6	41	the	the	DET
dpc-4515	6	42	original	original	ADJ
dpc-4515	6	43	authors	author	NOUN
dpc-4515	6	44	and	and	CCONJ
dpc-4515	6	45	source	source	NOUN
dpc-4515	6	46	are	be	AUX
dpc-4515	6	47	credited	credit	VERB
dpc-4515	6	48	.	.	PUNCT
dpc-4515	7	1	funding	funding	NOUN
dpc-4515	7	2	:	:	PUNCT
dpc-4515	7	3	none	none	NOUN
dpc-4515	7	4	.	.	PUNCT
dpc-4515	8	1	competing	compete	VERB
dpc-4515	8	2	interests	interest	NOUN
dpc-4515	8	3	:	:	PUNCT
dpc-4515	8	4	none	none	NOUN
dpc-4515	8	5	.	.	PUNCT
dpc-4515	9	1	authorship	authorship	NOUN
dpc-4515	9	2	:	:	PUNCT
dpc-4515	9	3	all	all	DET
dpc-4515	9	4	authors	author	NOUN
dpc-4515	9	5	have	have	AUX
dpc-4515	9	6	contributed	contribute	VERB
dpc-4515	9	7	significantly	significantly	ADV
dpc-4515	9	8	to	to	ADP
dpc-4515	9	9	this	this	DET
dpc-4515	9	10	publication	publication	NOUN
dpc-4515	9	11	.	.	PUNCT
dpc-4515	10	1	corresponding	correspond	VERB
dpc-4515	10	2	author	author	NOUN
dpc-4515	10	3	:	:	PUNCT
dpc-4515	10	4	giacomo	giacomo	PROPN
dpc-4515	10	5	clarizio	clarizio	PROPN
dpc-4515	10	6	,	,	PUNCT
dpc-4515	10	7	dermatology	dermatology	NOUN
dpc-4515	10	8	unit	unit	NOUN
dpc-4515	10	9	,	,	PUNCT
dpc-4515	10	10	irccs	irccs	PROPN
dpc-4515	10	11	azienda	azienda	PROPN
dpc-4515	10	12	ospedaliero	ospedaliero	PROPN
dpc-4515	10	13	-	-	PUNCT
dpc-4515	10	14	universitaria	universitaria	PROPN
dpc-4515	10	15	di	di	PROPN
dpc-4515	10	16	bologna	bologna	PROPN
dpc-4515	10	17	,	,	PUNCT
dpc-4515	10	18	via	via	ADP
dpc-4515	10	19	massarenti	massarenti	NOUN
dpc-4515	10	20	1	1	NUM
dpc-4515	10	21	,	,	PUNCT
dpc-4515	10	22	40138	40138	NUM
dpc-4515	10	23	bologna	bologna	PROPN
dpc-4515	10	24	,	,	PUNCT
dpc-4515	10	25	italy	italy	PROPN
dpc-4515	10	26	.	.	PUNCT
dpc-4515	11	1	email	email	NOUN
dpc-4515	11	2	:	:	PUNCT
dpc-4515	11	3	giacomo.clarizio@studio.unibo.it	giacomo.clarizio@studio.unibo.it	NOUN
dpc-4515	11	4	introduction	introduction	NOUN
dpc-4515	11	5	:	:	PUNCT
dpc-4515	11	6	pyoderma	pyoderma	NOUN
dpc-4515	11	7	gangrenosum	gangrenosum	NOUN
dpc-4515	11	8	(	(	PUNCT
dpc-4515	11	9	pg	pg	NOUN
dpc-4515	11	10	)	)	PUNCT
dpc-4515	11	11	poses	pose	VERB
dpc-4515	11	12	a	a	DET
dpc-4515	11	13	significant	significant	ADJ
dpc-4515	11	14	dermatological	dermatological	ADJ
dpc-4515	11	15	challenge	challenge	NOUN
dpc-4515	11	16	due	due	ADP
dpc-4515	11	17	to	to	ADP
dpc-4515	11	18	its	its	PRON
dpc-4515	11	19	rapidly	rapidly	ADV
dpc-4515	11	20	evolving	evolve	VERB
dpc-4515	11	21	painful	painful	ADJ
dpc-4515	11	22	necrotic	necrotic	ADJ
dpc-4515	11	23	ulcerations	ulceration	NOUN
dpc-4515	11	24	.	.	PUNCT
dpc-4515	12	1	understanding	understand	VERB
dpc-4515	12	2	its	its	PRON
dpc-4515	12	3	multifaceted	multifaceted	ADJ
dpc-4515	12	4	pathogenesis	pathogenesis	NOUN
dpc-4515	12	5	and	and	CCONJ
dpc-4515	12	6	diverse	diverse	ADJ
dpc-4515	12	7	clinical	clinical	ADJ
dpc-4515	12	8	presentation	presentation	NOUN
dpc-4515	12	9	is	be	AUX
dpc-4515	12	10	crucial	crucial	ADJ
dpc-4515	12	11	for	for	ADP
dpc-4515	12	12	effective	effective	ADJ
dpc-4515	12	13	management	management	NOUN
dpc-4515	12	14	.	.	PUNCT
dpc-4515	13	1	objectives	objective	NOUN
dpc-4515	13	2	:	:	PUNCT
dpc-4515	13	3	we	we	PRON
dpc-4515	13	4	aimed	aim	VERB
dpc-4515	13	5	to	to	PART
dpc-4515	13	6	analyze	analyze	VERB
dpc-4515	13	7	demographic	demographic	ADJ
dpc-4515	13	8	characteristics	characteristic	NOUN
dpc-4515	13	9	,	,	PUNCT
dpc-4515	13	10	clinical	clinical	ADJ
dpc-4515	13	11	manifestations	manifestation	NOUN
dpc-4515	13	12	,	,	PUNCT
dpc-4515	13	13	lesion	lesion	NOUN
dpc-4515	13	14	distributions	distribution	NOUN
dpc-4515	13	15	,	,	PUNCT
dpc-4515	13	16	systemic	systemic	ADJ
dpc-4515	13	17	disease	disease	NOUN
dpc-4515	13	18	associations	association	NOUN
dpc-4515	13	19	,	,	PUNCT
dpc-4515	13	20	therapeutic	therapeutic	ADJ
dpc-4515	13	21	interventions	intervention	NOUN
dpc-4515	13	22	,	,	PUNCT
dpc-4515	13	23	and	and	CCONJ
dpc-4515	13	24	patient	patient	ADJ
dpc-4515	13	25	outcomes	outcome	NOUN
dpc-4515	13	26	in	in	ADP
dpc-4515	13	27	pg	pg	NOUN
dpc-4515	13	28	cases	case	NOUN
dpc-4515	13	29	.	.	PUNCT
dpc-4515	14	1	methods	method	NOUN
dpc-4515	14	2	:	:	PUNCT
dpc-4515	14	3	medical	medical	ADJ
dpc-4515	14	4	records	record	NOUN
dpc-4515	14	5	from	from	ADP
dpc-4515	14	6	2017	2017	NUM
dpc-4515	14	7	to	to	ADP
dpc-4515	14	8	2023	2023	NUM
dpc-4515	14	9	of	of	ADP
dpc-4515	14	10	pg	pg	NOUN
dpc-4515	14	11	patients	patient	NOUN
dpc-4515	14	12	at	at	ADP
dpc-4515	14	13	irccs	irccs	NOUN
dpc-4515	14	14	sant’orsola	sant’orsola	PROPN
dpc-4515	14	15	malpighi	malpighi	PROPN
dpc-4515	14	16	hospital	hospital	PROPN
dpc-4515	14	17	,	,	PUNCT
dpc-4515	14	18	bologna	bologna	PROPN
dpc-4515	14	19	,	,	PUNCT
dpc-4515	14	20	italy	italy	PROPN
dpc-4515	14	21	,	,	PUNCT
dpc-4515	14	22	were	be	AUX
dpc-4515	14	23	retrospectively	retrospectively	ADV
dpc-4515	14	24	analyzed	analyze	VERB
dpc-4515	14	25	.	.	PUNCT
dpc-4515	15	1	inclusion	inclusion	NOUN
dpc-4515	15	2	criteria	criterion	NOUN
dpc-4515	15	3	encompassed	encompass	VERB
dpc-4515	15	4	persistent	persistent	ADJ
dpc-4515	15	5	ulcers	ulcer	NOUN
dpc-4515	15	6	with	with	ADP
dpc-4515	15	7	clinical	clinical	ADJ
dpc-4515	15	8	and	and	CCONJ
dpc-4515	15	9	histological	histological	ADJ
dpc-4515	15	10	evidence	evidence	NOUN
dpc-4515	15	11	of	of	ADP
dpc-4515	15	12	pg	pg	NOUN
dpc-4515	15	13	,	,	PUNCT
dpc-4515	15	14	excluding	exclude	VERB
dpc-4515	15	15	cases	case	NOUN
dpc-4515	15	16	with	with	ADP
dpc-4515	15	17	alternative	alternative	ADJ
dpc-4515	15	18	diagnoses	diagnosis	NOUN
dpc-4515	15	19	or	or	CCONJ
dpc-4515	15	20	inadequate	inadequate	ADJ
dpc-4515	15	21	follow	follow	NOUN
dpc-4515	15	22	-	-	PUNCT
dpc-4515	15	23	up	up	NOUN
dpc-4515	15	24	.	.	PUNCT
dpc-4515	16	1	clinical	clinical	ADJ
dpc-4515	16	2	evaluations	evaluation	NOUN
dpc-4515	16	3	,	,	PUNCT
dpc-4515	16	4	including	include	VERB
dpc-4515	16	5	pain	pain	NOUN
dpc-4515	16	6	assessment	assessment	NOUN
dpc-4515	16	7	and	and	CCONJ
dpc-4515	16	8	lesion	lesion	NOUN
dpc-4515	16	9	measurements	measurement	NOUN
dpc-4515	16	10	,	,	PUNCT
dpc-4515	16	11	were	be	AUX
dpc-4515	16	12	conducted	conduct	VERB
dpc-4515	16	13	at	at	ADP
dpc-4515	16	14	diagnosis	diagnosis	NOUN
dpc-4515	16	15	and	and	CCONJ
dpc-4515	16	16	follow	follow	VERB
dpc-4515	16	17	-	-	PUNCT
dpc-4515	16	18	up	up	ADP
dpc-4515	16	19	visits	visit	NOUN
dpc-4515	16	20	.	.	PUNCT
dpc-4515	17	1	results	result	NOUN
dpc-4515	17	2	:	:	PUNCT
dpc-4515	17	3	a	a	DET
dpc-4515	17	4	total	total	NOUN
dpc-4515	17	5	of	of	ADP
dpc-4515	17	6	44	44	NUM
dpc-4515	17	7	patients	patient	NOUN
dpc-4515	17	8	were	be	AUX
dpc-4515	17	9	evaluated	evaluate	VERB
dpc-4515	17	10	.	.	PUNCT
dpc-4515	18	1	pain	pain	NOUN
dpc-4515	18	2	was	be	AUX
dpc-4515	18	3	a	a	DET
dpc-4515	18	4	universal	universal	ADJ
dpc-4515	18	5	symptom	symptom	NOUN
dpc-4515	18	6	,	,	PUNCT
dpc-4515	18	7	and	and	CCONJ
dpc-4515	18	8	tissue	tissue	NOUN
dpc-4515	18	9	pathergy	pathergy	NOUN
dpc-4515	18	10	was	be	AUX
dpc-4515	18	11	documented	document	VERB
dpc-4515	18	12	in	in	ADP
dpc-4515	18	13	28.6	28.6	NUM
dpc-4515	18	14	%	%	NOUN
dpc-4515	18	15	of	of	ADP
dpc-4515	18	16	patients	patient	NOUN
dpc-4515	18	17	.	.	PUNCT
dpc-4515	19	1	ulcerative	ulcerative	ADJ
dpc-4515	19	2	pg	pg	PROPN
dpc-4515	19	3	was	be	AUX
dpc-4515	19	4	the	the	DET
dpc-4515	19	5	most	most	ADV
dpc-4515	19	6	common	common	ADJ
dpc-4515	19	7	subtype	subtype	NOUN
dpc-4515	19	8	(	(	PUNCT
dpc-4515	19	9	88.1	88.1	NUM
dpc-4515	19	10	%	%	NOUN
dpc-4515	19	11	)	)	PUNCT
dpc-4515	19	12	.	.	PUNCT
dpc-4515	20	1	associations	association	NOUN
dpc-4515	20	2	with	with	ADP
dpc-4515	20	3	inflammatory	inflammatory	ADJ
dpc-4515	20	4	bowel	bowel	NOUN
dpc-4515	20	5	diseases	disease	NOUN
dpc-4515	20	6	(	(	PUNCT
dpc-4515	20	7	25	25	NUM
dpc-4515	20	8	%	%	NOUN
dpc-4515	20	9	)	)	PUNCT
dpc-4515	20	10	,	,	PUNCT
dpc-4515	20	11	rheumatoid	rheumatoid	VERB
dpc-4515	20	12	arthritis	arthritis	NOUN
dpc-4515	20	13	(	(	PUNCT
dpc-4515	20	14	9.1	9.1	NUM
dpc-4515	20	15	%	%	NOUN
dpc-4515	20	16	)	)	PUNCT
dpc-4515	20	17	,	,	PUNCT
dpc-4515	20	18	and	and	CCONJ
dpc-4515	20	19	hematological	hematological	ADJ
dpc-4515	20	20	diseases	disease	NOUN
dpc-4515	20	21	(	(	PUNCT
dpc-4515	20	22	17.2	17.2	NUM
dpc-4515	20	23	%	%	NOUN
dpc-4515	20	24	)	)	PUNCT
dpc-4515	20	25	were	be	AUX
dpc-4515	20	26	noted	note	VERB
dpc-4515	20	27	.	.	PUNCT
dpc-4515	21	1	lower	low	ADJ
dpc-4515	21	2	limbs	limb	NOUN
dpc-4515	21	3	were	be	AUX
dpc-4515	21	4	frequently	frequently	ADV
dpc-4515	21	5	affected	affect	VERB
dpc-4515	21	6	(	(	PUNCT
dpc-4515	21	7	63.6	63.6	NUM
dpc-4515	21	8	%	%	NOUN
dpc-4515	21	9	)	)	PUNCT
dpc-4515	21	10	.	.	PUNCT
dpc-4515	22	1	treatment	treatment	NOUN
dpc-4515	22	2	approaches	approach	NOUN
dpc-4515	22	3	included	include	VERB
dpc-4515	22	4	wound	wound	NOUN
dpc-4515	22	5	management	management	NOUN
dpc-4515	22	6	,	,	PUNCT
dpc-4515	22	7	topical	topical	ADJ
dpc-4515	22	8	and	and	CCONJ
dpc-4515	22	9	systemic	systemic	ADJ
dpc-4515	22	10	corticosteroids	corticosteroid	NOUN
dpc-4515	22	11	,	,	PUNCT
dpc-4515	22	12	and	and	CCONJ
dpc-4515	22	13	immunosuppressive	immunosuppressive	ADJ
dpc-4515	22	14	therapy	therapy	NOUN
dpc-4515	22	15	,	,	PUNCT
dpc-4515	22	16	with	with	ADP
dpc-4515	22	17	varying	vary	VERB
dpc-4515	22	18	response	response	NOUN
dpc-4515	22	19	rates	rate	NOUN
dpc-4515	22	20	.	.	PUNCT
dpc-4515	23	1	conclusion	conclusion	NOUN
dpc-4515	23	2	:	:	PUNCT
dpc-4515	23	3	advanced	advanced	ADJ
dpc-4515	23	4	dressing	dressing	NOUN
dpc-4515	23	5	and	and	CCONJ
dpc-4515	23	6	steroid	steroid	NOUN
dpc-4515	23	7	therapy	therapy	NOUN
dpc-4515	23	8	were	be	AUX
dpc-4515	23	9	pivotal	pivotal	ADJ
dpc-4515	23	10	in	in	ADP
dpc-4515	23	11	mild	mild	ADJ
dpc-4515	23	12	pg	pg	NOUN
dpc-4515	23	13	cases	case	NOUN
dpc-4515	23	14	,	,	PUNCT
dpc-4515	23	15	while	while	SCONJ
dpc-4515	23	16	moderate	moderate	ADJ
dpc-4515	23	17	-	-	PUNCT
dpc-4515	23	18	to	to	ADP
dpc-4515	23	19	-	-	PUNCT
dpc-4515	23	20	severe	severe	ADJ
dpc-4515	23	21	cases	case	NOUN
dpc-4515	23	22	often	often	ADV
dpc-4515	23	23	associated	associate	VERB
dpc-4515	23	24	with	with	ADP
dpc-4515	23	25	systemic	systemic	ADJ
dpc-4515	23	26	diseases	disease	NOUN
dpc-4515	23	27	showed	show	VERB
dpc-4515	23	28	incomplete	incomplete	ADJ
dpc-4515	23	29	healing	healing	NOUN
dpc-4515	23	30	despite	despite	SCONJ
dpc-4515	23	31	treatment	treatment	NOUN
dpc-4515	23	32	,	,	PUNCT
dpc-4515	23	33	especially	especially	ADV
dpc-4515	23	34	in	in	ADP
dpc-4515	23	35	patients	patient	NOUN
dpc-4515	23	36	with	with	ADP
dpc-4515	23	37	inflammatory	inflammatory	ADJ
dpc-4515	23	38	bowel	bowel	NOUN
dpc-4515	23	39	diseases	disease	NOUN
dpc-4515	23	40	and	and	CCONJ
dpc-4515	23	41	hematological	hematological	ADJ
dpc-4515	23	42	disorders	disorder	NOUN
dpc-4515	23	43	.	.	PUNCT
dpc-4515	24	1	this	this	DET
dpc-4515	24	2	study	study	NOUN
dpc-4515	24	3	contributes	contribute	VERB
dpc-4515	24	4	to	to	ADP
dpc-4515	24	5	the	the	DET
dpc-4515	24	6	understanding	understanding	NOUN
dpc-4515	24	7	of	of	ADP
dpc-4515	24	8	pg	pg	PROPN
dpc-4515	24	9	’s	’s	PART
dpc-4515	24	10	complexities	complexity	NOUN
dpc-4515	24	11	,	,	PUNCT
dpc-4515	24	12	suggesting	suggest	VERB
dpc-4515	24	13	the	the	DET
dpc-4515	24	14	use	use	NOUN
dpc-4515	24	15	of	of	ADP
dpc-4515	24	16	biological	biological	ADJ
dpc-4515	24	17	therapy	therapy	NOUN
dpc-4515	24	18	as	as	ADP
dpc-4515	24	19	first	first	ADJ
dpc-4515	24	20	line	line	NOUN
dpc-4515	24	21	in	in	ADP
dpc-4515	24	22	moderate	moderate	ADJ
dpc-4515	24	23	-	-	PUNCT
dpc-4515	24	24	to	to	ADP
dpc-4515	24	25	-	-	PUNCT
dpc-4515	24	26	severe	severe	ADJ
dpc-4515	24	27	pg	pg	NOUN
dpc-4515	24	28	.	.	PUNCT
dpc-4515	25	1	abstract	abstract	ADJ
dpc-4515	25	2	2	2	NUM
dpc-4515	25	3	original	original	ADJ
dpc-4515	25	4	article	article	NOUN
dpc-4515	25	5	|	|	ADV
dpc-4515	25	6	dermatol	dermatol	ADJ
dpc-4515	25	7	pract	pract	NOUN
dpc-4515	25	8	concept	concept	NOUN
dpc-4515	25	9	.	.	PUNCT
dpc-4515	26	1	2024;14(4):e2024265	2024;14(4):e2024265	NUM
dpc-4515	26	2	introduction	introduction	NOUN
dpc-4515	26	3	pyoderma	pyoderma	NOUN
dpc-4515	26	4	gangrenosum	gangrenosum	NOUN
dpc-4515	26	5	(	(	PUNCT
dpc-4515	26	6	pg	pg	NOUN
dpc-4515	26	7	)	)	PUNCT
dpc-4515	26	8	is	be	AUX
dpc-4515	26	9	recognized	recognize	VERB
dpc-4515	26	10	as	as	ADP
dpc-4515	26	11	a	a	DET
dpc-4515	26	12	complex	complex	ADJ
dpc-4515	26	13	dermatological	dermatological	ADJ
dpc-4515	26	14	challenge	challenge	NOUN
dpc-4515	26	15	,	,	PUNCT
dpc-4515	26	16	manifesting	manifest	VERB
dpc-4515	26	17	as	as	ADP
dpc-4515	26	18	rapidly	rapidly	ADV
dpc-4515	26	19	evolving	evolve	VERB
dpc-4515	26	20	painful	painful	ADJ
dpc-4515	26	21	necrotic	necrotic	ADJ
dpc-4515	26	22	ulcerations	ulceration	NOUN
dpc-4515	26	23	.	.	PUNCT
dpc-4515	27	1	despite	despite	SCONJ
dpc-4515	27	2	its	its	PRON
dpc-4515	27	3	misleading	misleading	ADJ
dpc-4515	27	4	nomenclature	nomenclature	NOUN
dpc-4515	27	5	,	,	PUNCT
dpc-4515	27	6	pg	pg	PROPN
dpc-4515	27	7	is	be	AUX
dpc-4515	27	8	acknowledged	acknowledge	VERB
dpc-4515	27	9	as	as	ADP
dpc-4515	27	10	a	a	DET
dpc-4515	27	11	non	non	ADJ
dpc-4515	27	12	-	-	ADJ
dpc-4515	27	13	infectious	infectious	ADJ
dpc-4515	27	14	neutrophilic	neutrophilic	ADJ
dpc-4515	27	15	dermatosis	dermatosis	NOUN
dpc-4515	27	16	,	,	PUNCT
dpc-4515	27	17	with	with	ADP
dpc-4515	27	18	predominant	predominant	ADJ
dpc-4515	27	19	skin	skin	NOUN
dpc-4515	27	20	involvement	involvement	NOUN
dpc-4515	27	21	but	but	CCONJ
dpc-4515	27	22	frequently	frequently	ADV
dpc-4515	27	23	associated	associate	VERB
dpc-4515	27	24	with	with	ADP
dpc-4515	27	25	systemic	systemic	ADJ
dpc-4515	27	26	inflammatory	inflammatory	ADJ
dpc-4515	27	27	conditions	condition	NOUN
dpc-4515	27	28	[	[	X
dpc-4515	27	29	1	1	NUM
dpc-4515	27	30	]	]	PUNCT
dpc-4515	27	31	.	.	PUNCT
dpc-4515	28	1	the	the	DET
dpc-4515	28	2	pathogenesis	pathogenesis	NOUN
dpc-4515	28	3	of	of	ADP
dpc-4515	28	4	pg	pg	PROPN
dpc-4515	28	5	is	be	AUX
dpc-4515	28	6	multifaceted	multifaceted	ADJ
dpc-4515	28	7	,	,	PUNCT
dpc-4515	28	8	implicating	implicate	VERB
dpc-4515	28	9	immune	immune	ADJ
dpc-4515	28	10	dysregulation	dysregulation	NOUN
dpc-4515	28	11	,	,	PUNCT
dpc-4515	28	12	genetic	genetic	ADJ
dpc-4515	28	13	susceptibilities	susceptibility	NOUN
dpc-4515	28	14	,	,	PUNCT
dpc-4515	28	15	and	and	CCONJ
dpc-4515	28	16	environmental	environmental	ADJ
dpc-4515	28	17	factors	factor	NOUN
dpc-4515	28	18	.	.	PUNCT
dpc-4515	29	1	the	the	DET
dpc-4515	29	2	clinical	clinical	ADJ
dpc-4515	29	3	manifestation	manifestation	NOUN
dpc-4515	29	4	of	of	ADP
dpc-4515	29	5	pg	pg	PROPN
dpc-4515	29	6	is	be	AUX
dpc-4515	29	7	diverse	diverse	ADJ
dpc-4515	29	8	,	,	PUNCT
dpc-4515	29	9	often	often	ADV
dpc-4515	29	10	mimicking	mimic	VERB
dpc-4515	29	11	other	other	ADJ
dpc-4515	29	12	dermatological	dermatological	ADJ
dpc-4515	29	13	conditions	condition	NOUN
dpc-4515	29	14	,	,	PUNCT
dpc-4515	29	15	thereby	thereby	ADV
dpc-4515	29	16	necessitating	necessitate	VERB
dpc-4515	29	17	a	a	DET
dpc-4515	29	18	heightened	heightened	ADJ
dpc-4515	29	19	diagnostic	diagnostic	ADJ
dpc-4515	29	20	vigilance	vigilance	NOUN
dpc-4515	29	21	[	[	X
dpc-4515	29	22	2	2	NUM
dpc-4515	29	23	-	-	SYM
dpc-4515	29	24	4	4	NUM
dpc-4515	29	25	]	]	PUNCT
dpc-4515	29	26	.	.	PUNCT
dpc-4515	30	1	the	the	DET
dpc-4515	30	2	management	management	NOUN
dpc-4515	30	3	of	of	ADP
dpc-4515	30	4	pg	pg	NOUN
dpc-4515	30	5	requires	require	VERB
dpc-4515	30	6	a	a	DET
dpc-4515	30	7	collaborative	collaborative	ADJ
dpc-4515	30	8	approach	approach	NOUN
dpc-4515	30	9	,	,	PUNCT
dpc-4515	30	10	integrating	integrate	VERB
dpc-4515	30	11	expertise	expertise	NOUN
dpc-4515	30	12	from	from	ADP
dpc-4515	30	13	dermatology	dermatology	NOUN
dpc-4515	30	14	,	,	PUNCT
dpc-4515	30	15	rheumatology	rheumatology	NOUN
dpc-4515	30	16	,	,	PUNCT
dpc-4515	30	17	gastroenterology	gastroenterology	NOUN
dpc-4515	30	18	and	and	CCONJ
dpc-4515	30	19	often	often	ADV
dpc-4515	30	20	surgery	surgery	NOUN
dpc-4515	30	21	[	[	X
dpc-4515	30	22	5	5	NUM
dpc-4515	30	23	]	]	PUNCT
dpc-4515	30	24	.	.	PUNCT
dpc-4515	31	1	objectives	objective	VERB
dpc-4515	31	2	this	this	DET
dpc-4515	31	3	retrospective	retrospective	ADJ
dpc-4515	31	4	investigation	investigation	NOUN
dpc-4515	31	5	collected	collect	VERB
dpc-4515	31	6	the	the	DET
dpc-4515	31	7	demographic	demographic	ADJ
dpc-4515	31	8	characteristics	characteristic	NOUN
dpc-4515	31	9	,	,	PUNCT
dpc-4515	31	10	clinical	clinical	ADJ
dpc-4515	31	11	manifestations	manifestation	NOUN
dpc-4515	31	12	,	,	PUNCT
dpc-4515	31	13	lesion	lesion	NOUN
dpc-4515	31	14	distributions	distribution	NOUN
dpc-4515	31	15	,	,	PUNCT
dpc-4515	31	16	systemic	systemic	ADJ
dpc-4515	31	17	disease	disease	NOUN
dpc-4515	31	18	associations	association	NOUN
dpc-4515	31	19	,	,	PUNCT
dpc-4515	31	20	and	and	CCONJ
dpc-4515	31	21	therapeutic	therapeutic	ADJ
dpc-4515	31	22	interventions	intervention	NOUN
dpc-4515	31	23	of	of	ADP
dpc-4515	31	24	patients	patient	NOUN
dpc-4515	31	25	diagnosed	diagnose	VERB
dpc-4515	31	26	with	with	ADP
dpc-4515	31	27	pg	pg	NOUN
dpc-4515	31	28	attending	attend	VERB
dpc-4515	31	29	our	our	PRON
dpc-4515	31	30	department	department	NOUN
dpc-4515	31	31	from	from	ADP
dpc-4515	31	32	2017	2017	NUM
dpc-4515	31	33	to	to	ADP
dpc-4515	31	34	2023	2023	NUM
dpc-4515	31	35	.	.	PUNCT
dpc-4515	32	1	the	the	DET
dpc-4515	32	2	study	study	NOUN
dpc-4515	32	3	further	far	ADV
dpc-4515	32	4	aimed	aim	VERB
dpc-4515	32	5	to	to	PART
dpc-4515	32	6	assess	assess	VERB
dpc-4515	32	7	the	the	DET
dpc-4515	32	8	efficacy	efficacy	NOUN
dpc-4515	32	9	of	of	ADP
dpc-4515	32	10	treatments	treatment	NOUN
dpc-4515	32	11	and	and	CCONJ
dpc-4515	32	12	patient	patient	ADJ
dpc-4515	32	13	outcomes	outcome	NOUN
dpc-4515	32	14	,	,	PUNCT
dpc-4515	32	15	contributing	contribute	VERB
dpc-4515	32	16	valuable	valuable	ADJ
dpc-4515	32	17	insights	insight	NOUN
dpc-4515	32	18	into	into	ADP
dpc-4515	32	19	the	the	DET
dpc-4515	32	20	management	management	NOUN
dpc-4515	32	21	and	and	CCONJ
dpc-4515	32	22	prognosis	prognosis	NOUN
dpc-4515	32	23	of	of	ADP
dpc-4515	32	24	pg	pg	PROPN
dpc-4515	32	25	.	.	PUNCT
dpc-4515	33	1	methods	method	NOUN
dpc-4515	33	2	study	study	NOUN
dpc-4515	33	3	design	design	NOUN
dpc-4515	33	4	we	we	PRON
dpc-4515	33	5	adopted	adopt	VERB
dpc-4515	33	6	a	a	DET
dpc-4515	33	7	retrospective	retrospective	ADJ
dpc-4515	33	8	study	study	NOUN
dpc-4515	33	9	design	design	NOUN
dpc-4515	33	10	,	,	PUNCT
dpc-4515	33	11	meticulously	meticulously	ADV
dpc-4515	33	12	analyzing	analyze	VERB
dpc-4515	33	13	medical	medical	ADJ
dpc-4515	33	14	records	record	NOUN
dpc-4515	33	15	from	from	ADP
dpc-4515	33	16	the	the	DET
dpc-4515	33	17	“	"	PUNCT
dpc-4515	33	18	ambulatorio	ambulatorio	NOUN
dpc-4515	33	19	lesioni	lesioni	PROPN
dpc-4515	33	20	aperte	aperte	PROPN
dpc-4515	33	21	”	"	PUNCT
dpc-4515	33	22	at	at	ADP
dpc-4515	33	23	irccs	irccs	NOUN
dpc-4515	33	24	sant’orsola	sant’orsola	PROPN
dpc-4515	33	25	malpighi	malpighi	PROPN
dpc-4515	33	26	hospital	hospital	PROPN
dpc-4515	33	27	,	,	PUNCT
dpc-4515	33	28	bologna	bologna	PROPN
dpc-4515	33	29	,	,	PUNCT
dpc-4515	33	30	italy	italy	PROPN
dpc-4515	33	31	,	,	PUNCT
dpc-4515	33	32	over	over	ADP
dpc-4515	33	33	a	a	DET
dpc-4515	33	34	6	6	NUM
dpc-4515	33	35	-	-	PUNCT
dpc-4515	33	36	year	year	NOUN
dpc-4515	33	37	span	span	NOUN
dpc-4515	33	38	.	.	PUNCT
dpc-4515	34	1	clinical	clinical	ADJ
dpc-4515	34	2	records	record	NOUN
dpc-4515	34	3	of	of	ADP
dpc-4515	34	4	pg	pg	NOUN
dpc-4515	34	5	patients	patient	NOUN
dpc-4515	34	6	were	be	AUX
dpc-4515	34	7	reviewed	review	VERB
dpc-4515	34	8	by	by	ADP
dpc-4515	34	9	three	three	NUM
dpc-4515	34	10	independent	independent	ADJ
dpc-4515	34	11	researchers	researcher	NOUN
dpc-4515	34	12	,	,	PUNCT
dpc-4515	34	13	ensuring	ensure	VERB
dpc-4515	34	14	the	the	DET
dpc-4515	34	15	exclusion	exclusion	NOUN
dpc-4515	34	16	of	of	ADP
dpc-4515	34	17	differential	differential	ADJ
dpc-4515	34	18	diagnoses	diagnosis	NOUN
dpc-4515	34	19	through	through	ADP
dpc-4515	34	20	comprehensive	comprehensive	ADJ
dpc-4515	34	21	histological	histological	ADJ
dpc-4515	34	22	evaluations	evaluation	NOUN
dpc-4515	34	23	.	.	PUNCT
dpc-4515	35	1	our	our	PRON
dpc-4515	35	2	inclusion	inclusion	NOUN
dpc-4515	35	3	criteria	criterion	NOUN
dpc-4515	35	4	were	be	AUX
dpc-4515	35	5	persistent	persistent	ADJ
dpc-4515	35	6	ulcers	ulcer	NOUN
dpc-4515	35	7	exceeding	exceed	VERB
dpc-4515	35	8	three	three	NUM
dpc-4515	35	9	months	month	NOUN
dpc-4515	35	10	,	,	PUNCT
dpc-4515	35	11	corroborated	corroborate	VERB
dpc-4515	35	12	by	by	ADP
dpc-4515	35	13	clinical	clinical	ADJ
dpc-4515	35	14	and	and	CCONJ
dpc-4515	35	15	histological	histological	ADJ
dpc-4515	35	16	evidence	evidence	NOUN
dpc-4515	35	17	of	of	ADP
dpc-4515	35	18	pg	pg	PROPN
dpc-4515	35	19	,	,	PUNCT
dpc-4515	35	20	and	and	CCONJ
dpc-4515	35	21	the	the	DET
dpc-4515	35	22	absence	absence	NOUN
dpc-4515	35	23	of	of	ADP
dpc-4515	35	24	pathogenic	pathogenic	ADJ
dpc-4515	35	25	organisms	organism	NOUN
dpc-4515	35	26	in	in	ADP
dpc-4515	35	27	cultures	culture	NOUN
dpc-4515	35	28	.	.	PUNCT
dpc-4515	36	1	we	we	PRON
dpc-4515	36	2	excluded	exclude	VERB
dpc-4515	36	3	cases	case	NOUN
dpc-4515	36	4	lacking	lack	VERB
dpc-4515	36	5	histopathological	histopathological	ADJ
dpc-4515	36	6	confirmation	confirmation	NOUN
dpc-4515	36	7	or	or	CCONJ
dpc-4515	36	8	those	those	PRON
dpc-4515	36	9	with	with	ADP
dpc-4515	36	10	inadequate	inadequate	ADJ
dpc-4515	36	11	treatment	treatment	NOUN
dpc-4515	36	12	initiation	initiation	NOUN
dpc-4515	36	13	or	or	CCONJ
dpc-4515	36	14	follow	follow	NOUN
dpc-4515	36	15	-	-	PUNCT
dpc-4515	36	16	up	up	NOUN
dpc-4515	36	17	.	.	PUNCT
dpc-4515	37	1	all	all	DET
dpc-4515	37	2	patients	patient	NOUN
dpc-4515	37	3	were	be	AUX
dpc-4515	37	4	evaluated	evaluate	VERB
dpc-4515	37	5	at	at	ADP
dpc-4515	37	6	diagnosis	diagnosis	NOUN
dpc-4515	37	7	and	and	CCONJ
dpc-4515	37	8	at	at	ADP
dpc-4515	37	9	every	every	DET
dpc-4515	37	10	follow	follow	VERB
dpc-4515	37	11	-	-	PUNCT
dpc-4515	37	12	up	up	NOUN
dpc-4515	37	13	visit	visit	NOUN
dpc-4515	37	14	through	through	ADP
dpc-4515	37	15	clinical	clinical	ADJ
dpc-4515	37	16	photography	photography	NOUN
dpc-4515	37	17	.	.	PUNCT
dpc-4515	38	1	the	the	DET
dpc-4515	38	2	change	change	NOUN
dpc-4515	38	3	in	in	ADP
dpc-4515	38	4	lesion	lesion	NOUN
dpc-4515	38	5	size	size	NOUN
dpc-4515	38	6	was	be	AUX
dpc-4515	38	7	measured	measure	VERB
dpc-4515	38	8	by	by	ADP
dpc-4515	38	9	taking	take	VERB
dpc-4515	38	10	a	a	DET
dpc-4515	38	11	cast	cast	NOUN
dpc-4515	38	12	on	on	ADP
dpc-4515	38	13	transparent	transparent	ADJ
dpc-4515	38	14	graph	graph	NOUN
dpc-4515	38	15	paper	paper	NOUN
dpc-4515	38	16	at	at	ADP
dpc-4515	38	17	each	each	DET
dpc-4515	38	18	follow	follow	VERB
dpc-4515	38	19	-	-	PUNCT
dpc-4515	38	20	up	up	ADP
dpc-4515	38	21	visit	visit	NOUN
dpc-4515	38	22	.	.	PUNCT
dpc-4515	39	1	we	we	PRON
dpc-4515	39	2	considered	consider	VERB
dpc-4515	39	3	the	the	DET
dpc-4515	39	4	lesions	lesion	NOUN
dpc-4515	39	5	healed	heal	VERB
dpc-4515	39	6	when	when	SCONJ
dpc-4515	39	7	there	there	PRON
dpc-4515	39	8	was	be	VERB
dpc-4515	39	9	no	no	ADV
dpc-4515	39	10	longer	long	ADJ
dpc-4515	39	11	need	need	NOUN
dpc-4515	39	12	of	of	ADP
dpc-4515	39	13	sequential	sequential	ADJ
dpc-4515	39	14	dressing	dressing	NOUN
dpc-4515	39	15	.	.	PUNCT
dpc-4515	40	1	our	our	PRON
dpc-4515	40	2	approach	approach	NOUN
dpc-4515	40	3	to	to	ADP
dpc-4515	40	4	comorbidities	comorbiditie	NOUN
dpc-4515	40	5	tended	tend	VERB
dpc-4515	40	6	to	to	PART
dpc-4515	40	7	exclude	exclude	VERB
dpc-4515	40	8	common	common	ADJ
dpc-4515	40	9	ailments	ailment	NOUN
dpc-4515	40	10	like	like	ADP
dpc-4515	40	11	diabetes	diabetes	NOUN
dpc-4515	40	12	,	,	PUNCT
dpc-4515	40	13	hypertension	hypertension	NOUN
dpc-4515	40	14	,	,	PUNCT
dpc-4515	40	15	hypercholesterolemia	hypercholesterolemia	NOUN
dpc-4515	40	16	,	,	PUNCT
dpc-4515	40	17	and	and	CCONJ
dpc-4515	40	18	peripheral	peripheral	ADJ
dpc-4515	40	19	vascular	vascular	ADJ
dpc-4515	40	20	disease	disease	NOUN
dpc-4515	40	21	,	,	PUNCT
dpc-4515	40	22	which	which	PRON
dpc-4515	40	23	are	be	AUX
dpc-4515	40	24	prevalent	prevalent	ADJ
dpc-4515	40	25	in	in	ADP
dpc-4515	40	26	the	the	DET
dpc-4515	40	27	older	old	ADJ
dpc-4515	40	28	population	population	NOUN
dpc-4515	40	29	.	.	PUNCT
dpc-4515	41	1	data	datum	NOUN
dpc-4515	41	2	analysis	analysis	NOUN
dpc-4515	41	3	data	datum	NOUN
dpc-4515	41	4	are	be	AUX
dpc-4515	41	5	presented	present	VERB
dpc-4515	41	6	as	as	ADP
dpc-4515	41	7	mean	mean	ADJ
dpc-4515	41	8	for	for	ADP
dpc-4515	41	9	continuous	continuous	ADJ
dpc-4515	41	10	distributed	distribute	VERB
dpc-4515	41	11	variables	variable	NOUN
dpc-4515	41	12	and	and	CCONJ
dpc-4515	41	13	as	as	ADP
dpc-4515	41	14	number	number	NOUN
dpc-4515	41	15	and	and	CCONJ
dpc-4515	41	16	%	%	NOUN
dpc-4515	41	17	for	for	ADP
dpc-4515	41	18	categorical	categorical	ADJ
dpc-4515	41	19	variables	variable	NOUN
dpc-4515	41	20	.	.	PUNCT
dpc-4515	42	1	all	all	DET
dpc-4515	42	2	the	the	DET
dpc-4515	42	3	data	datum	NOUN
dpc-4515	42	4	were	be	AUX
dpc-4515	42	5	collected	collect	VERB
dpc-4515	42	6	using	use	VERB
dpc-4515	42	7	microsoft	microsoft	PROPN
dpc-4515	42	8	excel	excel	PROPN
dpc-4515	42	9	®	®	NOUN
dpc-4515	42	10	(	(	PUNCT
dpc-4515	42	11	version	version	NOUN
dpc-4515	42	12	2403	2403	NUM
dpc-4515	42	13	)	)	PUNCT
dpc-4515	42	14	.	.	PUNCT
dpc-4515	43	1	results	result	VERB
dpc-4515	43	2	patient	patient	ADJ
dpc-4515	43	3	demographics	demographic	NOUN
dpc-4515	43	4	a	a	DET
dpc-4515	43	5	total	total	NOUN
dpc-4515	43	6	of	of	ADP
dpc-4515	43	7	44	44	NUM
dpc-4515	43	8	patients	patient	NOUN
dpc-4515	43	9	affected	affect	VERB
dpc-4515	43	10	by	by	ADP
dpc-4515	43	11	pg	pg	PROPN
dpc-4515	43	12	were	be	AUX
dpc-4515	43	13	evaluated	evaluate	VERB
dpc-4515	43	14	.	.	PUNCT
dpc-4515	44	1	data	datum	NOUN
dpc-4515	44	2	analysis	analysis	NOUN
dpc-4515	44	3	showed	show	VERB
dpc-4515	44	4	the	the	DET
dpc-4515	44	5	prevalence	prevalence	NOUN
dpc-4515	44	6	of	of	ADP
dpc-4515	44	7	females	female	NOUN
dpc-4515	44	8	(	(	PUNCT
dpc-4515	44	9	54.5	54.5	NUM
dpc-4515	44	10	%	%	NOUN
dpc-4515	44	11	,	,	PUNCT
dpc-4515	44	12	n	n	CCONJ
dpc-4515	44	13	:	:	PUNCT
dpc-4515	44	14	24	24	NUM
dpc-4515	44	15	)	)	PUNCT
dpc-4515	44	16	.	.	PUNCT
dpc-4515	45	1	mean	mean	VERB
dpc-4515	45	2	age	age	NOUN
dpc-4515	45	3	at	at	ADP
dpc-4515	45	4	the	the	DET
dpc-4515	45	5	time	time	NOUN
dpc-4515	45	6	of	of	ADP
dpc-4515	45	7	diagnosis	diagnosis	NOUN
dpc-4515	45	8	was	be	AUX
dpc-4515	45	9	57	57	NUM
dpc-4515	45	10	years	year	NOUN
dpc-4515	45	11	(	(	PUNCT
dpc-4515	45	12	range	range	NOUN
dpc-4515	45	13	15	15	NUM
dpc-4515	45	14	-	-	SYM
dpc-4515	45	15	91	91	NUM
dpc-4515	45	16	)	)	PUNCT
dpc-4515	45	17	.	.	PUNCT
dpc-4515	46	1	for	for	ADP
dpc-4515	46	2	males	male	NOUN
dpc-4515	46	3	,	,	PUNCT
dpc-4515	46	4	the	the	DET
dpc-4515	46	5	mean	mean	ADJ
dpc-4515	46	6	age	age	NOUN
dpc-4515	46	7	at	at	ADP
dpc-4515	46	8	the	the	DET
dpc-4515	46	9	onset	onset	NOUN
dpc-4515	46	10	was	be	AUX
dpc-4515	46	11	56.3	56.3	NUM
dpc-4515	46	12	years	year	NOUN
dpc-4515	46	13	(	(	PUNCT
dpc-4515	46	14	range	range	NOUN
dpc-4515	46	15	16	16	NUM
dpc-4515	46	16	-	-	SYM
dpc-4515	46	17	84	84	NUM
dpc-4515	46	18	)	)	PUNCT
dpc-4515	46	19	and	and	CCONJ
dpc-4515	46	20	for	for	ADP
dpc-4515	46	21	females	female	NOUN
dpc-4515	46	22	it	it	PRON
dpc-4515	46	23	was	be	AUX
dpc-4515	46	24	55.3	55.3	NUM
dpc-4515	46	25	years	year	NOUN
dpc-4515	46	26	(	(	PUNCT
dpc-4515	46	27	range	range	NOUN
dpc-4515	46	28	15	15	NUM
dpc-4515	46	29	-	-	SYM
dpc-4515	46	30	91	91	NUM
dpc-4515	46	31	)	)	PUNCT
dpc-4515	46	32	.	.	PUNCT
dpc-4515	47	1	the	the	DET
dpc-4515	47	2	percentage	percentage	NOUN
dpc-4515	47	3	of	of	ADP
dpc-4515	47	4	white	white	ADJ
dpc-4515	47	5	⁄caucasian	⁄caucasian	ADJ
dpc-4515	47	6	individuals	individual	NOUN
dpc-4515	47	7	in	in	ADP
dpc-4515	47	8	our	our	PRON
dpc-4515	47	9	study	study	NOUN
dpc-4515	47	10	was	be	AUX
dpc-4515	47	11	97.6	97.6	NUM
dpc-4515	47	12	%	%	NOUN
dpc-4515	47	13	,	,	PUNCT
dpc-4515	47	14	followed	follow	VERB
dpc-4515	47	15	by	by	ADP
dpc-4515	47	16	black	black	ADJ
dpc-4515	47	17	⁄african	⁄african	ADJ
dpc-4515	47	18	americans	americans	PROPN
dpc-4515	47	19	(	(	PUNCT
dpc-4515	47	20	4.8	4.8	NUM
dpc-4515	47	21	%	%	NOUN
dpc-4515	47	22	)	)	PUNCT
dpc-4515	47	23	and	and	CCONJ
dpc-4515	47	24	asian	asian	ADJ
dpc-4515	47	25	and	and	CCONJ
dpc-4515	47	26	hispanics	hispanic	NOUN
dpc-4515	47	27	(	(	PUNCT
dpc-4515	47	28	2.4	2.4	NUM
dpc-4515	47	29	%	%	NOUN
dpc-4515	47	30	)	)	PUNCT
dpc-4515	47	31	.	.	PUNCT
dpc-4515	48	1	we	we	PRON
dpc-4515	48	2	examined	examine	VERB
dpc-4515	48	3	the	the	DET
dpc-4515	48	4	histopathological	histopathological	ADJ
dpc-4515	48	5	records	record	NOUN
dpc-4515	48	6	to	to	PART
dpc-4515	48	7	rule	rule	VERB
dpc-4515	48	8	out	out	ADP
dpc-4515	48	9	other	other	ADJ
dpc-4515	48	10	possible	possible	ADJ
dpc-4515	48	11	diagnoses	diagnosis	NOUN
dpc-4515	48	12	such	such	ADJ
dpc-4515	48	13	as	as	ADP
dpc-4515	48	14	vasculitis	vasculitis	NOUN
dpc-4515	48	15	,	,	PUNCT
dpc-4515	48	16	infection	infection	NOUN
dpc-4515	48	17	,	,	PUNCT
dpc-4515	48	18	and	and	CCONJ
dpc-4515	48	19	malignancy	malignancy	NOUN
dpc-4515	48	20	.	.	PUNCT
dpc-4515	49	1	the	the	DET
dpc-4515	49	2	mean	mean	ADJ
dpc-4515	49	3	follow	follow	VERB
dpc-4515	49	4	-	-	PUNCT
dpc-4515	49	5	up	up	ADP
dpc-4515	49	6	duration	duration	NOUN
dpc-4515	49	7	was	be	AUX
dpc-4515	49	8	24	24	NUM
dpc-4515	49	9	months	month	NOUN
dpc-4515	49	10	(	(	PUNCT
dpc-4515	49	11	range	range	NOUN
dpc-4515	49	12	6	6	NUM
dpc-4515	49	13	-	-	SYM
dpc-4515	49	14	78	78	NUM
dpc-4515	49	15	)	)	PUNCT
dpc-4515	49	16	;	;	PUNCT
dpc-4515	49	17	six	six	NUM
dpc-4515	49	18	patients	patient	NOUN
dpc-4515	49	19	were	be	AUX
dpc-4515	49	20	lost	lose	VERB
dpc-4515	49	21	to	to	PART
dpc-4515	49	22	follow	follow	VERB
dpc-4515	49	23	-	-	PUNCT
dpc-4515	49	24	up	up	NOUN
dpc-4515	49	25	after	after	ADP
dpc-4515	49	26	6	6	NUM
dpc-4515	49	27	months	month	NOUN
dpc-4515	49	28	.	.	PUNCT
dpc-4515	50	1	clinical	clinical	ADJ
dpc-4515	50	2	presentation	presentation	NOUN
dpc-4515	50	3	and	and	CCONJ
dpc-4515	50	4	associated	associated	ADJ
dpc-4515	50	5	diseases	disease	NOUN
dpc-4515	50	6	pain	pain	NOUN
dpc-4515	50	7	was	be	AUX
dpc-4515	50	8	a	a	DET
dpc-4515	50	9	universal	universal	ADJ
dpc-4515	50	10	symptom	symptom	NOUN
dpc-4515	50	11	and	and	CCONJ
dpc-4515	50	12	was	be	AUX
dpc-4515	50	13	explicitly	explicitly	ADV
dpc-4515	50	14	recorded	record	VERB
dpc-4515	50	15	for	for	ADP
dpc-4515	50	16	all	all	DET
dpc-4515	50	17	the	the	DET
dpc-4515	50	18	patients	patient	NOUN
dpc-4515	50	19	.	.	PUNCT
dpc-4515	51	1	pain	pain	NOUN
dpc-4515	51	2	was	be	AUX
dpc-4515	51	3	evaluated	evaluate	VERB
dpc-4515	51	4	with	with	ADP
dpc-4515	51	5	a	a	DET
dpc-4515	51	6	visual	visual	ADJ
dpc-4515	51	7	analogue	analogue	NOUN
dpc-4515	51	8	scale	scale	NOUN
dpc-4515	51	9	(	(	PUNCT
dpc-4515	51	10	vas	vas	X
dpc-4515	51	11	)	)	PUNCT
dpc-4515	51	12	at	at	ADP
dpc-4515	51	13	the	the	DET
dpc-4515	51	14	time	time	NOUN
dpc-4515	51	15	of	of	ADP
dpc-4515	51	16	diagnosis	diagnosis	NOUN
dpc-4515	51	17	with	with	ADP
dpc-4515	51	18	a	a	DET
dpc-4515	51	19	mean	mean	ADJ
dpc-4515	51	20	pain	pain	NOUN
dpc-4515	51	21	of	of	ADP
dpc-4515	51	22	around	around	ADV
dpc-4515	51	23	7.6	7.6	NUM
dpc-4515	51	24	points	point	NOUN
dpc-4515	51	25	(	(	PUNCT
dpc-4515	51	26	range	range	NOUN
dpc-4515	51	27	3	3	NUM
dpc-4515	51	28	-	-	SYM
dpc-4515	51	29	9	9	NUM
dpc-4515	51	30	)	)	PUNCT
dpc-4515	51	31	.	.	PUNCT
dpc-4515	52	1	tissue	tissue	NOUN
dpc-4515	52	2	pathergy	pathergy	NOUN
dpc-4515	52	3	,	,	PUNCT
dpc-4515	52	4	reported	report	VERB
dpc-4515	52	5	as	as	ADP
dpc-4515	52	6	worsening	worsen	VERB
dpc-4515	52	7	or	or	CCONJ
dpc-4515	52	8	development	development	NOUN
dpc-4515	52	9	of	of	ADP
dpc-4515	52	10	new	new	ADJ
dpc-4515	52	11	lesions	lesion	NOUN
dpc-4515	52	12	after	after	ADP
dpc-4515	52	13	minor	minor	ADJ
dpc-4515	52	14	trauma	trauma	NOUN
dpc-4515	52	15	,	,	PUNCT
dpc-4515	52	16	was	be	AUX
dpc-4515	52	17	documented	document	VERB
dpc-4515	52	18	in	in	ADP
dpc-4515	52	19	28.6	28.6	NUM
dpc-4515	52	20	%	%	NOUN
dpc-4515	52	21	(	(	PUNCT
dpc-4515	52	22	n	n	CCONJ
dpc-4515	52	23	:	:	SYM
dpc-4515	52	24	12	12	NUM
dpc-4515	52	25	)	)	PUNCT
dpc-4515	52	26	of	of	ADP
dpc-4515	52	27	patients	patient	NOUN
dpc-4515	52	28	within	within	ADP
dpc-4515	52	29	the	the	DET
dpc-4515	52	30	period	period	NOUN
dpc-4515	52	31	of	of	ADP
dpc-4515	52	32	follow	follow	NOUN
dpc-4515	52	33	-	-	PUNCT
dpc-4515	52	34	up	up	NOUN
dpc-4515	52	35	.	.	PUNCT
dpc-4515	53	1	the	the	DET
dpc-4515	53	2	majority	majority	NOUN
dpc-4515	53	3	of	of	ADP
dpc-4515	53	4	the	the	DET
dpc-4515	53	5	patients	patient	NOUN
dpc-4515	53	6	presented	present	VERB
dpc-4515	53	7	ulcerative	ulcerative	ADJ
dpc-4515	53	8	pg	pg	PROPN
dpc-4515	53	9	(	(	PUNCT
dpc-4515	53	10	88.1	88.1	NUM
dpc-4515	53	11	%	%	NOUN
dpc-4515	53	12	,	,	PUNCT
dpc-4515	53	13	n	n	CCONJ
dpc-4515	53	14	:	:	PUNCT
dpc-4515	53	15	37	37	NUM
dpc-4515	53	16	)	)	PUNCT
dpc-4515	53	17	(	(	PUNCT
dpc-4515	53	18	figure	figure	NOUN
dpc-4515	53	19	1	1	NUM
dpc-4515	53	20	)	)	PUNCT
dpc-4515	53	21	.	.	PUNCT
dpc-4515	54	1	lower	low	ADJ
dpc-4515	54	2	incidences	incidence	NOUN
dpc-4515	54	3	were	be	AUX
dpc-4515	54	4	reported	report	VERB
dpc-4515	54	5	for	for	ADP
dpc-4515	54	6	bullous	bullous	ADJ
dpc-4515	54	7	pg	pg	NOUN
dpc-4515	54	8	(	(	PUNCT
dpc-4515	54	9	4.8	4.8	NUM
dpc-4515	54	10	%	%	NOUN
dpc-4515	54	11	,	,	PUNCT
dpc-4515	54	12	n	n	CCONJ
dpc-4515	54	13	:	:	PUNCT
dpc-4515	54	14	2	2	NUM
dpc-4515	54	15	)	)	PUNCT
dpc-4515	54	16	(	(	PUNCT
dpc-4515	54	17	figure	figure	NOUN
dpc-4515	54	18	2	2	NUM
dpc-4515	54	19	)	)	PUNCT
dpc-4515	54	20	,	,	PUNCT
dpc-4515	54	21	vegetative	vegetative	ADJ
dpc-4515	54	22	pg	pg	NOUN
dpc-4515	54	23	(	(	PUNCT
dpc-4515	54	24	4.8	4.8	NUM
dpc-4515	54	25	%	%	NOUN
dpc-4515	54	26	,	,	PUNCT
dpc-4515	54	27	n	n	CCONJ
dpc-4515	54	28	:	:	PUNCT
dpc-4515	54	29	2	2	NUM
dpc-4515	54	30	)	)	PUNCT
dpc-4515	54	31	(	(	PUNCT
dpc-4515	54	32	figure	figure	NOUN
dpc-4515	54	33	3	3	NUM
dpc-4515	54	34	)	)	PUNCT
dpc-4515	54	35	,	,	PUNCT
dpc-4515	54	36	and	and	CCONJ
dpc-4515	54	37	pustular	pustular	ADJ
dpc-4515	54	38	pg	pg	NOUN
dpc-4515	54	39	subtypes	subtype	NOUN
dpc-4515	54	40	(	(	PUNCT
dpc-4515	54	41	2.4	2.4	NUM
dpc-4515	54	42	%	%	NOUN
dpc-4515	54	43	,	,	PUNCT
dpc-4515	54	44	n	n	CCONJ
dpc-4515	54	45	:	:	PUNCT
dpc-4515	54	46	1	1	NUM
dpc-4515	54	47	)	)	PUNCT
dpc-4515	54	48	(	(	PUNCT
dpc-4515	54	49	figure	figure	VERB
dpc-4515	54	50	4	4	NUM
dpc-4515	54	51	)	)	PUNCT
dpc-4515	54	52	.	.	PUNCT
dpc-4515	55	1	we	we	PRON
dpc-4515	55	2	looked	look	VERB
dpc-4515	55	3	at	at	ADP
dpc-4515	55	4	associated	associated	ADJ
dpc-4515	55	5	major	major	ADJ
dpc-4515	55	6	comorbidities	comorbiditie	NOUN
dpc-4515	55	7	in	in	ADP
dpc-4515	55	8	our	our	PRON
dpc-4515	55	9	cohort	cohort	NOUN
dpc-4515	55	10	of	of	ADP
dpc-4515	55	11	study	study	NOUN
dpc-4515	55	12	:	:	PUNCT
dpc-4515	55	13	25	25	NUM
dpc-4515	55	14	%	%	NOUN
dpc-4515	55	15	(	(	PUNCT
dpc-4515	55	16	n	n	CCONJ
dpc-4515	55	17	:	:	PUNCT
dpc-4515	55	18	11	11	NUM
dpc-4515	55	19	)	)	PUNCT
dpc-4515	55	20	of	of	ADP
dpc-4515	55	21	the	the	DET
dpc-4515	55	22	patients	patient	NOUN
dpc-4515	55	23	presented	present	VERB
dpc-4515	55	24	inflammatory	inflammatory	ADJ
dpc-4515	55	25	figure	figure	NOUN
dpc-4515	55	26	1	1	NUM
dpc-4515	55	27	.	.	PUNCT
dpc-4515	55	28	ulcerative	ulcerative	ADJ
dpc-4515	55	29	pyoderma	pyoderma	NOUN
dpc-4515	55	30	gangrenosum	gangrenosum	NOUN
dpc-4515	55	31	.	.	PUNCT
dpc-4515	56	1	original	original	ADJ
dpc-4515	56	2	article	article	NOUN
dpc-4515	56	3	|	|	ADV
dpc-4515	56	4	dermatol	dermatol	ADJ
dpc-4515	56	5	pract	pract	NOUN
dpc-4515	56	6	concept	concept	NOUN
dpc-4515	56	7	.	.	PUNCT
dpc-4515	57	1	2024;14(4):e2024265	2024;14(4):e2024265	NUM
dpc-4515	57	2	3	3	NUM
dpc-4515	57	3	bowel	bowel	NOUN
dpc-4515	57	4	diseases	disease	NOUN
dpc-4515	57	5	(	(	PUNCT
dpc-4515	57	6	ibd	ibd	PROPN
dpc-4515	57	7	)	)	PUNCT
dpc-4515	57	8	,	,	PUNCT
dpc-4515	57	9	five	five	NUM
dpc-4515	57	10	patients	patient	NOUN
dpc-4515	57	11	had	have	VERB
dpc-4515	57	12	chron	chron	NOUN
dpc-4515	57	13	’s	’s	PART
dpc-4515	57	14	disease	disease	NOUN
dpc-4515	57	15	,	,	PUNCT
dpc-4515	57	16	six	six	NUM
dpc-4515	57	17	had	have	VERB
dpc-4515	57	18	ulcerative	ulcerative	ADJ
dpc-4515	57	19	colitis	colitis	NOUN
dpc-4515	57	20	,	,	PUNCT
dpc-4515	57	21	9.1	9.1	NUM
dpc-4515	57	22	%	%	NOUN
dpc-4515	57	23	of	of	ADP
dpc-4515	57	24	patients	patient	NOUN
dpc-4515	57	25	(	(	PUNCT
dpc-4515	57	26	n	n	CCONJ
dpc-4515	57	27	:	:	PUNCT
dpc-4515	57	28	4	4	X
dpc-4515	57	29	)	)	PUNCT
dpc-4515	57	30	had	have	VERB
dpc-4515	57	31	rheumatoid	rheumatoid	VERB
dpc-4515	57	32	arthritis	arthritis	NOUN
dpc-4515	57	33	.	.	PUNCT
dpc-4515	58	1	an	an	DET
dpc-4515	58	2	important	important	ADJ
dpc-4515	58	3	association	association	NOUN
dpc-4515	58	4	was	be	AUX
dpc-4515	58	5	also	also	ADV
dpc-4515	58	6	found	find	VERB
dpc-4515	58	7	with	with	ADP
dpc-4515	58	8	hematological	hematological	ADJ
dpc-4515	58	9	diseases	disease	NOUN
dpc-4515	58	10	:	:	PUNCT
dpc-4515	58	11	11.4	11.4	NUM
dpc-4515	58	12	%	%	NOUN
dpc-4515	58	13	(	(	PUNCT
dpc-4515	58	14	n	n	CCONJ
dpc-4515	58	15	:	:	PUNCT
dpc-4515	58	16	5	5	NUM
dpc-4515	58	17	)	)	PUNCT
dpc-4515	58	18	of	of	ADP
dpc-4515	58	19	the	the	DET
dpc-4515	58	20	patients	patient	NOUN
dpc-4515	58	21	were	be	AUX
dpc-4515	58	22	affected	affect	VERB
dpc-4515	58	23	with	with	ADP
dpc-4515	58	24	an	an	DET
dpc-4515	58	25	mgus	mgus	ADJ
dpc-4515	58	26	and	and	CCONJ
dpc-4515	58	27	6.8	6.8	NUM
dpc-4515	58	28	%	%	NOUN
dpc-4515	58	29	(	(	PUNCT
dpc-4515	58	30	n	n	CCONJ
dpc-4515	58	31	:	:	SYM
dpc-4515	58	32	3	3	X
dpc-4515	58	33	)	)	PUNCT
dpc-4515	58	34	presented	present	VERB
dpc-4515	58	35	hematological	hematological	ADJ
dpc-4515	58	36	malignancies	malignancy	NOUN
dpc-4515	58	37	such	such	ADJ
dpc-4515	58	38	as	as	ADP
dpc-4515	58	39	follicular	follicular	ADJ
dpc-4515	58	40	lymphoma	lymphoma	NOUN
dpc-4515	58	41	,	,	PUNCT
dpc-4515	58	42	acute	acute	ADJ
dpc-4515	58	43	myeloid	myeloid	ADJ
dpc-4515	58	44	leukemia	leukemia	NOUN
dpc-4515	58	45	,	,	PUNCT
dpc-4515	58	46	and	and	CCONJ
dpc-4515	58	47	chronic	chronic	ADJ
dpc-4515	58	48	myeloid	myeloid	NOUN
dpc-4515	58	49	leukemia	leukemia	NOUN
dpc-4515	58	50	(	(	PUNCT
dpc-4515	58	51	one	one	NUM
dpc-4515	58	52	patient	patient	NOUN
dpc-4515	58	53	each	each	PRON
dpc-4515	58	54	)	)	PUNCT
dpc-4515	58	55	.	.	PUNCT
dpc-4515	59	1	psoriasis	psoriasis	NOUN
dpc-4515	59	2	was	be	AUX
dpc-4515	59	3	diagnosed	diagnose	VERB
dpc-4515	59	4	in	in	ADP
dpc-4515	59	5	9.1	9.1	NUM
dpc-4515	59	6	%	%	NOUN
dpc-4515	59	7	(	(	PUNCT
dpc-4515	59	8	n	n	CCONJ
dpc-4515	59	9	:	:	PUNCT
dpc-4515	59	10	4	4	NUM
dpc-4515	59	11	)	)	PUNCT
dpc-4515	59	12	of	of	ADP
dpc-4515	59	13	the	the	DET
dpc-4515	59	14	patients	patient	NOUN
dpc-4515	59	15	in	in	ADP
dpc-4515	59	16	the	the	DET
dpc-4515	59	17	analysis	analysis	NOUN
dpc-4515	59	18	,	,	PUNCT
dpc-4515	59	19	of	of	ADP
dpc-4515	59	20	whom	whom	PRON
dpc-4515	59	21	two	two	NUM
dpc-4515	59	22	also	also	ADV
dpc-4515	59	23	presented	present	VERB
dpc-4515	59	24	psoriatic	psoriatic	ADJ
dpc-4515	59	25	arthritis	arthritis	NOUN
dpc-4515	59	26	.	.	PUNCT
dpc-4515	60	1	obesity	obesity	NOUN
dpc-4515	60	2	was	be	AUX
dpc-4515	60	3	the	the	DET
dpc-4515	60	4	most	most	ADV
dpc-4515	60	5	common	common	ADJ
dpc-4515	60	6	comorbidity	comorbidity	NOUN
dpc-4515	60	7	among	among	ADP
dpc-4515	60	8	our	our	PRON
dpc-4515	60	9	patients	patient	NOUN
dpc-4515	60	10	;	;	PUNCT
dpc-4515	60	11	a	a	DET
dpc-4515	60	12	total	total	NOUN
dpc-4515	60	13	of	of	ADP
dpc-4515	60	14	17	17	NUM
dpc-4515	60	15	(	(	PUNCT
dpc-4515	60	16	38.6	38.6	NUM
dpc-4515	60	17	%	%	NOUN
dpc-4515	60	18	)	)	PUNCT
dpc-4515	61	1	patients	patient	NOUN
dpc-4515	61	2	presented	present	VERB
dpc-4515	61	3	various	various	ADJ
dpc-4515	61	4	grades	grade	NOUN
dpc-4515	61	5	of	of	ADP
dpc-4515	61	6	obesity	obesity	NOUN
dpc-4515	61	7	(	(	PUNCT
dpc-4515	61	8	table	table	NOUN
dpc-4515	61	9	1	1	NUM
dpc-4515	61	10	)	)	PUNCT
dpc-4515	61	11	.	.	PUNCT
dpc-4515	62	1	in	in	ADP
dpc-4515	62	2	analyzing	analyze	VERB
dpc-4515	62	3	the	the	DET
dpc-4515	62	4	location	location	NOUN
dpc-4515	62	5	of	of	ADP
dpc-4515	62	6	the	the	DET
dpc-4515	62	7	ulcers	ulcer	NOUN
dpc-4515	62	8	,	,	PUNCT
dpc-4515	62	9	we	we	PRON
dpc-4515	62	10	noticed	notice	VERB
dpc-4515	62	11	that	that	SCONJ
dpc-4515	62	12	29.5	29.5	NUM
dpc-4515	62	13	%	%	NOUN
dpc-4515	62	14	of	of	ADP
dpc-4515	62	15	the	the	DET
dpc-4515	62	16	patients	patient	NOUN
dpc-4515	62	17	(	(	PUNCT
dpc-4515	62	18	n	n	CCONJ
dpc-4515	62	19	:	:	SYM
dpc-4515	62	20	13	13	NUM
dpc-4515	62	21	)	)	PUNCT
dpc-4515	62	22	developed	develop	VERB
dpc-4515	62	23	a	a	DET
dpc-4515	62	24	single	single	ADJ
dpc-4515	62	25	lesion	lesion	NOUN
dpc-4515	62	26	,	,	PUNCT
dpc-4515	62	27	while	while	SCONJ
dpc-4515	62	28	the	the	DET
dpc-4515	62	29	other	other	ADJ
dpc-4515	62	30	31	31	NUM
dpc-4515	62	31	patients	patient	NOUN
dpc-4515	62	32	developed	develop	VERB
dpc-4515	62	33	multiple	multiple	ADJ
dpc-4515	62	34	lesions	lesion	NOUN
dpc-4515	62	35	or	or	CCONJ
dpc-4515	62	36	simultaneous	simultaneous	ADJ
dpc-4515	62	37	involvement	involvement	NOUN
dpc-4515	62	38	of	of	ADP
dpc-4515	62	39	different	different	ADJ
dpc-4515	62	40	body	body	NOUN
dpc-4515	62	41	areas	area	NOUN
dpc-4515	62	42	.	.	PUNCT
dpc-4515	63	1	lower	low	ADJ
dpc-4515	63	2	limbs	limb	NOUN
dpc-4515	63	3	were	be	AUX
dpc-4515	63	4	the	the	DET
dpc-4515	63	5	most	most	ADV
dpc-4515	63	6	frequent	frequent	ADJ
dpc-4515	63	7	site	site	NOUN
dpc-4515	63	8	for	for	ADP
dpc-4515	63	9	pg	pg	PRON
dpc-4515	63	10	in	in	ADP
dpc-4515	63	11	our	our	PRON
dpc-4515	63	12	cohort	cohort	NOUN
dpc-4515	63	13	,	,	PUNCT
dpc-4515	63	14	with	with	ADP
dpc-4515	63	15	a	a	DET
dpc-4515	63	16	total	total	NOUN
dpc-4515	63	17	of	of	ADP
dpc-4515	63	18	28	28	NUM
dpc-4515	63	19	patients	patient	NOUN
dpc-4515	63	20	(	(	PUNCT
dpc-4515	63	21	63.6	63.6	NUM
dpc-4515	63	22	%	%	NOUN
dpc-4515	63	23	)	)	PUNCT
dpc-4515	63	24	with	with	ADP
dpc-4515	63	25	lower	low	ADJ
dpc-4515	63	26	limb	limb	NOUN
dpc-4515	63	27	involvement	involvement	NOUN
dpc-4515	63	28	.	.	PUNCT
dpc-4515	64	1	the	the	DET
dpc-4515	64	2	second	second	ADJ
dpc-4515	64	3	most	most	ADV
dpc-4515	64	4	affected	affected	ADJ
dpc-4515	64	5	region	region	NOUN
dpc-4515	64	6	was	be	AUX
dpc-4515	64	7	the	the	DET
dpc-4515	64	8	abdomen	abdoman	NOUN
dpc-4515	64	9	,	,	PUNCT
dpc-4515	64	10	with	with	ADP
dpc-4515	64	11	a	a	DET
dpc-4515	64	12	total	total	NOUN
dpc-4515	64	13	of	of	ADP
dpc-4515	64	14	nine	nine	NUM
dpc-4515	64	15	cases	case	NOUN
dpc-4515	64	16	(	(	PUNCT
dpc-4515	64	17	20.5	20.5	NUM
dpc-4515	64	18	%	%	NOUN
dpc-4515	64	19	)	)	PUNCT
dpc-4515	64	20	,	,	PUNCT
dpc-4515	64	21	of	of	ADP
dpc-4515	64	22	which	which	PRON
dpc-4515	64	23	four	four	NUM
dpc-4515	64	24	were	be	AUX
dpc-4515	64	25	peristomal	peristomal	ADJ
dpc-4515	64	26	involvement	involvement	NOUN
dpc-4515	64	27	.	.	PUNCT
dpc-4515	65	1	less	less	ADV
dpc-4515	65	2	frequent	frequent	ADJ
dpc-4515	65	3	were	be	AUX
dpc-4515	65	4	the	the	DET
dpc-4515	65	5	involvement	involvement	NOUN
dpc-4515	65	6	of	of	ADP
dpc-4515	65	7	the	the	DET
dpc-4515	65	8	upper	upper	ADJ
dpc-4515	65	9	limbs	limb	NOUN
dpc-4515	65	10	(	(	PUNCT
dpc-4515	65	11	six	six	NUM
dpc-4515	65	12	patients	patient	NOUN
dpc-4515	65	13	)	)	PUNCT
dpc-4515	65	14	,	,	PUNCT
dpc-4515	65	15	mammary	mammary	ADJ
dpc-4515	65	16	region	region	NOUN
dpc-4515	65	17	(	(	PUNCT
dpc-4515	65	18	three	three	NUM
dpc-4515	65	19	patients	patient	NOUN
dpc-4515	65	20	)	)	PUNCT
dpc-4515	65	21	,	,	PUNCT
dpc-4515	65	22	back	back	ADV
dpc-4515	65	23	(	(	PUNCT
dpc-4515	65	24	three	three	NUM
dpc-4515	65	25	patients	patient	NOUN
dpc-4515	65	26	)	)	PUNCT
dpc-4515	65	27	,	,	PUNCT
dpc-4515	65	28	and	and	CCONJ
dpc-4515	65	29	hands	hand	NOUN
dpc-4515	65	30	(	(	PUNCT
dpc-4515	65	31	one	one	NUM
dpc-4515	65	32	patient	patient	NOUN
dpc-4515	65	33	)	)	PUNCT
dpc-4515	65	34	.	.	PUNCT
dpc-4515	66	1	the	the	DET
dpc-4515	66	2	temporal	temporal	ADJ
dpc-4515	66	3	analysis	analysis	NOUN
dpc-4515	66	4	showed	show	VERB
dpc-4515	66	5	no	no	DET
dpc-4515	66	6	increase	increase	NOUN
dpc-4515	66	7	in	in	ADP
dpc-4515	66	8	diagnoses	diagnosis	NOUN
dpc-4515	66	9	after	after	ADP
dpc-4515	66	10	march	march	PROPN
dpc-4515	66	11	2020	2020	NUM
dpc-4515	66	12	,	,	PUNCT
dpc-4515	66	13	coinciding	coincide	VERB
dpc-4515	66	14	with	with	ADP
dpc-4515	66	15	the	the	DET
dpc-4515	66	16	outbreak	outbreak	NOUN
dpc-4515	66	17	of	of	ADP
dpc-4515	66	18	covid-19	covid-19	PROPN
dpc-4515	66	19	pandemic	pandemic	NOUN
dpc-4515	66	20	.	.	PUNCT
dpc-4515	67	1	twenty	twenty	NUM
dpc-4515	67	2	-	-	PUNCT
dpc-4515	67	3	four	four	NUM
dpc-4515	67	4	cases	case	NOUN
dpc-4515	67	5	of	of	ADP
dpc-4515	67	6	pg	pg	NOUN
dpc-4515	67	7	(	(	PUNCT
dpc-4515	67	8	54.55	54.55	NUM
dpc-4515	67	9	%	%	NOUN
dpc-4515	67	10	)	)	PUNCT
dpc-4515	67	11	were	be	AUX
dpc-4515	67	12	diagnosed	diagnose	VERB
dpc-4515	67	13	before	before	ADP
dpc-4515	67	14	march	march	PROPN
dpc-4515	67	15	2020	2020	NUM
dpc-4515	67	16	and	and	CCONJ
dpc-4515	67	17	20	20	NUM
dpc-4515	67	18	after	after	ADP
dpc-4515	67	19	that	that	DET
dpc-4515	67	20	date	date	NOUN
dpc-4515	67	21	.	.	PUNCT
dpc-4515	68	1	seventeen	seventeen	NUM
dpc-4515	68	2	out	out	ADP
dpc-4515	68	3	of	of	ADP
dpc-4515	68	4	20	20	NUM
dpc-4515	68	5	patients	patient	NOUN
dpc-4515	68	6	diagnosed	diagnose	VERB
dpc-4515	68	7	after	after	ADP
dpc-4515	68	8	the	the	DET
dpc-4515	68	9	onset	onset	NOUN
dpc-4515	68	10	of	of	ADP
dpc-4515	68	11	the	the	DET
dpc-4515	68	12	covid-19	covid-19	PROPN
dpc-4515	68	13	pandemic	pandemic	ADJ
dpc-4515	68	14	reported	report	VERB
dpc-4515	68	15	sars	sars	PROPN
dpc-4515	68	16	-	-	PUNCT
dpc-4515	68	17	cov2	cov2	PROPN
dpc-4515	68	18	infection	infection	NOUN
dpc-4515	68	19	or	or	CCONJ
dpc-4515	68	20	vaccination	vaccination	NOUN
dpc-4515	68	21	during	during	ADP
dpc-4515	68	22	the	the	DET
dpc-4515	68	23	six	six	NUM
dpc-4515	68	24	months	month	NOUN
dpc-4515	68	25	preceding	precede	VERB
dpc-4515	68	26	the	the	DET
dpc-4515	68	27	emergence	emergence	NOUN
dpc-4515	68	28	of	of	ADP
dpc-4515	68	29	pg	pg	PROPN
dpc-4515	68	30	.	.	PUNCT
dpc-4515	69	1	treatment	treatment	NOUN
dpc-4515	69	2	in	in	ADP
dpc-4515	69	3	all	all	DET
dpc-4515	69	4	patients	patient	NOUN
dpc-4515	69	5	,	,	PUNCT
dpc-4515	69	6	wound	wound	ADJ
dpc-4515	69	7	management	management	NOUN
dpc-4515	69	8	was	be	AUX
dpc-4515	69	9	guaranteed	guarantee	VERB
dpc-4515	69	10	in	in	ADP
dpc-4515	69	11	our	our	PRON
dpc-4515	69	12	outpatient	outpatient	NOUN
dpc-4515	69	13	clinic	clinic	NOUN
dpc-4515	69	14	every	every	DET
dpc-4515	69	15	2	2	NUM
dpc-4515	69	16	-	-	SYM
dpc-4515	69	17	6	6	NUM
dpc-4515	69	18	weeks	week	NOUN
dpc-4515	69	19	.	.	PUNCT
dpc-4515	70	1	in	in	ADP
dpc-4515	70	2	this	this	DET
dpc-4515	70	3	setting	setting	NOUN
dpc-4515	70	4	,	,	PUNCT
dpc-4515	70	5	they	they	PRON
dpc-4515	70	6	also	also	ADV
dpc-4515	70	7	underwent	undergo	VERB
dpc-4515	70	8	a	a	DET
dpc-4515	70	9	gentle	gentle	ADJ
dpc-4515	70	10	sharp	sharp	ADJ
dpc-4515	70	11	debridement	debridement	NOUN
dpc-4515	70	12	of	of	ADP
dpc-4515	70	13	nonviable	nonviable	ADJ
dpc-4515	70	14	tissue	tissue	NOUN
dpc-4515	70	15	,	,	PUNCT
dpc-4515	70	16	performed	perform	VERB
dpc-4515	70	17	by	by	ADP
dpc-4515	70	18	a	a	DET
dpc-4515	70	19	wound	wound	NOUN
dpc-4515	70	20	care	care	NOUN
dpc-4515	70	21	specialist	specialist	NOUN
dpc-4515	70	22	.	.	PUNCT
dpc-4515	71	1	among	among	ADP
dpc-4515	71	2	the	the	DET
dpc-4515	71	3	follow	follow	NOUN
dpc-4515	71	4	-	-	PUNCT
dpc-4515	71	5	up	up	ADP
dpc-4515	71	6	visits	visit	NOUN
dpc-4515	71	7	,	,	PUNCT
dpc-4515	71	8	our	our	PRON
dpc-4515	71	9	medication	medication	NOUN
dpc-4515	71	10	was	be	AUX
dpc-4515	71	11	repeated	repeat	VERB
dpc-4515	71	12	by	by	ADP
dpc-4515	71	13	a	a	DET
dpc-4515	71	14	wound	wound	ADJ
dpc-4515	71	15	specialist	specialist	NOUN
dpc-4515	71	16	nurse	nurse	NOUN
dpc-4515	71	17	2	2	NUM
dpc-4515	71	18	-	-	SYM
dpc-4515	71	19	3	3	NUM
dpc-4515	71	20	times	time	NOUN
dpc-4515	71	21	per	per	ADP
dpc-4515	71	22	week	week	NOUN
dpc-4515	71	23	.	.	PUNCT
dpc-4515	72	1	following	follow	VERB
dpc-4515	72	2	the	the	DET
dpc-4515	72	3	therapeutic	therapeutic	ADJ
dpc-4515	72	4	algorithm	algorithm	NOUN
dpc-4515	72	5	by	by	ADP
dpc-4515	72	6	maronese	maronese	PROPN
dpc-4515	72	7	et	et	PROPN
dpc-4515	72	8	al	al	PROPN
dpc-4515	72	9	.	.	PROPN
dpc-4515	72	10	,	,	PUNCT
dpc-4515	72	11	we	we	PRON
dpc-4515	72	12	differentiated	differentiate	VERB
dpc-4515	72	13	mild	mild	ADJ
dpc-4515	72	14	disease	disease	NOUN
dpc-4515	72	15	(	(	PUNCT
dpc-4515	72	16	ulcer	ulcer	NOUN
dpc-4515	72	17	diameter	diameter	NOUN
dpc-4515	72	18	≤3	≤3	PROPN
dpc-4515	72	19	cm	cm	PROPN
dpc-4515	72	20	,	,	PUNCT
dpc-4515	72	21	≤3	≤3	ADJ
dpc-4515	72	22	lesions	lesion	NOUN
dpc-4515	72	23	,	,	PUNCT
dpc-4515	72	24	≤5	≤5	NOUN
dpc-4515	72	25	%	%	NOUN
dpc-4515	72	26	body	body	NOUN
dpc-4515	72	27	surface	surface	NOUN
dpc-4515	72	28	area	area	NOUN
dpc-4515	72	29	involved	involve	VERB
dpc-4515	72	30	)	)	PUNCT
dpc-4515	72	31	from	from	ADP
dpc-4515	72	32	moderate	moderate	ADJ
dpc-4515	72	33	to	to	AUX
dpc-4515	72	34	-	-	PUNCT
dpc-4515	72	35	severe	severe	ADJ
dpc-4515	72	36	(	(	PUNCT
dpc-4515	72	37	ulcer	ulcer	NOUN
dpc-4515	72	38	diameter	diameter	NOUN
dpc-4515	72	39	>	>	X
dpc-4515	72	40	3	3	NUM
dpc-4515	72	41	cm	cm	NOUN
dpc-4515	72	42	,	,	PUNCT
dpc-4515	72	43	visualization	visualization	NOUN
dpc-4515	72	44	of	of	ADP
dpc-4515	72	45	tendon	tendon	NOUN
dpc-4515	72	46	,	,	PUNCT
dpc-4515	72	47	muscle	muscle	NOUN
dpc-4515	72	48	,	,	PUNCT
dpc-4515	72	49	or	or	CCONJ
dpc-4515	72	50	bone	bone	NOUN
dpc-4515	72	51	)	)	PUNCT
dpc-4515	73	1	[	[	X
dpc-4515	73	2	5	5	NUM
dpc-4515	73	3	]	]	PUNCT
dpc-4515	73	4	.	.	PUNCT
dpc-4515	74	1	mild	mild	ADJ
dpc-4515	74	2	disease	disease	NOUN
dpc-4515	74	3	was	be	AUX
dpc-4515	74	4	treated	treat	VERB
dpc-4515	74	5	with	with	ADP
dpc-4515	74	6	superpotent	superpotent	NOUN
dpc-4515	74	7	topical	topical	ADJ
dpc-4515	74	8	corticosteroids	corticosteroid	NOUN
dpc-4515	74	9	as	as	ADP
dpc-4515	74	10	first	first	ADJ
dpc-4515	74	11	-	-	PUNCT
dpc-4515	74	12	line	line	NOUN
dpc-4515	74	13	therapy	therapy	NOUN
dpc-4515	74	14	.	.	PUNCT
dpc-4515	75	1	if	if	SCONJ
dpc-4515	75	2	there	there	PRON
dpc-4515	75	3	was	be	VERB
dpc-4515	75	4	no	no	DET
dpc-4515	75	5	improvement	improvement	NOUN
dpc-4515	75	6	in	in	ADP
dpc-4515	75	7	4	4	NUM
dpc-4515	75	8	-	-	SYM
dpc-4515	75	9	6	6	NUM
dpc-4515	75	10	weeks	week	NOUN
dpc-4515	75	11	,	,	PUNCT
dpc-4515	75	12	we	we	PRON
dpc-4515	75	13	added	add	VERB
dpc-4515	75	14	systemic	systemic	ADJ
dpc-4515	75	15	therapy	therapy	NOUN
dpc-4515	75	16	.	.	PUNCT
dpc-4515	76	1	in	in	ADP
dpc-4515	76	2	the	the	DET
dpc-4515	76	3	four	four	NUM
dpc-4515	76	4	(	(	PUNCT
dpc-4515	76	5	9.1	9.1	NUM
dpc-4515	76	6	%	%	NOUN
dpc-4515	76	7	)	)	PUNCT
dpc-4515	76	8	cases	case	NOUN
dpc-4515	76	9	of	of	ADP
dpc-4515	76	10	peristomal	peristomal	ADJ
dpc-4515	76	11	pg	pg	NOUN
dpc-4515	76	12	(	(	PUNCT
dpc-4515	76	13	ppg	ppg	PROPN
dpc-4515	76	14	)	)	PUNCT
dpc-4515	76	15	,	,	PUNCT
dpc-4515	76	16	we	we	PRON
dpc-4515	76	17	dressed	dress	VERB
dpc-4515	76	18	the	the	DET
dpc-4515	76	19	wound	wound	NOUN
dpc-4515	76	20	with	with	ADP
dpc-4515	76	21	crushed	crush	VERB
dpc-4515	76	22	prednisolone	prednisolone	PROPN
dpc-4515	76	23	and	and	CCONJ
dpc-4515	76	24	hydrocolloid	hydrocolloid	NOUN
dpc-4515	76	25	powder	powder	NOUN
dpc-4515	76	26	,	,	PUNCT
dpc-4515	76	27	as	as	SCONJ
dpc-4515	76	28	already	already	ADV
dpc-4515	76	29	proven	prove	VERB
dpc-4515	76	30	by	by	ADP
dpc-4515	76	31	wendy	wendy	PROPN
dpc-4515	76	32	et	et	PROPN
dpc-4515	76	33	al	al	PROPN
dpc-4515	76	34	.	.	PUNCT
dpc-4515	77	1	[	[	X
dpc-4515	77	2	6	6	NUM
dpc-4515	77	3	]	]	PUNCT
dpc-4515	77	4	.	.	PUNCT
dpc-4515	78	1	for	for	ADP
dpc-4515	78	2	moderate	moderate	ADJ
dpc-4515	78	3	-	-	PUNCT
dpc-4515	78	4	tosevere	tosevere	NOUN
dpc-4515	78	5	disease	disease	NOUN
dpc-4515	78	6	,	,	PUNCT
dpc-4515	78	7	we	we	PRON
dpc-4515	78	8	started	start	VERB
dpc-4515	78	9	directly	directly	ADV
dpc-4515	78	10	with	with	ADP
dpc-4515	78	11	systemic	systemic	ADJ
dpc-4515	78	12	and	and	CCONJ
dpc-4515	78	13	topical	topical	ADJ
dpc-4515	78	14	therapy	therapy	NOUN
dpc-4515	78	15	.	.	PUNCT
dpc-4515	79	1	systemic	systemic	ADJ
dpc-4515	79	2	corticosteroids	corticosteroid	NOUN
dpc-4515	79	3	was	be	AUX
dpc-4515	79	4	by	by	ADP
dpc-4515	79	5	far	far	ADV
dpc-4515	79	6	the	the	DET
dpc-4515	79	7	most	most	ADV
dpc-4515	79	8	frequent	frequent	ADJ
dpc-4515	79	9	treatment	treatment	NOUN
dpc-4515	79	10	used	use	VERB
dpc-4515	79	11	as	as	ADP
dpc-4515	79	12	first	first	ADJ
dpc-4515	79	13	-	-	PUNCT
dpc-4515	79	14	line	line	NOUN
dpc-4515	79	15	systemic	systemic	ADJ
dpc-4515	79	16	therapy	therapy	NOUN
dpc-4515	79	17	.	.	PUNCT
dpc-4515	80	1	twenty	twenty	NUM
dpc-4515	80	2	out	out	ADP
dpc-4515	80	3	of	of	ADP
dpc-4515	80	4	44	44	NUM
dpc-4515	80	5	patients	patient	NOUN
dpc-4515	80	6	received	receive	VERB
dpc-4515	80	7	0.5	0.5	NUM
dpc-4515	80	8	-	-	SYM
dpc-4515	80	9	1	1	NUM
dpc-4515	80	10	mg	mg	PROPN
dpc-4515	80	11	/	/	SYM
dpc-4515	80	12	kg	kg	NOUN
dpc-4515	80	13	of	of	ADP
dpc-4515	80	14	oral	oral	ADJ
dpc-4515	80	15	prednisone	prednisone	NOUN
dpc-4515	80	16	(	(	PUNCT
dpc-4515	80	17	or	or	CCONJ
dpc-4515	80	18	equivalent	equivalent	ADJ
dpc-4515	80	19	steroid	steroid	PROPN
dpc-4515	80	20	dose	dose	NOUN
dpc-4515	80	21	)	)	PUNCT
dpc-4515	80	22	for	for	ADP
dpc-4515	80	23	a	a	DET
dpc-4515	80	24	duration	duration	NOUN
dpc-4515	80	25	of	of	ADP
dpc-4515	80	26	8	8	NUM
dpc-4515	80	27	-	-	SYM
dpc-4515	80	28	42	42	NUM
dpc-4515	80	29	weeks	week	NOUN
dpc-4515	80	30	.	.	PUNCT
dpc-4515	81	1	eighteen	eighteen	NUM
dpc-4515	81	2	patients	patient	NOUN
dpc-4515	81	3	(	(	PUNCT
dpc-4515	81	4	41	41	NUM
dpc-4515	81	5	%	%	NOUN
dpc-4515	81	6	)	)	PUNCT
dpc-4515	81	7	were	be	AUX
dpc-4515	81	8	steroid	steroid	NOUN
dpc-4515	81	9	-	-	PUNCT
dpc-4515	81	10	resistant	resistant	ADJ
dpc-4515	81	11	and	and	CCONJ
dpc-4515	81	12	needed	need	VERB
dpc-4515	81	13	other	other	ADJ
dpc-4515	81	14	immunosuppressive	immunosuppressive	ADJ
dpc-4515	81	15	therapy	therapy	NOUN
dpc-4515	81	16	.	.	PUNCT
dpc-4515	82	1	steroid	steroid	NOUN
dpc-4515	82	2	-	-	PUNCT
dpc-4515	82	3	sparing	spare	VERB
dpc-4515	82	4	drugs	drug	NOUN
dpc-4515	82	5	such	such	ADJ
dpc-4515	82	6	as	as	ADP
dpc-4515	82	7	cyclosporine	cyclosporine	NOUN
dpc-4515	82	8	,	,	PUNCT
dpc-4515	82	9	methotrexate	methotrexate	NOUN
dpc-4515	82	10	and	and	CCONJ
dpc-4515	82	11	dapsone	dapsone	NOUN
dpc-4515	82	12	were	be	AUX
dpc-4515	82	13	used	use	VERB
dpc-4515	82	14	.	.	PUNCT
dpc-4515	83	1	seven	seven	NUM
dpc-4515	83	2	patients	patient	NOUN
dpc-4515	83	3	(	(	PUNCT
dpc-4515	83	4	15.9	15.9	NUM
dpc-4515	83	5	%	%	NOUN
dpc-4515	83	6	)	)	PUNCT
dpc-4515	83	7	were	be	AUX
dpc-4515	83	8	treated	treat	VERB
dpc-4515	83	9	with	with	ADP
dpc-4515	83	10	cyclosporine	cyclosporine	NOUN
dpc-4515	83	11	(	(	PUNCT
dpc-4515	83	12	200	200	NUM
dpc-4515	83	13	mg	mg	NUM
dpc-4515	83	14	/	/	SYM
dpc-4515	83	15	day	day	NOUN
dpc-4515	83	16	)	)	PUNCT
dpc-4515	83	17	for	for	ADP
dpc-4515	83	18	a	a	DET
dpc-4515	83	19	duration	duration	NOUN
dpc-4515	83	20	of	of	ADP
dpc-4515	83	21	8–30	8–30	PROPN
dpc-4515	83	22	weeks	week	NOUN
dpc-4515	83	23	,	,	PUNCT
dpc-4515	83	24	and	and	CCONJ
dpc-4515	83	25	three	three	NUM
dpc-4515	83	26	patients	patient	NOUN
dpc-4515	83	27	obtained	obtain	VERB
dpc-4515	83	28	clinical	clinical	ADJ
dpc-4515	83	29	improvement	improvement	NOUN
dpc-4515	83	30	.	.	PUNCT
dpc-4515	84	1	methotrexate	methotrexate	PROPN
dpc-4515	84	2	was	be	AUX
dpc-4515	84	3	used	use	VERB
dpc-4515	84	4	in	in	ADP
dpc-4515	84	5	three	three	NUM
dpc-4515	84	6	patients	patient	NOUN
dpc-4515	84	7	without	without	ADP
dpc-4515	84	8	any	any	DET
dpc-4515	84	9	significant	significant	ADJ
dpc-4515	84	10	improvement	improvement	NOUN
dpc-4515	84	11	of	of	ADP
dpc-4515	84	12	the	the	DET
dpc-4515	84	13	disease	disease	NOUN
dpc-4515	84	14	.	.	PUNCT
dpc-4515	85	1	two	two	NUM
dpc-4515	85	2	patients	patient	NOUN
dpc-4515	85	3	were	be	AUX
dpc-4515	85	4	treated	treat	VERB
dpc-4515	85	5	with	with	ADP
dpc-4515	85	6	dapsone	dapsone	PROPN
dpc-4515	85	7	,	,	PUNCT
dpc-4515	85	8	of	of	ADP
dpc-4515	85	9	whom	whom	PRON
dpc-4515	85	10	one	one	NUM
dpc-4515	85	11	obtained	obtain	VERB
dpc-4515	85	12	a	a	DET
dpc-4515	85	13	good	good	ADJ
dpc-4515	85	14	clinical	clinical	ADJ
dpc-4515	85	15	response	response	NOUN
dpc-4515	85	16	.	.	PUNCT
dpc-4515	86	1	twenty	twenty	NUM
dpc-4515	86	2	-	-	PUNCT
dpc-4515	86	3	two	two	NUM
dpc-4515	86	4	(	(	PUNCT
dpc-4515	86	5	50	50	NUM
dpc-4515	86	6	%	%	NOUN
dpc-4515	86	7	)	)	PUNCT
dpc-4515	86	8	figure	figure	NOUN
dpc-4515	86	9	2	2	NUM
dpc-4515	86	10	.	.	PUNCT
dpc-4515	86	11	vegetative	vegetative	ADJ
dpc-4515	86	12	pyoderma	pyoderma	NOUN
dpc-4515	86	13	gangrenosum	gangrenosum	NOUN
dpc-4515	86	14	.	.	PUNCT
dpc-4515	87	1	figure	figure	VERB
dpc-4515	87	2	3	3	NUM
dpc-4515	87	3	.	.	PUNCT
dpc-4515	87	4	bullous	bullous	ADJ
dpc-4515	87	5	pyoderma	pyoderma	NOUN
dpc-4515	87	6	gangrenosum	gangrenosum	NOUN
dpc-4515	87	7	.	.	PUNCT
dpc-4515	88	1	figure	figure	VERB
dpc-4515	88	2	4	4	NUM
dpc-4515	88	3	.	.	PUNCT
dpc-4515	89	1	pustular	pustular	ADJ
dpc-4515	89	2	pyoderma	pyoderma	NOUN
dpc-4515	89	3	gangrenosum	gangrenosum	NOUN
dpc-4515	89	4	.	.	PUNCT
dpc-4515	90	1	4	4	NUM
dpc-4515	90	2	original	original	ADJ
dpc-4515	90	3	article	article	NOUN
dpc-4515	90	4	|	|	ADV
dpc-4515	90	5	dermatol	dermatol	ADJ
dpc-4515	90	6	pract	pract	NOUN
dpc-4515	90	7	concept	concept	NOUN
dpc-4515	90	8	.	.	PUNCT
dpc-4515	91	1	2024;14(4):e2024265	2024;14(4):e2024265	NUM
dpc-4515	91	2	the	the	DET
dpc-4515	91	3	comparable	comparable	ADJ
dpc-4515	91	4	prevalence	prevalence	NOUN
dpc-4515	91	5	of	of	ADP
dpc-4515	91	6	hematologic	hematologic	NOUN
dpc-4515	91	7	malignancies	malignancy	NOUN
dpc-4515	91	8	and	and	CCONJ
dpc-4515	91	9	monoclonal	monoclonal	NOUN
dpc-4515	91	10	gammopathy	gammopathy	ADJ
dpc-4515	91	11	of	of	ADP
dpc-4515	91	12	undetermined	undetermined	ADJ
dpc-4515	91	13	significance	significance	NOUN
dpc-4515	91	14	(	(	PUNCT
dpc-4515	91	15	mgus	mgus	ADJ
dpc-4515	91	16	)	)	PUNCT
dpc-4515	91	17	in	in	ADP
dpc-4515	91	18	our	our	PRON
dpc-4515	91	19	cohort	cohort	NOUN
dpc-4515	91	20	aligns	align	VERB
dpc-4515	91	21	with	with	ADP
dpc-4515	91	22	previous	previous	ADJ
dpc-4515	91	23	findings	finding	NOUN
dpc-4515	91	24	,	,	PUNCT
dpc-4515	91	25	further	far	ADV
dpc-4515	91	26	emphasizing	emphasize	VERB
dpc-4515	91	27	the	the	DET
dpc-4515	91	28	need	need	NOUN
dpc-4515	91	29	for	for	ADP
dpc-4515	91	30	a	a	DET
dpc-4515	91	31	comprehensive	comprehensive	ADJ
dpc-4515	91	32	systemic	systemic	ADJ
dpc-4515	91	33	evaluation	evaluation	NOUN
dpc-4515	91	34	in	in	ADP
dpc-4515	91	35	patients	patient	NOUN
dpc-4515	91	36	presenting	present	VERB
dpc-4515	91	37	with	with	ADP
dpc-4515	91	38	pg	pg	PROPN
dpc-4515	92	1	[	[	X
dpc-4515	92	2	10	10	NUM
dpc-4515	92	3	-	-	SYM
dpc-4515	92	4	12	12	NUM
dpc-4515	92	5	]	]	PUNCT
dpc-4515	92	6	.	.	PUNCT
dpc-4515	93	1	advanced	advanced	ADJ
dpc-4515	93	2	dressing	dressing	NOUN
dpc-4515	93	3	and	and	CCONJ
dpc-4515	93	4	use	use	NOUN
dpc-4515	93	5	of	of	ADP
dpc-4515	93	6	high	high	ADJ
dpc-4515	93	7	-	-	PUNCT
dpc-4515	93	8	potency	potency	NOUN
dpc-4515	93	9	topical	topical	ADJ
dpc-4515	93	10	steroids	steroid	NOUN
dpc-4515	93	11	play	play	VERB
dpc-4515	93	12	a	a	DET
dpc-4515	93	13	fundamental	fundamental	ADJ
dpc-4515	93	14	role	role	NOUN
dpc-4515	93	15	in	in	ADP
dpc-4515	93	16	the	the	DET
dpc-4515	93	17	management	management	NOUN
dpc-4515	93	18	of	of	ADP
dpc-4515	93	19	pg	pg	PROPN
dpc-4515	93	20	,	,	PUNCT
dpc-4515	93	21	often	often	ADV
dpc-4515	93	22	leading	lead	VERB
dpc-4515	93	23	to	to	ADP
dpc-4515	93	24	the	the	DET
dpc-4515	93	25	resolution	resolution	NOUN
dpc-4515	93	26	in	in	ADP
dpc-4515	93	27	mild	mild	ADJ
dpc-4515	93	28	forms	form	NOUN
dpc-4515	93	29	.	.	PUNCT
dpc-4515	94	1	we	we	PRON
dpc-4515	94	2	observed	observe	VERB
dpc-4515	94	3	that	that	SCONJ
dpc-4515	94	4	patients	patient	NOUN
dpc-4515	94	5	without	without	ADP
dpc-4515	94	6	systemic	systemic	ADJ
dpc-4515	94	7	associations	association	NOUN
dpc-4515	94	8	responded	respond	VERB
dpc-4515	94	9	positively	positively	ADV
dpc-4515	94	10	to	to	ADP
dpc-4515	94	11	first	first	ADJ
dpc-4515	94	12	-	-	PUNCT
dpc-4515	94	13	line	line	NOUN
dpc-4515	94	14	treatments	treatment	NOUN
dpc-4515	94	15	.	.	PUNCT
dpc-4515	95	1	conversely	conversely	ADV
dpc-4515	95	2	,	,	PUNCT
dpc-4515	95	3	as	as	SCONJ
dpc-4515	95	4	agarwal	agarwal	PROPN
dpc-4515	95	5	et	et	PROPN
dpc-4515	95	6	al	al	PROPN
dpc-4515	95	7	.	.	PROPN
dpc-4515	95	8	also	also	ADV
dpc-4515	95	9	observed	observe	VERB
dpc-4515	95	10	,	,	PUNCT
dpc-4515	95	11	patients	patient	NOUN
dpc-4515	95	12	with	with	ADP
dpc-4515	95	13	ibd	ibd	NOUN
dpc-4515	95	14	and	and	CCONJ
dpc-4515	95	15	hematologic	hematologic	NOUN
dpc-4515	95	16	comorbidities	comorbiditie	NOUN
dpc-4515	95	17	required	require	VERB
dpc-4515	95	18	biologic	biologic	NOUN
dpc-4515	95	19	agents	agent	NOUN
dpc-4515	95	20	to	to	PART
dpc-4515	95	21	control	control	VERB
dpc-4515	95	22	their	their	PRON
dpc-4515	95	23	lesions	lesion	NOUN
dpc-4515	95	24	[	[	X
dpc-4515	95	25	13	13	NUM
dpc-4515	95	26	]	]	PUNCT
dpc-4515	95	27	.	.	PUNCT
dpc-4515	96	1	the	the	DET
dpc-4515	96	2	associated	associated	ADJ
dpc-4515	96	3	disease	disease	NOUN
dpc-4515	96	4	can	can	AUX
dpc-4515	96	5	precede	precede	VERB
dpc-4515	96	6	,	,	PUNCT
dpc-4515	96	7	coexist	coexist	VERB
dpc-4515	96	8	,	,	PUNCT
dpc-4515	96	9	or	or	CCONJ
dpc-4515	96	10	follow	follow	VERB
dpc-4515	96	11	pg	pg	PROPN
dpc-4515	97	1	[	[	X
dpc-4515	97	2	4,10,14	4,10,14	NUM
dpc-4515	97	3	]	]	PUNCT
dpc-4515	97	4	.	.	PUNCT
dpc-4515	98	1	systemic	systemic	ADJ
dpc-4515	98	2	disorders	disorder	NOUN
dpc-4515	98	3	started	start	VERB
dpc-4515	98	4	,	,	PUNCT
dpc-4515	98	5	for	for	ADP
dpc-4515	98	6	most	most	ADJ
dpc-4515	98	7	of	of	ADP
dpc-4515	98	8	our	our	PRON
dpc-4515	98	9	patients	patient	NOUN
dpc-4515	98	10	,	,	PUNCT
dpc-4515	98	11	within	within	ADP
dpc-4515	98	12	one	one	NUM
dpc-4515	98	13	year	year	NOUN
dpc-4515	98	14	before	before	ADV
dpc-4515	98	15	and	and	CCONJ
dpc-4515	98	16	one	one	NUM
dpc-4515	98	17	year	year	NOUN
dpc-4515	98	18	after	after	SCONJ
dpc-4515	98	19	pg	pg	PROPN
dpc-4515	98	20	was	be	AUX
dpc-4515	98	21	diagnosed	diagnose	VERB
dpc-4515	98	22	.	.	PUNCT
dpc-4515	99	1	based	base	VERB
dpc-4515	99	2	on	on	ADP
dpc-4515	99	3	our	our	PRON
dpc-4515	99	4	findings	finding	NOUN
dpc-4515	99	5	and	and	CCONJ
dpc-4515	99	6	on	on	ADP
dpc-4515	99	7	the	the	DET
dpc-4515	99	8	existing	exist	VERB
dpc-4515	99	9	literature	literature	NOUN
dpc-4515	99	10	,	,	PUNCT
dpc-4515	99	11	conducting	conduct	VERB
dpc-4515	99	12	a	a	DET
dpc-4515	99	13	thorough	thorough	ADJ
dpc-4515	99	14	investigation	investigation	NOUN
dpc-4515	99	15	for	for	ADP
dpc-4515	99	16	ibd	ibd	NOUN
dpc-4515	99	17	and	and	CCONJ
dpc-4515	99	18	hematologic	hematologic	NOUN
dpc-4515	99	19	conditions	condition	NOUN
dpc-4515	99	20	in	in	ADP
dpc-4515	99	21	patients	patient	NOUN
dpc-4515	99	22	diagnosed	diagnose	VERB
dpc-4515	99	23	with	with	ADP
dpc-4515	99	24	pg	pg	PROPN
dpc-4515	99	25	is	be	AUX
dpc-4515	99	26	recommended	recommend	VERB
dpc-4515	99	27	.	.	PUNCT
dpc-4515	100	1	indeed	indeed	ADV
dpc-4515	100	2	,	,	PUNCT
dpc-4515	100	3	we	we	PRON
dpc-4515	100	4	suggest	suggest	VERB
dpc-4515	100	5	extending	extend	VERB
dpc-4515	100	6	the	the	DET
dpc-4515	100	7	observation	observation	NOUN
dpc-4515	100	8	period	period	NOUN
dpc-4515	100	9	to	to	ADP
dpc-4515	100	10	at	at	ADV
dpc-4515	100	11	least	least	ADV
dpc-4515	100	12	two	two	NUM
dpc-4515	100	13	years	year	NOUN
dpc-4515	100	14	post	post	ADJ
dpc-4515	100	15	-	-	NOUN
dpc-4515	100	16	diagnosis	diagnosis	NOUN
dpc-4515	100	17	,	,	PUNCT
dpc-4515	100	18	although	although	SCONJ
dpc-4515	100	19	there	there	PRON
dpc-4515	100	20	is	be	VERB
dpc-4515	100	21	a	a	DET
dpc-4515	100	22	lack	lack	NOUN
dpc-4515	100	23	of	of	ADP
dpc-4515	100	24	consensus	consensus	NOUN
dpc-4515	100	25	regarding	regard	VERB
dpc-4515	100	26	the	the	DET
dpc-4515	100	27	criteria	criterion	NOUN
dpc-4515	100	28	for	for	ADP
dpc-4515	100	29	the	the	DET
dpc-4515	100	30	duration	duration	NOUN
dpc-4515	100	31	and	and	CCONJ
dpc-4515	100	32	frequency	frequency	NOUN
dpc-4515	100	33	of	of	ADP
dpc-4515	100	34	follow	follow	NOUN
dpc-4515	100	35	-	-	PUNCT
dpc-4515	100	36	up	up	NOUN
dpc-4515	100	37	[	[	X
dpc-4515	100	38	15	15	NUM
dpc-4515	100	39	]	]	PUNCT
dpc-4515	100	40	.	.	PUNCT
dpc-4515	101	1	we	we	PRON
dpc-4515	101	2	noticed	notice	VERB
dpc-4515	101	3	that	that	SCONJ
dpc-4515	101	4	obesity	obesity	NOUN
dpc-4515	101	5	reduced	reduce	VERB
dpc-4515	101	6	the	the	DET
dpc-4515	101	7	therapeutic	therapeutic	ADJ
dpc-4515	101	8	response	response	NOUN
dpc-4515	101	9	,	,	PUNCT
dpc-4515	101	10	as	as	ADP
dpc-4515	101	11	in	in	ADP
dpc-4515	101	12	other	other	ADJ
dpc-4515	101	13	inflammatory	inflammatory	ADJ
dpc-4515	101	14	dermatosis	dermatosis	NOUN
dpc-4515	101	15	such	such	ADJ
dpc-4515	101	16	as	as	ADP
dpc-4515	101	17	psoriasis	psoriasis	NOUN
dpc-4515	101	18	.	.	PUNCT
dpc-4515	102	1	in	in	ADP
dpc-4515	102	2	our	our	PRON
dpc-4515	102	3	opinion	opinion	NOUN
dpc-4515	102	4	,	,	PUNCT
dpc-4515	102	5	this	this	PRON
dpc-4515	102	6	may	may	AUX
dpc-4515	102	7	be	be	AUX
dpc-4515	102	8	due	due	ADJ
dpc-4515	102	9	to	to	ADP
dpc-4515	102	10	the	the	DET
dpc-4515	102	11	higher	high	ADJ
dpc-4515	102	12	levels	level	NOUN
dpc-4515	102	13	of	of	ADP
dpc-4515	102	14	proinflammatory	proinflammatory	ADJ
dpc-4515	102	15	cytokines	cytokine	NOUN
dpc-4515	102	16	in	in	ADP
dpc-4515	102	17	obese	obese	ADJ
dpc-4515	102	18	patients	patient	NOUN
dpc-4515	102	19	.	.	PUNCT
dpc-4515	103	1	instead	instead	ADV
dpc-4515	103	2	,	,	PUNCT
dpc-4515	103	3	we	we	PRON
dpc-4515	103	4	saw	see	VERB
dpc-4515	103	5	no	no	DET
dpc-4515	103	6	increase	increase	NOUN
dpc-4515	103	7	in	in	ADP
dpc-4515	103	8	pg	pg	PROPN
dpc-4515	103	9	diagnoses	diagnosis	NOUN
dpc-4515	103	10	following	follow	VERB
dpc-4515	103	11	the	the	DET
dpc-4515	103	12	onset	onset	NOUN
dpc-4515	103	13	of	of	ADP
dpc-4515	103	14	the	the	DET
dpc-4515	103	15	covid-19	covid-19	PROPN
dpc-4515	103	16	pandemic	pandemic	NOUN
dpc-4515	103	17	,	,	PUNCT
dpc-4515	103	18	consistent	consistent	ADJ
dpc-4515	103	19	with	with	ADP
dpc-4515	103	20	previous	previous	ADJ
dpc-4515	103	21	findings	finding	NOUN
dpc-4515	103	22	[	[	X
dpc-4515	103	23	16	16	NUM
dpc-4515	103	24	]	]	PUNCT
dpc-4515	103	25	.	.	PUNCT
dpc-4515	104	1	the	the	DET
dpc-4515	104	2	anatomical	anatomical	ADJ
dpc-4515	104	3	predilection	predilection	NOUN
dpc-4515	104	4	for	for	ADP
dpc-4515	104	5	lower	low	ADJ
dpc-4515	104	6	extremity	extremity	NOUN
dpc-4515	104	7	involvement	involvement	NOUN
dpc-4515	104	8	in	in	ADP
dpc-4515	104	9	pg	pg	PROPN
dpc-4515	104	10	,	,	PUNCT
dpc-4515	104	11	observed	observe	VERB
dpc-4515	104	12	in	in	ADP
dpc-4515	104	13	our	our	PRON
dpc-4515	104	14	study	study	NOUN
dpc-4515	104	15	,	,	PUNCT
dpc-4515	104	16	is	be	AUX
dpc-4515	104	17	consistent	consistent	ADJ
dpc-4515	104	18	with	with	ADP
dpc-4515	104	19	prior	prior	ADJ
dpc-4515	104	20	reports	report	NOUN
dpc-4515	104	21	and	and	CCONJ
dpc-4515	104	22	suggests	suggest	VERB
dpc-4515	104	23	potential	potential	ADJ
dpc-4515	104	24	contributing	contribute	VERB
dpc-4515	104	25	factors	factor	NOUN
dpc-4515	104	26	such	such	ADJ
dpc-4515	104	27	as	as	ADP
dpc-4515	104	28	trauma	trauma	NOUN
dpc-4515	104	29	,	,	PUNCT
dpc-4515	104	30	vascular	vascular	ADJ
dpc-4515	104	31	insufficiency	insufficiency	NOUN
dpc-4515	104	32	,	,	PUNCT
dpc-4515	104	33	or	or	CCONJ
dpc-4515	104	34	localized	localized	ADJ
dpc-4515	104	35	immune	immune	ADJ
dpc-4515	104	36	dysregulation	dysregulation	NOUN
dpc-4515	104	37	,	,	PUNCT
dpc-4515	104	38	which	which	PRON
dpc-4515	104	39	warrant	warrant	VERB
dpc-4515	104	40	further	further	ADJ
dpc-4515	104	41	investigation	investigation	NOUN
dpc-4515	104	42	[	[	X
dpc-4515	104	43	17	17	NUM
dpc-4515	104	44	,	,	PUNCT
dpc-4515	104	45	18	18	NUM
dpc-4515	104	46	]	]	PUNCT
dpc-4515	104	47	.	.	PUNCT
dpc-4515	105	1	furthermore	furthermore	ADV
dpc-4515	105	2	,	,	PUNCT
dpc-4515	105	3	five	five	NUM
dpc-4515	105	4	of	of	ADP
dpc-4515	105	5	the	the	DET
dpc-4515	105	6	six	six	NUM
dpc-4515	105	7	patients	patient	NOUN
dpc-4515	105	8	treated	treat	VERB
dpc-4515	105	9	with	with	ADP
dpc-4515	105	10	biological	biological	ADJ
dpc-4515	105	11	therapy	therapy	NOUN
dpc-4515	105	12	presented	present	VERB
dpc-4515	105	13	pg	pg	VERB
dpc-4515	105	14	localized	localize	VERB
dpc-4515	105	15	to	to	ADP
dpc-4515	105	16	lower	low	ADJ
dpc-4515	105	17	extremities	extremity	NOUN
dpc-4515	105	18	.	.	PUNCT
dpc-4515	106	1	we	we	PRON
dpc-4515	106	2	hypothesize	hypothesize	VERB
dpc-4515	106	3	that	that	SCONJ
dpc-4515	106	4	,	,	PUNCT
dpc-4515	106	5	as	as	ADP
dpc-4515	106	6	in	in	ADP
dpc-4515	106	7	other	other	ADJ
dpc-4515	106	8	inflammatory	inflammatory	ADJ
dpc-4515	106	9	skin	skin	NOUN
dpc-4515	106	10	conditions	condition	NOUN
dpc-4515	106	11	,	,	PUNCT
dpc-4515	106	12	there	there	PRON
dpc-4515	106	13	is	be	VERB
dpc-4515	106	14	a	a	DET
dpc-4515	106	15	heightened	heightened	ADJ
dpc-4515	106	16	concentration	concentration	NOUN
dpc-4515	106	17	of	of	ADP
dpc-4515	106	18	resident	resident	ADJ
dpc-4515	106	19	t	t	PROPN
dpc-4515	106	20	lymphocytes	lymphocyte	NOUN
dpc-4515	106	21	and	and	CCONJ
dpc-4515	106	22	memory	memory	NOUN
dpc-4515	106	23	t	t	NOUN
dpc-4515	106	24	cells	cell	NOUN
dpc-4515	106	25	in	in	ADP
dpc-4515	106	26	the	the	DET
dpc-4515	106	27	legs	leg	NOUN
dpc-4515	106	28	.	.	PUNCT
dpc-4515	107	1	this	this	PRON
dpc-4515	107	2	can	can	AUX
dpc-4515	107	3	be	be	AUX
dpc-4515	107	4	one	one	NUM
dpc-4515	107	5	of	of	ADP
dpc-4515	107	6	the	the	DET
dpc-4515	107	7	causes	cause	NOUN
dpc-4515	107	8	for	for	ADP
dpc-4515	107	9	a	a	DET
dpc-4515	107	10	lower	low	ADJ
dpc-4515	107	11	response	response	NOUN
dpc-4515	107	12	to	to	ADP
dpc-4515	107	13	the	the	DET
dpc-4515	107	14	first	first	ADJ
dpc-4515	107	15	-	-	PUNCT
dpc-4515	107	16	line	line	NOUN
dpc-4515	107	17	therapies	therapy	NOUN
dpc-4515	107	18	[	[	X
dpc-4515	107	19	19	19	NUM
dpc-4515	107	20	]	]	PUNCT
dpc-4515	107	21	.	.	PUNCT
dpc-4515	108	1	patients	patient	NOUN
dpc-4515	108	2	completely	completely	ADV
dpc-4515	108	3	healed	heal	VERB
dpc-4515	108	4	.	.	PUNCT
dpc-4515	109	1	eleven	eleven	NUM
dpc-4515	109	2	(	(	PUNCT
dpc-4515	109	3	25	25	NUM
dpc-4515	109	4	%	%	NOUN
dpc-4515	109	5	)	)	PUNCT
dpc-4515	109	6	patients	patient	NOUN
dpc-4515	109	7	recovered	recover	VERB
dpc-4515	109	8	thanks	thank	NOUN
dpc-4515	109	9	to	to	ADP
dpc-4515	109	10	high	high	ADJ
dpc-4515	109	11	-	-	PUNCT
dpc-4515	109	12	potency	potency	NOUN
dpc-4515	109	13	topical	topical	ADJ
dpc-4515	109	14	steroid	steroid	NOUN
dpc-4515	109	15	and	and	CCONJ
dpc-4515	109	16	advanced	advanced	ADJ
dpc-4515	109	17	dressing	dressing	NOUN
dpc-4515	109	18	,	,	PUNCT
dpc-4515	109	19	six	six	NUM
dpc-4515	109	20	(	(	PUNCT
dpc-4515	109	21	13.6	13.6	NUM
dpc-4515	109	22	%	%	NOUN
dpc-4515	109	23	)	)	PUNCT
dpc-4515	109	24	with	with	ADP
dpc-4515	109	25	both	both	CCONJ
dpc-4515	109	26	topical	topical	ADJ
dpc-4515	109	27	and	and	CCONJ
dpc-4515	109	28	oral	oral	ADJ
dpc-4515	109	29	steroids	steroid	NOUN
dpc-4515	109	30	.	.	PUNCT
dpc-4515	110	1	five	five	NUM
dpc-4515	110	2	patients	patient	NOUN
dpc-4515	110	3	(	(	PUNCT
dpc-4515	110	4	11.4	11.4	NUM
dpc-4515	110	5	%	%	NOUN
dpc-4515	110	6	)	)	PUNCT
dpc-4515	110	7	recovered	recover	VERB
dpc-4515	110	8	with	with	ADP
dpc-4515	110	9	non	non	ADJ
dpc-4515	110	10	-	-	ADJ
dpc-4515	110	11	steroid	steroid	ADJ
dpc-4515	110	12	immunosuppressants	immunosuppressant	NOUN
dpc-4515	110	13	,	,	PUNCT
dpc-4515	110	14	one	one	NUM
dpc-4515	110	15	of	of	ADP
dpc-4515	110	16	whom	whom	PRON
dpc-4515	110	17	also	also	ADV
dpc-4515	110	18	receiving	receive	VERB
dpc-4515	110	19	one	one	NUM
dpc-4515	110	20	cycle	cycle	NOUN
dpc-4515	110	21	of	of	ADP
dpc-4515	110	22	rituximab	rituximab	NOUN
dpc-4515	110	23	(	(	PUNCT
dpc-4515	110	24	1	1	NUM
dpc-4515	110	25	g	g	NOUN
dpc-4515	110	26	at	at	ADP
dpc-4515	110	27	day	day	NOUN
dpc-4515	110	28	0	0	NUM
dpc-4515	110	29	and	and	CCONJ
dpc-4515	110	30	1	1	NUM
dpc-4515	110	31	g	g	NOUN
dpc-4515	110	32	at	at	ADP
dpc-4515	110	33	day	day	NOUN
dpc-4515	110	34	15	15	NUM
dpc-4515	110	35	)	)	PUNCT
dpc-4515	110	36	.	.	PUNCT
dpc-4515	111	1	a	a	DET
dpc-4515	111	2	total	total	NOUN
dpc-4515	111	3	of	of	ADP
dpc-4515	111	4	six	six	NUM
dpc-4515	111	5	patients	patient	NOUN
dpc-4515	111	6	presented	present	VERB
dpc-4515	111	7	no	no	DET
dpc-4515	111	8	clinical	clinical	ADJ
dpc-4515	111	9	improvement	improvement	NOUN
dpc-4515	111	10	or	or	CCONJ
dpc-4515	111	11	worsening	worsening	NOUN
dpc-4515	111	12	of	of	ADP
dpc-4515	111	13	the	the	DET
dpc-4515	111	14	disease	disease	NOUN
dpc-4515	111	15	and	and	CCONJ
dpc-4515	111	16	had	have	VERB
dpc-4515	111	17	to	to	PART
dpc-4515	111	18	shift	shift	VERB
dpc-4515	111	19	to	to	ADP
dpc-4515	111	20	biologic	biologic	NOUN
dpc-4515	111	21	agents	agent	NOUN
dpc-4515	111	22	to	to	PART
dpc-4515	111	23	control	control	VERB
dpc-4515	111	24	their	their	PRON
dpc-4515	111	25	pg	pg	NOUN
dpc-4515	111	26	.	.	PUNCT
dpc-4515	111	27	adalimumab	adalimumab	PROPN
dpc-4515	111	28	was	be	AUX
dpc-4515	111	29	used	use	VERB
dpc-4515	111	30	as	as	ADP
dpc-4515	111	31	firstline	firstline	ADJ
dpc-4515	111	32	biological	biological	ADJ
dpc-4515	111	33	therapy	therapy	NOUN
dpc-4515	111	34	in	in	ADP
dpc-4515	111	35	five	five	NUM
dpc-4515	111	36	patients	patient	NOUN
dpc-4515	111	37	,	,	PUNCT
dpc-4515	111	38	administered	administer	VERB
dpc-4515	111	39	at	at	ADP
dpc-4515	111	40	an	an	DET
dpc-4515	111	41	initial	initial	ADJ
dpc-4515	111	42	dose	dose	NOUN
dpc-4515	111	43	of	of	ADP
dpc-4515	111	44	80	80	NUM
dpc-4515	111	45	mg	mg	PROPN
dpc-4515	111	46	,	,	PUNCT
dpc-4515	111	47	followed	follow	VERB
dpc-4515	111	48	by	by	ADP
dpc-4515	111	49	40	40	NUM
dpc-4515	111	50	mg	mg	NOUN
dpc-4515	111	51	every	every	DET
dpc-4515	111	52	2	2	NUM
dpc-4515	111	53	weeks	week	NOUN
dpc-4515	111	54	(	(	PUNCT
dpc-4515	111	55	if	if	SCONJ
dpc-4515	111	56	body	body	NOUN
dpc-4515	111	57	weight	weight	NOUN
dpc-4515	111	58	was	be	AUX
dpc-4515	111	59	over	over	ADP
dpc-4515	111	60	90	90	NUM
dpc-4515	111	61	kg	kg	NOUN
dpc-4515	111	62	,	,	PUNCT
dpc-4515	111	63	the	the	DET
dpc-4515	111	64	dose	dose	NOUN
dpc-4515	111	65	was	be	AUX
dpc-4515	111	66	doubled	double	VERB
dpc-4515	111	67	)	)	PUNCT
dpc-4515	111	68	.	.	PUNCT
dpc-4515	112	1	one	one	NUM
dpc-4515	112	2	patient	patient	NOUN
dpc-4515	112	3	with	with	ADP
dpc-4515	112	4	a	a	DET
dpc-4515	112	5	positive	positive	ADJ
dpc-4515	112	6	quantiferon	quantiferon	PROPN
dpc-4515	112	7	test	test	NOUN
dpc-4515	112	8	was	be	AUX
dpc-4515	112	9	treated	treat	VERB
dpc-4515	112	10	with	with	ADP
dpc-4515	112	11	secukinumab	secukinumab	NOUN
dpc-4515	112	12	administered	administer	VERB
dpc-4515	112	13	at	at	ADP
dpc-4515	112	14	an	an	DET
dpc-4515	112	15	initial	initial	ADJ
dpc-4515	112	16	dose	dose	NOUN
dpc-4515	112	17	of	of	ADP
dpc-4515	112	18	600	600	NUM
dpc-4515	112	19	mg	mg	PROPN
dpc-4515	112	20	,	,	PUNCT
dpc-4515	112	21	followed	follow	VERB
dpc-4515	112	22	by	by	ADP
dpc-4515	112	23	300	300	NUM
dpc-4515	112	24	mg	mg	NOUN
dpc-4515	112	25	every	every	DET
dpc-4515	112	26	two	two	NUM
dpc-4515	112	27	weeks	week	NOUN
dpc-4515	112	28	.	.	PUNCT
dpc-4515	113	1	the	the	DET
dpc-4515	113	2	biological	biological	ADJ
dpc-4515	113	3	treatment	treatment	NOUN
dpc-4515	113	4	is	be	AUX
dpc-4515	113	5	ongoing	ongoing	ADJ
dpc-4515	113	6	for	for	ADP
dpc-4515	113	7	these	these	DET
dpc-4515	113	8	six	six	NUM
dpc-4515	113	9	patients	patient	NOUN
dpc-4515	113	10	,	,	PUNCT
dpc-4515	113	11	with	with	ADP
dpc-4515	113	12	partial	partial	ADJ
dpc-4515	113	13	improvement	improvement	NOUN
dpc-4515	113	14	of	of	ADP
dpc-4515	113	15	the	the	DET
dpc-4515	113	16	pg	pg	NOUN
dpc-4515	113	17	lesions	lesion	NOUN
dpc-4515	113	18	.	.	PUNCT
dpc-4515	114	1	discussion	discussion	NOUN
dpc-4515	114	2	our	our	PRON
dpc-4515	114	3	retrospective	retrospective	ADJ
dpc-4515	114	4	case	case	NOUN
dpc-4515	114	5	series	series	NOUN
dpc-4515	114	6	of	of	ADP
dpc-4515	114	7	44	44	NUM
dpc-4515	114	8	patients	patient	NOUN
dpc-4515	114	9	with	with	ADP
dpc-4515	114	10	pg	pg	PROPN
dpc-4515	114	11	offers	offer	VERB
dpc-4515	114	12	a	a	DET
dpc-4515	114	13	nuanced	nuanced	ADJ
dpc-4515	114	14	perspective	perspective	NOUN
dpc-4515	114	15	on	on	ADP
dpc-4515	114	16	the	the	DET
dpc-4515	114	17	demographics	demographic	NOUN
dpc-4515	114	18	,	,	PUNCT
dpc-4515	114	19	clinical	clinical	ADJ
dpc-4515	114	20	manifestations	manifestation	NOUN
dpc-4515	114	21	,	,	PUNCT
dpc-4515	114	22	treatment	treatment	NOUN
dpc-4515	114	23	responses	response	NOUN
dpc-4515	114	24	,	,	PUNCT
dpc-4515	114	25	and	and	CCONJ
dpc-4515	114	26	associated	associated	ADJ
dpc-4515	114	27	comorbidities	comorbiditie	NOUN
dpc-4515	114	28	of	of	ADP
dpc-4515	114	29	this	this	DET
dpc-4515	114	30	troublesome	troublesome	ADJ
dpc-4515	114	31	dermatological	dermatological	ADJ
dpc-4515	114	32	condition	condition	NOUN
dpc-4515	114	33	.	.	PUNCT
dpc-4515	115	1	in	in	ADP
dpc-4515	115	2	line	line	NOUN
dpc-4515	115	3	with	with	ADP
dpc-4515	115	4	the	the	DET
dpc-4515	115	5	existing	exist	VERB
dpc-4515	115	6	literature	literature	NOUN
dpc-4515	115	7	,	,	PUNCT
dpc-4515	115	8	we	we	PRON
dpc-4515	115	9	found	find	VERB
dpc-4515	115	10	a	a	DET
dpc-4515	115	11	slight	slight	ADJ
dpc-4515	115	12	female	female	ADJ
dpc-4515	115	13	predominance	predominance	NOUN
dpc-4515	115	14	,	,	PUNCT
dpc-4515	115	15	without	without	ADP
dpc-4515	115	16	a	a	DET
dpc-4515	115	17	significant	significant	ADJ
dpc-4515	115	18	difference	difference	NOUN
dpc-4515	115	19	between	between	ADP
dpc-4515	115	20	sexes	sex	NOUN
dpc-4515	115	21	[	[	X
dpc-4515	115	22	7	7	NUM
dpc-4515	115	23	-	-	SYM
dpc-4515	115	24	9	9	NUM
dpc-4515	115	25	]	]	PUNCT
dpc-4515	115	26	.	.	PUNCT
dpc-4515	116	1	this	this	DET
dpc-4515	116	2	result	result	NOUN
dpc-4515	116	3	,	,	PUNCT
dpc-4515	116	4	aligning	align	VERB
dpc-4515	116	5	with	with	ADP
dpc-4515	116	6	previous	previous	ADJ
dpc-4515	116	7	reports	report	NOUN
dpc-4515	116	8	,	,	PUNCT
dpc-4515	116	9	raises	raise	VERB
dpc-4515	116	10	intriguing	intriguing	ADJ
dpc-4515	116	11	questions	question	NOUN
dpc-4515	116	12	about	about	ADP
dpc-4515	116	13	the	the	DET
dpc-4515	116	14	potential	potential	ADJ
dpc-4515	116	15	role	role	NOUN
dpc-4515	116	16	of	of	ADP
dpc-4515	116	17	hormonal	hormonal	ADJ
dpc-4515	116	18	,	,	PUNCT
dpc-4515	116	19	genetic	genetic	ADJ
dpc-4515	116	20	,	,	PUNCT
dpc-4515	116	21	or	or	CCONJ
dpc-4515	116	22	immunological	immunological	ADJ
dpc-4515	116	23	factors	factor	NOUN
dpc-4515	116	24	that	that	PRON
dpc-4515	116	25	might	might	AUX
dpc-4515	116	26	predispose	predispose	VERB
dpc-4515	116	27	females	female	NOUN
dpc-4515	116	28	to	to	PART
dpc-4515	116	29	pg	pg	VERB
dpc-4515	116	30	.	.	PUNCT
dpc-4515	117	1	this	this	PRON
dpc-4515	117	2	underscores	underscore	VERB
dpc-4515	117	3	the	the	DET
dpc-4515	117	4	need	need	NOUN
dpc-4515	117	5	for	for	ADP
dpc-4515	117	6	a	a	DET
dpc-4515	117	7	deeper	deep	ADJ
dpc-4515	117	8	exploration	exploration	NOUN
dpc-4515	117	9	into	into	ADP
dpc-4515	117	10	the	the	DET
dpc-4515	117	11	underlying	underlie	VERB
dpc-4515	117	12	mechanisms	mechanism	NOUN
dpc-4515	117	13	,	,	PUNCT
dpc-4515	117	14	including	include	VERB
dpc-4515	117	15	potential	potential	ADJ
dpc-4515	117	16	biases	bias	NOUN
dpc-4515	117	17	in	in	ADP
dpc-4515	117	18	diagnosis	diagnosis	NOUN
dpc-4515	117	19	or	or	CCONJ
dpc-4515	117	20	referral	referral	ADJ
dpc-4515	117	21	patterns	pattern	NOUN
dpc-4515	117	22	that	that	PRON
dpc-4515	117	23	might	might	AUX
dpc-4515	117	24	contribute	contribute	VERB
dpc-4515	117	25	to	to	ADP
dpc-4515	117	26	this	this	DET
dpc-4515	117	27	observation	observation	NOUN
dpc-4515	117	28	.	.	PUNCT
dpc-4515	118	1	our	our	PRON
dpc-4515	118	2	study	study	NOUN
dpc-4515	118	3	confirms	confirm	VERB
dpc-4515	118	4	that	that	SCONJ
dpc-4515	118	5	pg	pg	PROPN
dpc-4515	118	6	occurs	occur	VERB
dpc-4515	118	7	in	in	ADP
dpc-4515	118	8	most	most	ADJ
dpc-4515	118	9	cases	case	NOUN
dpc-4515	118	10	in	in	ADP
dpc-4515	118	11	older	old	ADJ
dpc-4515	118	12	individuals	individual	NOUN
dpc-4515	118	13	[	[	X
dpc-4515	118	14	9	9	NUM
dpc-4515	118	15	]	]	PUNCT
dpc-4515	118	16	.	.	PUNCT
dpc-4515	119	1	our	our	PRON
dpc-4515	119	2	data	datum	NOUN
dpc-4515	119	3	also	also	ADV
dpc-4515	119	4	reinforce	reinforce	VERB
dpc-4515	119	5	the	the	DET
dpc-4515	119	6	strong	strong	ADJ
dpc-4515	119	7	link	link	NOUN
dpc-4515	119	8	between	between	ADP
dpc-4515	119	9	pg	pg	PROPN
dpc-4515	119	10	and	and	CCONJ
dpc-4515	119	11	ibd	ibd	PROPN
dpc-4515	119	12	,	,	PUNCT
dpc-4515	119	13	such	such	ADJ
dpc-4515	119	14	as	as	ADP
dpc-4515	119	15	crohn	crohn	PROPN
dpc-4515	119	16	’s	’s	PART
dpc-4515	119	17	disease	disease	NOUN
dpc-4515	119	18	and	and	CCONJ
dpc-4515	119	19	ulcerative	ulcerative	ADJ
dpc-4515	119	20	colitis	colitis	NOUN
dpc-4515	119	21	,	,	PUNCT
dpc-4515	119	22	which	which	PRON
dpc-4515	119	23	is	be	AUX
dpc-4515	119	24	consistent	consistent	ADJ
dpc-4515	119	25	with	with	ADP
dpc-4515	119	26	the	the	DET
dpc-4515	119	27	literature	literature	NOUN
dpc-4515	119	28	,	,	PUNCT
dpc-4515	119	29	which	which	PRON
dpc-4515	119	30	that	that	PRON
dpc-4515	119	31	reports	report	VERB
dpc-4515	119	32	a	a	DET
dpc-4515	119	33	20%-30	20%-30	NUM
dpc-4515	119	34	%	%	NOUN
dpc-4515	119	35	prevalence	prevalence	NOUN
dpc-4515	119	36	.	.	PUNCT
dpc-4515	120	1	this	this	DET
dpc-4515	120	2	association	association	NOUN
dpc-4515	120	3	underscores	underscore	VERB
dpc-4515	120	4	the	the	DET
dpc-4515	120	5	systemic	systemic	ADJ
dpc-4515	120	6	nature	nature	NOUN
dpc-4515	120	7	of	of	ADP
dpc-4515	120	8	pg	pg	PROPN
dpc-4515	120	9	and	and	CCONJ
dpc-4515	120	10	its	its	PRON
dpc-4515	120	11	potential	potential	ADJ
dpc-4515	120	12	pathophysiological	pathophysiological	ADJ
dpc-4515	120	13	overlap	overlap	NOUN
dpc-4515	120	14	with	with	ADP
dpc-4515	120	15	other	other	ADJ
dpc-4515	120	16	inflammatory	inflammatory	ADJ
dpc-4515	120	17	conditions	condition	NOUN
dpc-4515	120	18	.	.	PUNCT
dpc-4515	121	1	table	table	NOUN
dpc-4515	121	2	1	1	NUM
dpc-4515	121	3	.	.	PUNCT
dpc-4515	122	1	demographics	demographic	NOUN
dpc-4515	122	2	and	and	CCONJ
dpc-4515	122	3	comorbidities	comorbiditie	NOUN
dpc-4515	122	4	of	of	ADP
dpc-4515	122	5	pyoderma	pyoderma	NOUN
dpc-4515	122	6	gangrenosum	gangrenosum	NOUN
dpc-4515	122	7	patients	patient	NOUN
dpc-4515	122	8	.	.	PUNCT
dpc-4515	123	1	comorbidities	comorbiditie	NOUN
dpc-4515	123	2	males	male	VERB
dpc-4515	123	3	females	female	NOUN
dpc-4515	123	4	total	total	VERB
dpc-4515	123	5	ulcerative	ulcerative	ADJ
dpc-4515	123	6	colitis	colitis	NOUN
dpc-4515	123	7	1	1	NUM
dpc-4515	123	8	(	(	PUNCT
dpc-4515	123	9	2.3	2.3	NUM
dpc-4515	123	10	%	%	NOUN
dpc-4515	123	11	)	)	PUNCT
dpc-4515	123	12	5	5	NUM
dpc-4515	123	13	(	(	PUNCT
dpc-4515	123	14	11.4	11.4	NUM
dpc-4515	123	15	%	%	NOUN
dpc-4515	123	16	)	)	PUNCT
dpc-4515	123	17	6	6	NUM
dpc-4515	123	18	(	(	PUNCT
dpc-4515	123	19	13.6	13.6	NUM
dpc-4515	123	20	%	%	NOUN
dpc-4515	123	21	)	)	PUNCT
dpc-4515	123	22	chron	chron	NOUN
dpc-4515	123	23	3	3	NUM
dpc-4515	123	24	(	(	PUNCT
dpc-4515	123	25	6.9	6.9	NUM
dpc-4515	123	26	%	%	NOUN
dpc-4515	123	27	)	)	PUNCT
dpc-4515	123	28	3	3	NUM
dpc-4515	123	29	(	(	PUNCT
dpc-4515	123	30	6.9	6.9	NUM
dpc-4515	123	31	%	%	NOUN
dpc-4515	123	32	)	)	PUNCT
dpc-4515	123	33	6	6	NUM
dpc-4515	123	34	(	(	PUNCT
dpc-4515	123	35	13.6	13.6	NUM
dpc-4515	123	36	%	%	NOUN
dpc-4515	123	37	)	)	PUNCT
dpc-4515	123	38	mgus	mgus	ADJ
dpc-4515	123	39	1	1	NUM
dpc-4515	123	40	(	(	PUNCT
dpc-4515	123	41	2.3	2.3	NUM
dpc-4515	123	42	%	%	NOUN
dpc-4515	123	43	)	)	PUNCT
dpc-4515	123	44	4	4	NUM
dpc-4515	123	45	(	(	PUNCT
dpc-4515	123	46	9.1	9.1	NUM
dpc-4515	123	47	%	%	NOUN
dpc-4515	123	48	)	)	PUNCT
dpc-4515	123	49	5	5	NUM
dpc-4515	123	50	(	(	PUNCT
dpc-4515	123	51	11.4	11.4	NUM
dpc-4515	123	52	%	%	NOUN
dpc-4515	123	53	)	)	PUNCT
dpc-4515	123	54	hematological	hematological	ADJ
dpc-4515	123	55	malignancies	malignancy	NOUN
dpc-4515	123	56	2	2	NUM
dpc-4515	123	57	(	(	PUNCT
dpc-4515	123	58	4.6	4.6	NUM
dpc-4515	123	59	%	%	NOUN
dpc-4515	123	60	)	)	PUNCT
dpc-4515	123	61	1	1	NUM
dpc-4515	123	62	(	(	PUNCT
dpc-4515	123	63	2.3	2.3	NUM
dpc-4515	123	64	%	%	NOUN
dpc-4515	123	65	)	)	PUNCT
dpc-4515	123	66	3	3	NUM
dpc-4515	123	67	(	(	PUNCT
dpc-4515	123	68	6.9	6.9	NUM
dpc-4515	123	69	%	%	NOUN
dpc-4515	123	70	)	)	PUNCT
dpc-4515	123	71	rheumatoid	rheumatoid	VERB
dpc-4515	123	72	arthritis	arthritis	NOUN
dpc-4515	123	73	1	1	NUM
dpc-4515	123	74	(	(	PUNCT
dpc-4515	123	75	2.3	2.3	NUM
dpc-4515	123	76	%	%	NOUN
dpc-4515	123	77	)	)	PUNCT
dpc-4515	123	78	2	2	NUM
dpc-4515	123	79	(	(	PUNCT
dpc-4515	123	80	4.6	4.6	NUM
dpc-4515	123	81	%	%	NOUN
dpc-4515	123	82	)	)	PUNCT
dpc-4515	123	83	3	3	NUM
dpc-4515	123	84	(	(	PUNCT
dpc-4515	123	85	6.9	6.9	NUM
dpc-4515	123	86	%	%	NOUN
dpc-4515	123	87	)	)	PUNCT
dpc-4515	123	88	psoriasis	psoriasis	NOUN
dpc-4515	123	89	1	1	NUM
dpc-4515	123	90	(	(	PUNCT
dpc-4515	123	91	2.3	2.3	NUM
dpc-4515	123	92	%	%	NOUN
dpc-4515	123	93	)	)	PUNCT
dpc-4515	123	94	3	3	NUM
dpc-4515	123	95	(	(	PUNCT
dpc-4515	123	96	6.9	6.9	NUM
dpc-4515	123	97	%	%	NOUN
dpc-4515	123	98	)	)	PUNCT
dpc-4515	123	99	4	4	NUM
dpc-4515	123	100	(	(	PUNCT
dpc-4515	123	101	9.1	9.1	NUM
dpc-4515	123	102	%	%	NOUN
dpc-4515	123	103	)	)	PUNCT
dpc-4515	123	104	obesity	obesity	NOUN
dpc-4515	123	105	(	(	PUNCT
dpc-4515	123	106	bmi	bmi	PROPN
dpc-4515	123	107	≥30	≥30	PROPN
dpc-4515	123	108	)	)	PUNCT
dpc-4515	123	109	3	3	NUM
dpc-4515	123	110	(	(	PUNCT
dpc-4515	123	111	6.9	6.9	NUM
dpc-4515	123	112	%	%	NOUN
dpc-4515	123	113	)	)	PUNCT
dpc-4515	123	114	5	5	NUM
dpc-4515	123	115	(	(	PUNCT
dpc-4515	123	116	11.4	11.4	NUM
dpc-4515	123	117	%	%	NOUN
dpc-4515	123	118	)	)	PUNCT
dpc-4515	123	119	8	8	NUM
dpc-4515	123	120	(	(	PUNCT
dpc-4515	123	121	18.2	18.2	NUM
dpc-4515	123	122	%	%	NOUN
dpc-4515	123	123	)	)	PUNCT
dpc-4515	123	124	abbreviations	abbreviation	NOUN
dpc-4515	123	125	:	:	PUNCT
dpc-4515	123	126	bmi	bmi	PROPN
dpc-4515	123	127	:	:	PUNCT
dpc-4515	123	128	body	body	NOUN
dpc-4515	123	129	mass	mass	PROPN
dpc-4515	123	130	index	index	NOUN
dpc-4515	123	131	;	;	PUNCT
dpc-4515	123	132	mgus=	mgus=	X
dpc-4515	123	133	monoclonal	monoclonal	NOUN
dpc-4515	123	134	gammopathy	gammopathy	ADJ
dpc-4515	123	135	of	of	ADP
dpc-4515	123	136	undetermined	undetermined	ADJ
dpc-4515	123	137	significance	significance	NOUN
dpc-4515	123	138	.	.	PUNCT
dpc-4515	124	1	original	original	ADJ
dpc-4515	124	2	article	article	NOUN
dpc-4515	124	3	|	|	ADV
dpc-4515	124	4	dermatol	dermatol	ADJ
dpc-4515	124	5	pract	pract	NOUN
dpc-4515	124	6	concept	concept	NOUN
dpc-4515	124	7	.	.	PUNCT
dpc-4515	125	1	2024;14(4):e2024265	2024;14(4):e2024265	NUM
dpc-4515	125	2	5	5	NUM
dpc-4515	125	3	3	3	NUM
dpc-4515	125	4	.	.	PUNCT
dpc-4515	125	5	binus	binus	PROPN
dpc-4515	125	6	am	am	PROPN
dpc-4515	125	7	,	,	PUNCT
dpc-4515	125	8	qureshi	qureshi	PROPN
dpc-4515	125	9	aa	aa	PROPN
dpc-4515	125	10	,	,	PUNCT
dpc-4515	125	11	li	li	PROPN
dpc-4515	125	12	vw	vw	PROPN
dpc-4515	125	13	,	,	PUNCT
dpc-4515	125	14	winterfield	winterfield	VERB
dpc-4515	125	15	ls	ls	ADJ
dpc-4515	125	16	.	.	PUNCT
dpc-4515	125	17	pyoderma	pyoderma	NOUN
dpc-4515	125	18	gangrenosum	gangrenosum	NOUN
dpc-4515	125	19	:	:	PUNCT
dpc-4515	125	20	a	a	DET
dpc-4515	125	21	retrospective	retrospective	ADJ
dpc-4515	125	22	review	review	NOUN
dpc-4515	125	23	of	of	ADP
dpc-4515	125	24	patient	patient	ADJ
dpc-4515	125	25	characteristics	characteristic	NOUN
dpc-4515	125	26	,	,	PUNCT
dpc-4515	125	27	comorbidities	comorbiditie	NOUN
dpc-4515	125	28	and	and	CCONJ
dpc-4515	125	29	therapy	therapy	NOUN
dpc-4515	125	30	in	in	ADP
dpc-4515	125	31	103	103	NUM
dpc-4515	125	32	patients	patient	NOUN
dpc-4515	125	33	.	.	PUNCT
dpc-4515	126	1	br	br	PROPN
dpc-4515	126	2	j	j	PROPN
dpc-4515	126	3	dermatol	dermatol	NOUN
dpc-4515	126	4	.	.	PUNCT
dpc-4515	127	1	2011;165(6):1244	2011;165(6):1244	NUM
dpc-4515	127	2	-	-	SYM
dpc-4515	127	3	1250	1250	NUM
dpc-4515	127	4	.	.	PUNCT
dpc-4515	128	1	doi:10.1111	doi:10.1111	ADJ
dpc-4515	128	2	/	/	SYM
dpc-4515	128	3	j.1365	j.1365	NOUN
dpc-4515	128	4	-	-	PUNCT
dpc-4515	128	5	2133.2011.10608	2133.2011.10608	NUM
dpc-4515	128	6	.	.	PUNCT
dpc-4515	129	1	4	4	NUM
dpc-4515	129	2	.	.	X
dpc-4515	129	3	park	park	PROPN
dpc-4515	129	4	an	an	PROPN
dpc-4515	129	5	,	,	PUNCT
dpc-4515	129	6	raj	raj	PROPN
dpc-4515	129	7	a	a	PRON
dpc-4515	129	8	,	,	PUNCT
dpc-4515	129	9	bajda	bajda	NOUN
dpc-4515	129	10	j	j	PROPN
dpc-4515	129	11	,	,	PUNCT
dpc-4515	129	12	gorantla	gorantla	PROPN
dpc-4515	129	13	vr	vr	PROPN
dpc-4515	129	14	.	.	PROPN
dpc-4515	129	15	narrative	narrative	PROPN
dpc-4515	129	16	review	review	PROPN
dpc-4515	129	17	:	:	PUNCT
dpc-4515	129	18	pyoderma	pyoderma	NOUN
dpc-4515	129	19	gangrenosum	gangrenosum	NOUN
dpc-4515	129	20	.	.	PUNCT
dpc-4515	130	1	cureus	cureus	NOUN
dpc-4515	130	2	.	.	PUNCT
dpc-4515	131	1	2024	2024	NUM
dpc-4515	131	2	jan	jan	PROPN
dpc-4515	131	3	7;16(1):e51805	7;16(1):e51805	PROPN
dpc-4515	131	4	.	.	PUNCT
dpc-4515	132	1	doi	doi	NOUN
dpc-4515	132	2	:	:	PUNCT
dpc-4515	132	3	10.7759	10.7759	NUM
dpc-4515	132	4	/cureus.51805	/cureus.51805	SYM
dpc-4515	132	5	.	.	PUNCT
dpc-4515	133	1	pmid	pmid	NOUN
dpc-4515	133	2	:	:	PUNCT
dpc-4515	133	3	38187026	38187026	NUM
dpc-4515	133	4	;	;	PUNCT
dpc-4515	133	5	pmcid	pmcid	ADJ
dpc-4515	133	6	:	:	PUNCT
dpc-4515	133	7	pmc10771820	pmc10771820	NOUN
dpc-4515	133	8	.	.	PUNCT
dpc-4515	134	1	5	5	X
dpc-4515	134	2	.	.	X
dpc-4515	135	1	maronese	maronese	PROPN
dpc-4515	135	2	ca	ca	PROPN
dpc-4515	135	3	,	,	PUNCT
dpc-4515	135	4	pimentel	pimentel	PROPN
dpc-4515	135	5	ma	ma	PROPN
dpc-4515	135	6	,	,	PUNCT
dpc-4515	135	7	li	li	PROPN
dpc-4515	135	8	mm	mm	PROPN
dpc-4515	135	9	,	,	PUNCT
dpc-4515	135	10	genovese	genovese	NOUN
dpc-4515	135	11	g	g	PROPN
dpc-4515	135	12	,	,	PUNCT
dpc-4515	135	13	ortega	ortega	PROPN
dpc-4515	135	14	loayza	loayza	PROPN
dpc-4515	135	15	ag	ag	PROPN
dpc-4515	135	16	,	,	PUNCT
dpc-4515	135	17	marzano	marzano	PROPN
dpc-4515	135	18	av	av	PROPN
dpc-4515	135	19	.	.	PUNCT
dpc-4515	135	20	pyoderma	pyoderma	PROPN
dpc-4515	135	21	gangrenosum	gangrenosum	NOUN
dpc-4515	135	22	:	:	PUNCT
dpc-4515	135	23	an	an	DET
dpc-4515	135	24	updated	update	VERB
dpc-4515	135	25	literature	literature	NOUN
dpc-4515	135	26	review	review	NOUN
dpc-4515	135	27	on	on	ADP
dpc-4515	135	28	established	establish	VERB
dpc-4515	135	29	and	and	CCONJ
dpc-4515	135	30	emerging	emerge	VERB
dpc-4515	135	31	pharmacological	pharmacological	ADJ
dpc-4515	135	32	treatments	treatment	NOUN
dpc-4515	135	33	.	.	PUNCT
dpc-4515	136	1	am	be	AUX
dpc-4515	136	2	j	j	PROPN
dpc-4515	136	3	clin	clin	PROPN
dpc-4515	136	4	dermatol	dermatol	NOUN
dpc-4515	136	5	.	.	PUNCT
dpc-4515	137	1	2022	2022	NUM
dpc-4515	137	2	sep;23(5):615	sep;23(5):615	NUM
dpc-4515	137	3	-	-	PUNCT
dpc-4515	137	4	634	634	NUM
dpc-4515	137	5	.	.	PUNCT
dpc-4515	138	1	doi	doi	NOUN
dpc-4515	138	2	:	:	PUNCT
dpc-4515	138	3	10.1007	10.1007	NUM
dpc-4515	138	4	/	/	SYM
dpc-4515	138	5	s40257	s40257	NOUN
dpc-4515	138	6	-	-	PUNCT
dpc-4515	138	7	022	022	NUM
dpc-4515	138	8	-	-	PUNCT
dpc-4515	138	9	00699	00699	NUM
dpc-4515	138	10	-	-	SYM
dpc-4515	138	11	8	8	NUM
dpc-4515	138	12	.	.	PUNCT
dpc-4515	139	1	epub	epub	NOUN
dpc-4515	139	2	2022	2022	NUM
dpc-4515	139	3	may	may	AUX
dpc-4515	139	4	24	24	NUM
dpc-4515	139	5	.	.	PUNCT
dpc-4515	140	1	pmid	pmid	NOUN
dpc-4515	140	2	:	:	PUNCT
dpc-4515	140	3	35606650	35606650	NUM
dpc-4515	140	4	;	;	PUNCT
dpc-4515	140	5	pmcid	pmcid	NOUN
dpc-4515	140	6	:	:	PUNCT
dpc-4515	140	7	pmc9464730	pmc9464730	NOUN
dpc-4515	140	8	.	.	PUNCT
dpc-4515	141	1	6	6	X
dpc-4515	141	2	.	.	X
dpc-4515	141	3	pearson	pearson	PROPN
dpc-4515	141	4	wa	wa	PROPN
dpc-4515	141	5	,	,	PUNCT
dpc-4515	141	6	prentice	prentice	PROPN
dpc-4515	141	7	da	da	PROPN
dpc-4515	141	8	,	,	PUNCT
dpc-4515	141	9	lim	lim	NOUN
dpc-4515	141	10	ly	ly	PROPN
dpc-4515	141	11	,	,	PUNCT
dpc-4515	141	12	gianoncelli	gianoncelli	PROPN
dpc-4515	141	13	o	o	PROPN
dpc-4515	141	14	,	,	PUNCT
dpc-4515	141	15	hashiguchi	hashiguchi	PROPN
dpc-4515	141	16	a	a	X
dpc-4515	141	17	,	,	PUNCT
dpc-4515	141	18	parisella	parisella	PROPN
dpc-4515	141	19	tk	tk	PROPN
dpc-4515	141	20	,	,	PUNCT
dpc-4515	141	21	ta	ta	PROPN
dpc-4515	141	22	jt	jt	PROPN
dpc-4515	141	23	.	.	PUNCT
dpc-4515	142	1	clinical	clinical	ADJ
dpc-4515	142	2	efficacy	efficacy	NOUN
dpc-4515	142	3	of	of	ADP
dpc-4515	142	4	crushed	crush	VERB
dpc-4515	142	5	prednisolone	prednisolone	PROPN
dpc-4515	142	6	and	and	CCONJ
dpc-4515	142	7	hydrocolloid	hydrocolloid	NOUN
dpc-4515	142	8	powder	powder	NOUN
dpc-4515	142	9	in	in	ADP
dpc-4515	142	10	the	the	DET
dpc-4515	142	11	primary	primary	ADJ
dpc-4515	142	12	treatment	treatment	NOUN
dpc-4515	142	13	of	of	ADP
dpc-4515	142	14	peristomal	peristomal	ADJ
dpc-4515	142	15	pyoderma	pyoderma	NOUN
dpc-4515	142	16	gangrenosum	gangrenosum	NOUN
dpc-4515	142	17	and	and	CCONJ
dpc-4515	142	18	correlation	correlation	NOUN
dpc-4515	142	19	to	to	ADP
dpc-4515	142	20	in	in	ADP
dpc-4515	142	21	vitro	vitro	X
dpc-4515	142	22	drug	drug	NOUN
dpc-4515	142	23	release	release	NOUN
dpc-4515	142	24	data	datum	NOUN
dpc-4515	142	25	.	.	PUNCT
dpc-4515	143	1	int	int	PROPN
dpc-4515	143	2	wound	wound	NOUN
dpc-4515	143	3	j.	j.	PROPN
dpc-4515	143	4	2024	2024	NUM
dpc-4515	143	5	mar;21(3):e14808	mar;21(3):e14808	NOUN
dpc-4515	143	6	.	.	PUNCT
dpc-4515	144	1	doi	doi	NOUN
dpc-4515	144	2	:	:	PUNCT
dpc-4515	144	3	10.1111	10.1111	NUM
dpc-4515	144	4	/iwj.14808	/iwj.14808	NOUN
dpc-4515	144	5	.	.	PUNCT
dpc-4515	145	1	pmid	pmid	NOUN
dpc-4515	145	2	:	:	PUNCT
dpc-4515	145	3	38425135	38425135	NUM
dpc-4515	145	4	;	;	PUNCT
dpc-4515	145	5	pmcid	pmcid	NOUN
dpc-4515	145	6	:	:	PUNCT
dpc-4515	145	7	pmc10904972	pmc10904972	NOUN
dpc-4515	145	8	.	.	PUNCT
dpc-4515	146	1	7	7	X
dpc-4515	146	2	.	.	X
dpc-4515	146	3	powell	powell	PROPN
dpc-4515	146	4	fc	fc	PROPN
dpc-4515	146	5	,	,	PUNCT
dpc-4515	146	6	su	su	PROPN
dpc-4515	146	7	wp	wp	PROPN
dpc-4515	146	8	,	,	PUNCT
dpc-4515	146	9	perry	perry	PROPN
dpc-4515	146	10	ho	ho	PROPN
dpc-4515	146	11	.	.	PROPN
dpc-4515	146	12	pyoderma	pyoderma	PROPN
dpc-4515	146	13	gangrenosum	gangrenosum	NOUN
dpc-4515	146	14	:	:	PUNCT
dpc-4515	146	15	classification	classification	NOUN
dpc-4515	146	16	and	and	CCONJ
dpc-4515	146	17	management	management	NOUN
dpc-4515	146	18	.	.	PUNCT
dpc-4515	147	1	j	j	PROPN
dpc-4515	147	2	am	be	AUX
dpc-4515	147	3	acad	acad	ADJ
dpc-4515	147	4	dermatol	dermatol	NOUN
dpc-4515	147	5	.	.	PUNCT
dpc-4515	148	1	1996	1996	NUM
dpc-4515	148	2	mar;34(3	mar;34(3	SYM
dpc-4515	148	3	):	):	PUNCT
dpc-4515	148	4	395	395	NUM
dpc-4515	148	5	-	-	SYM
dpc-4515	148	6	409	409	NUM
dpc-4515	148	7	;	;	PUNCT
dpc-4515	148	8	quiz	quiz	NOUN
dpc-4515	148	9	410	410	NUM
dpc-4515	148	10	-	-	SYM
dpc-4515	148	11	2	2	NUM
dpc-4515	148	12	.	.	PUNCT
dpc-4515	148	13	doi	doi	NOUN
dpc-4515	148	14	:	:	PUNCT
dpc-4515	148	15	10.1016	10.1016	NUM
dpc-4515	148	16	/	/	SYM
dpc-4515	148	17	s0190	s0190	VERB
dpc-4515	148	18	-	-	PUNCT
dpc-4515	148	19	9622(96)90428	9622(96)90428	NUM
dpc-4515	148	20	-	-	PUNCT
dpc-4515	148	21	4	4	NUM
dpc-4515	148	22	.	.	PUNCT
dpc-4515	148	23	pmid	pmid	NOUN
dpc-4515	148	24	:	:	PUNCT
dpc-4515	148	25	8609250	8609250	NUM
dpc-4515	148	26	.	.	PUNCT
dpc-4515	149	1	8	8	X
dpc-4515	149	2	.	.	X
dpc-4515	149	3	wollina	wollina	PROPN
dpc-4515	149	4	u.	u.	PROPN
dpc-4515	149	5	pyoderma	pyoderma	PROPN
dpc-4515	149	6	gangrenosum	gangrenosum	NOUN
dpc-4515	149	7	–	–	PUNCT
dpc-4515	149	8	a	a	DET
dpc-4515	149	9	review	review	NOUN
dpc-4515	149	10	.	.	PUNCT
dpc-4515	150	1	orphanet	orphanet	PROPN
dpc-4515	150	2	j	j	PROPN
dpc-4515	150	3	rare	rare	ADJ
dpc-4515	150	4	dis	dis	PROPN
dpc-4515	150	5	.	.	PUNCT
dpc-4515	151	1	2007	2007	NUM
dpc-4515	151	2	apr	apr	NOUN
dpc-4515	151	3	15;2:19	15;2:19	NUM
dpc-4515	151	4	.	.	PUNCT
dpc-4515	152	1	doi	doi	NOUN
dpc-4515	152	2	:	:	PUNCT
dpc-4515	152	3	10.1186/1750	10.1186/1750	NUM
dpc-4515	152	4	-	-	SYM
dpc-4515	152	5	1172	1172	NUM
dpc-4515	152	6	-	-	PUNCT
dpc-4515	152	7	2	2	NUM
dpc-4515	152	8	-	-	SYM
dpc-4515	152	9	19	19	NUM
dpc-4515	152	10	.	.	PUNCT
dpc-4515	153	1	pmid	pmid	NOUN
dpc-4515	153	2	:	:	PUNCT
dpc-4515	153	3	17433111	17433111	NUM
dpc-4515	153	4	;	;	PUNCT
dpc-4515	153	5	pmcid	pmcid	NOUN
dpc-4515	153	6	:	:	PUNCT
dpc-4515	153	7	pmc1857704	pmc1857704	ADJ
dpc-4515	153	8	.	.	PUNCT
dpc-4515	154	1	9	9	X
dpc-4515	154	2	.	.	X
dpc-4515	154	3	xu	xu	PROPN
dpc-4515	155	1	a	a	PRON
dpc-4515	155	2	,	,	PUNCT
dpc-4515	155	3	balgobind	balgobind	NOUN
dpc-4515	155	4	a	a	PRON
dpc-4515	155	5	,	,	PUNCT
dpc-4515	155	6	strunk	strunk	NOUN
dpc-4515	155	7	a	a	PROPN
dpc-4515	155	8	,	,	PUNCT
dpc-4515	155	9	garg	garg	PROPN
dpc-4515	155	10	a	a	PRON
dpc-4515	155	11	,	,	PUNCT
dpc-4515	155	12	alloo	alloo	ADJ
dpc-4515	155	13	a.	a.	NOUN
dpc-4515	155	14	prevalence	prevalence	NOUN
dpc-4515	155	15	estimates	estimate	NOUN
dpc-4515	155	16	for	for	ADP
dpc-4515	155	17	pyoderma	pyoderma	NOUN
dpc-4515	155	18	gangrenosum	gangrenosum	NOUN
dpc-4515	155	19	in	in	ADP
dpc-4515	155	20	the	the	DET
dpc-4515	155	21	united	united	PROPN
dpc-4515	155	22	states	states	PROPN
dpc-4515	155	23	:	:	PUNCT
dpc-4515	155	24	an	an	DET
dpc-4515	155	25	ageand	ageand	NOUN
dpc-4515	155	26	sex	sex	NOUN
dpc-4515	155	27	-	-	PUNCT
dpc-4515	155	28	adjusted	adjust	VERB
dpc-4515	155	29	population	population	NOUN
dpc-4515	155	30	analysis	analysis	NOUN
dpc-4515	155	31	.	.	PUNCT
dpc-4515	156	1	j	j	PROPN
dpc-4515	156	2	am	be	AUX
dpc-4515	156	3	acad	acad	ADJ
dpc-4515	156	4	dermatol	dermatol	NOUN
dpc-4515	156	5	.	.	PUNCT
dpc-4515	157	1	2020	2020	NUM
dpc-4515	157	2	aug;83(2):425	aug;83(2):425	NUM
dpc-4515	157	3	-	-	SYM
dpc-4515	157	4	429	429	NUM
dpc-4515	158	1	.	.	PUNCT
dpc-4515	158	2	doi	doi	NOUN
dpc-4515	158	3	:	:	PUNCT
dpc-4515	158	4	10.1016	10.1016	NUM
dpc-4515	158	5	/	/	SYM
dpc-4515	158	6	j.jaad.2019.08.001	j.jaad.2019.08.001	PROPN
dpc-4515	158	7	.	.	PUNCT
dpc-4515	159	1	epub	epub	PROPN
dpc-4515	159	2	2019	2019	NUM
dpc-4515	159	3	aug	aug	PROPN
dpc-4515	159	4	7	7	NUM
dpc-4515	159	5	.	.	PUNCT
dpc-4515	160	1	pmid	pmid	NOUN
dpc-4515	160	2	:	:	PUNCT
dpc-4515	160	3	31400451	31400451	NUM
dpc-4515	160	4	.	.	PUNCT
dpc-4515	161	1	10	10	NUM
dpc-4515	161	2	.	.	PUNCT
dpc-4515	161	3	ahronowitz	ahronowitz	PROPN
dpc-4515	161	4	i	i	PRON
dpc-4515	161	5	,	,	PUNCT
dpc-4515	161	6	harp	harp	PROPN
dpc-4515	161	7	j	j	PROPN
dpc-4515	161	8	,	,	PUNCT
dpc-4515	161	9	shinkai	shinkai	PROPN
dpc-4515	161	10	k.	k.	PROPN
dpc-4515	161	11	etiology	etiology	PROPN
dpc-4515	161	12	and	and	CCONJ
dpc-4515	161	13	management	management	NOUN
dpc-4515	161	14	of	of	ADP
dpc-4515	161	15	pyoderma	pyoderma	NOUN
dpc-4515	161	16	gangrenosum	gangrenosum	NOUN
dpc-4515	161	17	:	:	PUNCT
dpc-4515	161	18	a	a	DET
dpc-4515	161	19	comprehensive	comprehensive	ADJ
dpc-4515	161	20	review	review	NOUN
dpc-4515	161	21	.	.	PUNCT
dpc-4515	161	22	am	be	AUX
dpc-4515	161	23	j	j	PROPN
dpc-4515	161	24	clin	clin	PROPN
dpc-4515	161	25	dermatol	dermatol	NOUN
dpc-4515	161	26	.	.	PUNCT
dpc-4515	162	1	2012	2012	NUM
dpc-4515	162	2	jun	jun	PROPN
dpc-4515	162	3	1;13(3):191	1;13(3):191	NUM
dpc-4515	162	4	-	-	PUNCT
dpc-4515	162	5	211	211	NUM
dpc-4515	162	6	.	.	PUNCT
dpc-4515	163	1	doi	doi	NOUN
dpc-4515	163	2	:	:	PUNCT
dpc-4515	163	3	10.2165/11595240	10.2165/11595240	NUM
dpc-4515	163	4	-000000000	-000000000	PROPN
dpc-4515	163	5	-	-	PUNCT
dpc-4515	163	6	00000	00000	NUM
dpc-4515	163	7	.	.	PUNCT
dpc-4515	164	1	pmid	pmid	NOUN
dpc-4515	164	2	:	:	PUNCT
dpc-4515	164	3	22356259	22356259	NUM
dpc-4515	164	4	.	.	PUNCT
dpc-4515	165	1	11	11	NUM
dpc-4515	165	2	.	.	PUNCT
dpc-4515	166	1	langan	langan	PROPN
dpc-4515	166	2	sm	sm	PROPN
dpc-4515	166	3	,	,	PUNCT
dpc-4515	166	4	groves	grove	NOUN
dpc-4515	166	5	rw	rw	NOUN
dpc-4515	166	6	,	,	PUNCT
dpc-4515	166	7	card	card	NOUN
dpc-4515	166	8	tr	tr	VERB
dpc-4515	166	9	,	,	PUNCT
dpc-4515	166	10	gulliford	gulliford	PROPN
dpc-4515	166	11	mc	mc	PROPN
dpc-4515	166	12	.	.	PROPN
dpc-4515	166	13	incidence	incidence	PROPN
dpc-4515	166	14	,	,	PUNCT
dpc-4515	166	15	mortality	mortality	NOUN
dpc-4515	166	16	,	,	PUNCT
dpc-4515	166	17	and	and	CCONJ
dpc-4515	166	18	disease	disease	NOUN
dpc-4515	166	19	associations	association	NOUN
dpc-4515	166	20	of	of	ADP
dpc-4515	166	21	pyoderma	pyoderma	NOUN
dpc-4515	166	22	gangrenosum	gangrenosum	NOUN
dpc-4515	166	23	in	in	ADP
dpc-4515	166	24	the	the	DET
dpc-4515	166	25	united	united	ADJ
dpc-4515	166	26	kingdom	kingdom	PROPN
dpc-4515	166	27	:	:	PUNCT
dpc-4515	166	28	a	a	DET
dpc-4515	166	29	retrospective	retrospective	ADJ
dpc-4515	166	30	cohort	cohort	NOUN
dpc-4515	166	31	study	study	NOUN
dpc-4515	166	32	.	.	PUNCT
dpc-4515	167	1	j	j	PROPN
dpc-4515	167	2	invest	invest	VERB
dpc-4515	167	3	dermatol	dermatol	NOUN
dpc-4515	167	4	.	.	PUNCT
dpc-4515	168	1	2012	2012	NUM
dpc-4515	168	2	sep;132(9):2166	sep;132(9):2166	NOUN
dpc-4515	168	3	-	-	PUNCT
dpc-4515	168	4	70	70	NUM
dpc-4515	168	5	.	.	PUNCT
dpc-4515	169	1	doi	doi	NOUN
dpc-4515	169	2	:	:	PUNCT
dpc-4515	169	3	10.1038	10.1038	NUM
dpc-4515	169	4	/	/	SYM
dpc-4515	169	5	jid.2012.130	jid.2012.130	PROPN
dpc-4515	169	6	.	.	PUNCT
dpc-4515	170	1	epub	epub	PROPN
dpc-4515	170	2	2012	2012	NUM
dpc-4515	170	3	apr	apr	NOUN
dpc-4515	170	4	26	26	NUM
dpc-4515	170	5	.	.	PUNCT
dpc-4515	171	1	pmid	pmid	NOUN
dpc-4515	171	2	:	:	PUNCT
dpc-4515	171	3	22534879	22534879	NUM
dpc-4515	171	4	.	.	PUNCT
dpc-4515	172	1	12	12	NUM
dpc-4515	172	2	.	.	PUNCT
dpc-4515	173	1	kridin	kridin	VERB
dpc-4515	173	2	k	k	PROPN
dpc-4515	173	3	,	,	PUNCT
dpc-4515	173	4	cohen	cohen	PROPN
dpc-4515	173	5	ad	ad	PROPN
dpc-4515	173	6	,	,	PUNCT
dpc-4515	173	7	amber	amber	PROPN
dpc-4515	173	8	kt	kt	PROPN
dpc-4515	173	9	.	.	PUNCT
dpc-4515	174	1	underlying	underlie	VERB
dpc-4515	174	2	systemic	systemic	ADJ
dpc-4515	174	3	diseases	disease	NOUN
dpc-4515	174	4	in	in	ADP
dpc-4515	174	5	pyoderma	pyoderma	NOUN
dpc-4515	174	6	gangrenosum	gangrenosum	NOUN
dpc-4515	174	7	:	:	PUNCT
dpc-4515	174	8	a	a	DET
dpc-4515	174	9	systematic	systematic	ADJ
dpc-4515	174	10	review	review	NOUN
dpc-4515	174	11	and	and	CCONJ
dpc-4515	174	12	meta	meta	VERB
dpc-4515	174	13	analysis	analysis	NOUN
dpc-4515	174	14	.	.	PUNCT
dpc-4515	175	1	am	be	AUX
dpc-4515	175	2	j	j	PROPN
dpc-4515	175	3	clin	clin	PROPN
dpc-4515	175	4	dermatol	dermatol	NOUN
dpc-4515	175	5	.	.	PUNCT
dpc-4515	176	1	2018	2018	NUM
dpc-4515	176	2	aug;19(4):479	aug;19(4):479	NOUN
dpc-4515	176	3	-	-	PUNCT
dpc-4515	176	4	487	487	NUM
dpc-4515	176	5	.	.	PUNCT
dpc-4515	177	1	doi	doi	NOUN
dpc-4515	177	2	:	:	PUNCT
dpc-4515	177	3	10.1007	10.1007	NUM
dpc-4515	177	4	/	/	SYM
dpc-4515	177	5	s40257	s40257	NOUN
dpc-4515	177	6	-	-	PUNCT
dpc-4515	177	7	018	018	NUM
dpc-4515	177	8	-	-	PUNCT
dpc-4515	177	9	0356	0356	NUM
dpc-4515	177	10	-	-	PUNCT
dpc-4515	177	11	7	7	NUM
dpc-4515	177	12	.	.	PUNCT
dpc-4515	178	1	pmid	pmid	NOUN
dpc-4515	178	2	:	:	PUNCT
dpc-4515	178	3	29721816	29721816	NUM
dpc-4515	178	4	.	.	PUNCT
dpc-4515	179	1	13	13	NUM
dpc-4515	179	2	.	.	PUNCT
dpc-4515	180	1	agarwal	agarwal	PROPN
dpc-4515	180	2	a	a	PROPN
dpc-4515	180	3	,	,	PUNCT
dpc-4515	180	4	andrews	andrews	PROPN
dpc-4515	180	5	jm	jm	PROPN
dpc-4515	180	6	.	.	PROPN
dpc-4515	180	7	systematic	systematic	PROPN
dpc-4515	180	8	review	review	PROPN
dpc-4515	180	9	:	:	PUNCT
dpc-4515	180	10	ibd	ibd	NOUN
dpc-4515	180	11	-	-	PUNCT
dpc-4515	180	12	associated	associate	VERB
dpc-4515	180	13	pyoderma	pyoderma	NOUN
dpc-4515	180	14	gangrenosum	gangrenosum	NOUN
dpc-4515	180	15	in	in	ADP
dpc-4515	180	16	the	the	DET
dpc-4515	180	17	biologic	biologic	ADJ
dpc-4515	180	18	era	era	NOUN
dpc-4515	180	19	,	,	PUNCT
dpc-4515	180	20	the	the	DET
dpc-4515	180	21	response	response	NOUN
dpc-4515	180	22	to	to	ADP
dpc-4515	180	23	therapy	therapy	NOUN
dpc-4515	180	24	.	.	PUNCT
dpc-4515	181	1	aliment	aliment	NOUN
dpc-4515	181	2	pharmacol	pharmacol	VERB
dpc-4515	181	3	ther	ther	ADV
dpc-4515	181	4	.	.	PUNCT
dpc-4515	182	1	2013	2013	NUM
dpc-4515	182	2	sep;38(6):563	sep;38(6):563	ADV
dpc-4515	182	3	-	-	SYM
dpc-4515	182	4	72	72	NUM
dpc-4515	182	5	.	.	PUNCT
dpc-4515	183	1	doi	doi	NOUN
dpc-4515	183	2	:	:	PUNCT
dpc-4515	183	3	10.1111	10.1111	NUM
dpc-4515	183	4	/	/	SYM
dpc-4515	183	5	apt.12431	apt.12431	PROPN
dpc-4515	183	6	.	.	PUNCT
dpc-4515	184	1	epub	epub	PROPN
dpc-4515	184	2	2013	2013	NUM
dpc-4515	184	3	aug	aug	PROPN
dpc-4515	184	4	5	5	NUM
dpc-4515	184	5	.	.	PUNCT
dpc-4515	185	1	pmid	pmid	NOUN
dpc-4515	185	2	:	:	PUNCT
dpc-4515	185	3	23914999	23914999	NUM
dpc-4515	185	4	.	.	PUNCT
dpc-4515	186	1	14	14	NUM
dpc-4515	186	2	.	.	PUNCT
dpc-4515	187	1	ruocco	ruocco	PROPN
dpc-4515	187	2	e	e	NOUN
dpc-4515	187	3	,	,	PUNCT
dpc-4515	187	4	sangiuliano	sangiuliano	PROPN
dpc-4515	187	5	s	s	PROPN
dpc-4515	187	6	,	,	PUNCT
dpc-4515	187	7	gravina	gravina	PROPN
dpc-4515	187	8	ag	ag	PROPN
dpc-4515	187	9	,	,	PUNCT
dpc-4515	187	10	miranda	miranda	PROPN
dpc-4515	187	11	a	a	PRON
dpc-4515	187	12	,	,	PUNCT
dpc-4515	187	13	nicoletti	nicoletti	NOUN
dpc-4515	187	14	g.	g.	NOUN
dpc-4515	187	15	pyoderma	pyoderma	PROPN
dpc-4515	187	16	gangrenosum	gangrenosum	NOUN
dpc-4515	187	17	:	:	PUNCT
dpc-4515	187	18	an	an	DET
dpc-4515	187	19	updated	update	VERB
dpc-4515	187	20	review	review	NOUN
dpc-4515	187	21	.	.	PUNCT
dpc-4515	188	1	j	j	PROPN
dpc-4515	188	2	eur	eur	PROPN
dpc-4515	188	3	acad	acad	PROPN
dpc-4515	188	4	dermatol	dermatol	NOUN
dpc-4515	188	5	venereol	venereol	NOUN
dpc-4515	188	6	.	.	PUNCT
dpc-4515	189	1	2009	2009	NUM
dpc-4515	189	2	sep;23(9):1008	sep;23(9):1008	PROPN
dpc-4515	189	3	-	-	PUNCT
dpc-4515	189	4	17	17	PROPN
dpc-4515	189	5	.	.	PUNCT
dpc-4515	190	1	doi	doi	NOUN
dpc-4515	190	2	:	:	PUNCT
dpc-4515	190	3	10.1111	10.1111	NUM
dpc-4515	190	4	/	/	SYM
dpc-4515	190	5	j.1468	j.1468	PROPN
dpc-4515	190	6	-3083.2009.03199.x	-3083.2009.03199.x	PROPN
dpc-4515	190	7	.	.	PUNCT
dpc-4515	191	1	epub	epub	PROPN
dpc-4515	191	2	2009	2009	NUM
dpc-4515	191	3	mar	mar	PROPN
dpc-4515	191	4	11	11	NUM
dpc-4515	191	5	.	.	PUNCT
dpc-4515	192	1	pmid	pmid	NOUN
dpc-4515	192	2	:	:	PUNCT
dpc-4515	192	3	19470075	19470075	NUM
dpc-4515	192	4	.	.	PUNCT
dpc-4515	193	1	15	15	NUM
dpc-4515	193	2	.	.	PUNCT
dpc-4515	194	1	vacas	vacas	PROPN
dpc-4515	194	2	as	as	ADP
dpc-4515	194	3	,	,	PUNCT
dpc-4515	194	4	torre	torre	PROPN
dpc-4515	194	5	ac	ac	PROPN
dpc-4515	194	6	,	,	PUNCT
dpc-4515	194	7	bollea	bollea	NOUN
dpc-4515	194	8	-	-	PUNCT
dpc-4515	194	9	garlatti	garlatti	NOUN
dpc-4515	194	10	ml	ml	PROPN
dpc-4515	194	11	,	,	PUNCT
dpc-4515	194	12	warley	warley	PROPN
dpc-4515	194	13	f	f	PROPN
dpc-4515	194	14	,	,	PUNCT
dpc-4515	194	15	galimberti	galimberti	PROPN
dpc-4515	194	16	 	 	SPACE
dpc-4515	194	17	rl	rl	X
dpc-4515	194	18	.	.	PUNCT
dpc-4515	194	19	pyoderma	pyoderma	NOUN
dpc-4515	194	20	gangrenosum	gangrenosum	NOUN
dpc-4515	194	21	:	:	PUNCT
dpc-4515	194	22	clinical	clinical	ADJ
dpc-4515	194	23	characteristics	characteristic	NOUN
dpc-4515	194	24	,	,	PUNCT
dpc-4515	194	25	associated	associated	ADJ
dpc-4515	194	26	diseases	disease	NOUN
dpc-4515	194	27	,	,	PUNCT
dpc-4515	194	28	and	and	CCONJ
dpc-4515	194	29	responses	response	NOUN
dpc-4515	194	30	to	to	ADP
dpc-4515	194	31	treatment	treatment	NOUN
dpc-4515	194	32	in	in	ADP
dpc-4515	194	33	a	a	DET
dpc-4515	194	34	retrospective	retrospective	ADJ
dpc-4515	194	35	cohort	cohort	NOUN
dpc-4515	194	36	study	study	NOUN
dpc-4515	194	37	of	of	ADP
dpc-4515	194	38	31	31	NUM
dpc-4515	194	39	patients	patient	NOUN
dpc-4515	194	40	.	.	PUNCT
dpc-4515	195	1	int	int	NOUN
dpc-4515	195	2	j	j	PROPN
dpc-4515	195	3	dermatol	dermatol	NOUN
dpc-4515	195	4	.	.	PUNCT
dpc-4515	196	1	2017	2017	NUM
dpc-4515	196	2	apr;56(4):386	apr;56(4):386	NOUN
dpc-4515	196	3	-	-	SYM
dpc-4515	196	4	391	391	NUM
dpc-4515	197	1	.	.	PUNCT
dpc-4515	197	2	doi	doi	NOUN
dpc-4515	197	3	:	:	PUNCT
dpc-4515	197	4	10.1111	10.1111	NUM
dpc-4515	197	5	/	/	SYM
dpc-4515	197	6	ijd.13591	ijd.13591	NOUN
dpc-4515	197	7	.	.	PUNCT
dpc-4515	198	1	pmid	pmid	NOUN
dpc-4515	198	2	:	:	PUNCT
dpc-4515	198	3	28295267	28295267	NUM
dpc-4515	198	4	.	.	PUNCT
dpc-4515	199	1	16	16	NUM
dpc-4515	199	2	.	.	PUNCT
dpc-4515	200	1	zou	zou	PROPN
dpc-4515	200	2	h	h	PROPN
dpc-4515	200	3	,	,	PUNCT
dpc-4515	200	4	daveluy	daveluy	PROPN
dpc-4515	200	5	s.	s.	PROPN
dpc-4515	200	6	pyoderma	pyoderma	PROPN
dpc-4515	200	7	gangrenosum	gangrenosum	NOUN
dpc-4515	200	8	after	after	ADP
dpc-4515	200	9	covid-19	covid-19	PROPN
dpc-4515	200	10	infection	infection	NOUN
dpc-4515	200	11	and	and	CCONJ
dpc-4515	200	12	vaccination	vaccination	NOUN
dpc-4515	200	13	.	.	PUNCT
dpc-4515	201	1	clin	clin	PROPN
dpc-4515	201	2	dermatol	dermatol	NOUN
dpc-4515	201	3	.	.	PUNCT
dpc-4515	202	1	2023	2023	NUM
dpc-4515	202	2	jan	jan	PROPN
dpc-4515	202	3	-	-	PUNCT
dpc-4515	202	4	feb;41(1):129	feb;41(1):129	PROPN
dpc-4515	202	5	-	-	PUNCT
dpc-4515	202	6	131	131	PROPN
dpc-4515	202	7	.	.	PUNCT
dpc-4515	203	1	doi	doi	NOUN
dpc-4515	203	2	:	:	PUNCT
dpc-4515	203	3	10.1016	10.1016	NUM
dpc-4515	203	4	/	/	SYM
dpc-4515	203	5	j.clindermatol.2022.11.003	j.clindermatol.2022.11.003	PROPN
dpc-4515	203	6	.	.	PROPN
dpc-4515	203	7	epub	epub	PROPN
dpc-4515	203	8	2022	2022	NUM
dpc-4515	203	9	nov	nov	PROPN
dpc-4515	203	10	26	26	NUM
dpc-4515	203	11	.	.	PUNCT
dpc-4515	204	1	pmid	pmid	NOUN
dpc-4515	204	2	:	:	PUNCT
dpc-4515	204	3	36442730	36442730	NUM
dpc-4515	204	4	;	;	PUNCT
dpc-4515	204	5	pmcid	pmcid	ADJ
dpc-4515	204	6	:	:	PUNCT
dpc-4515	204	7	pmc9699819	pmc9699819	VERB
dpc-4515	204	8	.	.	PUNCT
dpc-4515	205	1	our	our	PRON
dpc-4515	205	2	findings	finding	NOUN
dpc-4515	205	3	on	on	ADP
dpc-4515	205	4	ppg	ppg	PROPN
dpc-4515	205	5	show	show	VERB
dpc-4515	205	6	that	that	SCONJ
dpc-4515	205	7	pain	pain	NOUN
dpc-4515	205	8	and	and	CCONJ
dpc-4515	205	9	burning	burning	NOUN
dpc-4515	205	10	were	be	AUX
dpc-4515	205	11	the	the	DET
dpc-4515	205	12	most	most	ADV
dpc-4515	205	13	common	common	ADJ
dpc-4515	205	14	symptoms	symptom	NOUN
dpc-4515	205	15	.	.	PUNCT
dpc-4515	206	1	in	in	ADP
dpc-4515	206	2	our	our	PRON
dpc-4515	206	3	cohort	cohort	NOUN
dpc-4515	206	4	,	,	PUNCT
dpc-4515	206	5	ppg	ppg	PROPN
dpc-4515	206	6	was	be	AUX
dpc-4515	206	7	predominantly	predominantly	ADV
dpc-4515	206	8	associated	associate	VERB
dpc-4515	206	9	with	with	ADP
dpc-4515	206	10	ibd	ibd	PROPN
dpc-4515	206	11	,	,	PUNCT
dpc-4515	206	12	suggesting	suggest	VERB
dpc-4515	206	13	that	that	SCONJ
dpc-4515	206	14	ppg	ppg	NOUN
dpc-4515	206	15	can	can	AUX
dpc-4515	206	16	be	be	AUX
dpc-4515	206	17	triggered	trigger	VERB
dpc-4515	206	18	by	by	ADP
dpc-4515	206	19	proinflammatory	proinflammatory	ADJ
dpc-4515	206	20	cytokines	cytokine	NOUN
dpc-4515	206	21	from	from	ADP
dpc-4515	206	22	active	active	ADJ
dpc-4515	206	23	ibd	ibd	NOUN
dpc-4515	206	24	  	  	SPACE
dpc-4515	207	1	[	[	X
dpc-4515	207	2	20	20	NUM
dpc-4515	207	3	]	]	PUNCT
dpc-4515	207	4	.	.	PUNCT
dpc-4515	208	1	as	as	SCONJ
dpc-4515	208	2	recently	recently	ADV
dpc-4515	208	3	stated	state	VERB
dpc-4515	208	4	by	by	ADP
dpc-4515	208	5	afifi	afifi	PROPN
dpc-4515	208	6	et	et	PROPN
dpc-4515	208	7	al	al	PROPN
dpc-4515	208	8	.	.	PROPN
dpc-4515	208	9	,	,	PUNCT
dpc-4515	208	10	pathergy	pathergy	NOUN
dpc-4515	208	11	is	be	AUX
dpc-4515	208	12	recurrent	recurrent	ADJ
dpc-4515	208	13	in	in	ADP
dpc-4515	208	14	ppg	ppg	NOUN
dpc-4515	208	15	because	because	SCONJ
dpc-4515	208	16	of	of	ADP
dpc-4515	208	17	ostomy	ostomy	NOUN
dpc-4515	208	18	leakages	leakage	NOUN
dpc-4515	208	19	and	and	CCONJ
dpc-4515	208	20	frequent	frequent	ADJ
dpc-4515	208	21	dressing	dressing	NOUN
dpc-4515	208	22	changes	change	NOUN
dpc-4515	208	23	[	[	X
dpc-4515	208	24	21	21	NUM
dpc-4515	208	25	]	]	PUNCT
dpc-4515	208	26	.	.	PUNCT
dpc-4515	209	1	the	the	DET
dpc-4515	209	2	diagnostic	diagnostic	ADJ
dpc-4515	209	3	utility	utility	NOUN
dpc-4515	209	4	of	of	ADP
dpc-4515	209	5	biopsy	biopsy	NOUN
dpc-4515	209	6	in	in	ADP
dpc-4515	209	7	our	our	PRON
dpc-4515	209	8	series	series	NOUN
dpc-4515	209	9	was	be	AUX
dpc-4515	209	10	primarily	primarily	ADV
dpc-4515	209	11	to	to	PART
dpc-4515	209	12	exclude	exclude	VERB
dpc-4515	209	13	other	other	ADJ
dpc-4515	209	14	conditions	condition	NOUN
dpc-4515	209	15	,	,	PUNCT
dpc-4515	209	16	reflecting	reflect	VERB
dpc-4515	209	17	the	the	DET
dpc-4515	209	18	ongoing	ongoing	ADJ
dpc-4515	209	19	challenge	challenge	NOUN
dpc-4515	209	20	in	in	ADP
dpc-4515	209	21	pg	pg	NOUN
dpc-4515	209	22	diagnosis	diagnosis	NOUN
dpc-4515	209	23	.	.	PUNCT
dpc-4515	210	1	histopathological	histopathological	ADJ
dpc-4515	210	2	findings	finding	NOUN
dpc-4515	210	3	often	often	ADV
dpc-4515	210	4	support	support	VERB
dpc-4515	210	5	the	the	DET
dpc-4515	210	6	diagnosis	diagnosis	NOUN
dpc-4515	210	7	by	by	ADP
dpc-4515	210	8	exclusion	exclusion	NOUN
dpc-4515	210	9	rather	rather	ADV
dpc-4515	210	10	than	than	ADP
dpc-4515	210	11	confirmation	confirmation	NOUN
dpc-4515	210	12	;	;	PUNCT
dpc-4515	210	13	this	this	PRON
dpc-4515	210	14	underscores	underscore	VERB
dpc-4515	210	15	the	the	DET
dpc-4515	210	16	importance	importance	NOUN
dpc-4515	210	17	of	of	ADP
dpc-4515	210	18	a	a	DET
dpc-4515	210	19	thorough	thorough	ADJ
dpc-4515	210	20	and	and	CCONJ
dpc-4515	210	21	multifaceted	multifaceted	ADJ
dpc-4515	210	22	diagnostic	diagnostic	ADJ
dpc-4515	210	23	approach	approach	NOUN
dpc-4515	210	24	in	in	ADP
dpc-4515	210	25	suspected	suspect	VERB
dpc-4515	210	26	cases	case	NOUN
dpc-4515	210	27	of	of	ADP
dpc-4515	210	28	pg	pg	NOUN
dpc-4515	210	29	[	[	X
dpc-4515	210	30	22	22	NUM
dpc-4515	210	31	]	]	PUNCT
dpc-4515	210	32	.	.	PUNCT
dpc-4515	211	1	limitations	limitation	NOUN
dpc-4515	211	2	our	our	PRON
dpc-4515	211	3	study	study	NOUN
dpc-4515	211	4	provides	provide	VERB
dpc-4515	211	5	a	a	DET
dpc-4515	211	6	comprehensive	comprehensive	ADJ
dpc-4515	211	7	overview	overview	NOUN
dpc-4515	211	8	of	of	ADP
dpc-4515	211	9	pg	pg	PRON
dpc-4515	211	10	in	in	ADP
dpc-4515	211	11	a	a	DET
dpc-4515	211	12	well	well	ADV
dpc-4515	211	13	-	-	PUNCT
dpc-4515	211	14	defined	define	VERB
dpc-4515	211	15	cohort	cohort	NOUN
dpc-4515	211	16	and	and	CCONJ
dpc-4515	211	17	is	be	AUX
dpc-4515	211	18	,	,	PUNCT
dpc-4515	211	19	to	to	ADP
dpc-4515	211	20	our	our	PRON
dpc-4515	211	21	knowledge	knowledge	NOUN
dpc-4515	211	22	,	,	PUNCT
dpc-4515	211	23	one	one	NUM
dpc-4515	211	24	of	of	ADP
dpc-4515	211	25	the	the	DET
dpc-4515	211	26	largest	large	ADJ
dpc-4515	211	27	in	in	ADP
dpc-4515	211	28	the	the	DET
dpc-4515	211	29	current	current	ADJ
dpc-4515	211	30	literature	literature	NOUN
dpc-4515	212	1	[	[	X
dpc-4515	212	2	3,11,15	3,11,15	NUM
dpc-4515	212	3	]	]	X
dpc-4515	212	4	.	.	PUNCT
dpc-4515	213	1	in	in	ADP
dpc-4515	213	2	our	our	PRON
dpc-4515	213	3	experience	experience	NOUN
dpc-4515	213	4	,	,	PUNCT
dpc-4515	213	5	we	we	PRON
dpc-4515	213	6	used	use	VERB
dpc-4515	213	7	biological	biological	ADJ
dpc-4515	213	8	therapy	therapy	NOUN
dpc-4515	213	9	in	in	ADP
dpc-4515	213	10	moderate	moderate	ADJ
dpc-4515	213	11	-	-	PUNCT
dpc-4515	213	12	to	to	ADP
dpc-4515	213	13	-	-	PUNCT
dpc-4515	213	14	severe	severe	ADJ
dpc-4515	213	15	pg	pg	NOUN
dpc-4515	213	16	,	,	PUNCT
dpc-4515	213	17	notably	notably	ADV
dpc-4515	213	18	when	when	SCONJ
dpc-4515	213	19	systemic	systemic	ADJ
dpc-4515	213	20	steroids	steroid	NOUN
dpc-4515	213	21	or	or	CCONJ
dpc-4515	213	22	other	other	ADJ
dpc-4515	213	23	immunosuppressants	immunosuppressant	NOUN
dpc-4515	213	24	achieved	achieve	VERB
dpc-4515	213	25	no	no	DET
dpc-4515	213	26	improvement	improvement	NOUN
dpc-4515	213	27	.	.	PUNCT
dpc-4515	214	1	given	give	VERB
dpc-4515	214	2	the	the	DET
dpc-4515	214	3	promising	promising	ADJ
dpc-4515	214	4	results	result	NOUN
dpc-4515	214	5	and	and	CCONJ
dpc-4515	214	6	the	the	DET
dpc-4515	214	7	current	current	ADJ
dpc-4515	214	8	accessibility	accessibility	NOUN
dpc-4515	214	9	to	to	PART
dpc-4515	214	10	biosimilar	biosimilar	VERB
dpc-4515	214	11	drugs	drug	NOUN
dpc-4515	214	12	,	,	PUNCT
dpc-4515	214	13	we	we	PRON
dpc-4515	214	14	suggest	suggest	VERB
dpc-4515	214	15	considering	consider	VERB
dpc-4515	214	16	biological	biological	ADJ
dpc-4515	214	17	therapy	therapy	NOUN
dpc-4515	214	18	as	as	ADP
dpc-4515	214	19	the	the	DET
dpc-4515	214	20	first	first	ADJ
dpc-4515	214	21	line	line	NOUN
dpc-4515	214	22	in	in	ADP
dpc-4515	214	23	moderate	moderate	ADJ
dpc-4515	214	24	-	-	PUNCT
dpc-4515	214	25	to	to	ADP
dpc-4515	214	26	-	-	PUNCT
dpc-4515	214	27	severe	severe	ADJ
dpc-4515	214	28	pg	pg	NOUN
dpc-4515	214	29	.	.	PUNCT
dpc-4515	215	1	at	at	ADP
dpc-4515	215	2	the	the	DET
dpc-4515	215	3	same	same	ADJ
dpc-4515	215	4	time	time	NOUN
dpc-4515	215	5	,	,	PUNCT
dpc-4515	215	6	we	we	PRON
dpc-4515	215	7	acknowledge	acknowledge	VERB
dpc-4515	215	8	the	the	DET
dpc-4515	215	9	limitations	limitation	NOUN
dpc-4515	215	10	inherent	inherent	ADJ
dpc-4515	215	11	in	in	ADP
dpc-4515	215	12	retrospective	retrospective	ADJ
dpc-4515	215	13	analyses	analysis	NOUN
dpc-4515	215	14	,	,	PUNCT
dpc-4515	215	15	including	include	VERB
dpc-4515	215	16	potential	potential	ADJ
dpc-4515	215	17	selection	selection	NOUN
dpc-4515	215	18	biases	bias	NOUN
dpc-4515	215	19	and	and	CCONJ
dpc-4515	215	20	the	the	DET
dpc-4515	215	21	influence	influence	NOUN
dpc-4515	215	22	of	of	ADP
dpc-4515	215	23	referral	referral	ADJ
dpc-4515	215	24	patterns	pattern	NOUN
dpc-4515	215	25	on	on	ADP
dpc-4515	215	26	comorbidity	comorbidity	NOUN
dpc-4515	215	27	profiles	profile	NOUN
dpc-4515	215	28	.	.	PUNCT
dpc-4515	216	1	our	our	PRON
dpc-4515	216	2	findings	finding	NOUN
dpc-4515	216	3	underscore	underscore	VERB
dpc-4515	216	4	the	the	DET
dpc-4515	216	5	complex	complex	ADJ
dpc-4515	216	6	and	and	CCONJ
dpc-4515	216	7	systemic	systemic	ADJ
dpc-4515	216	8	nature	nature	NOUN
dpc-4515	216	9	of	of	ADP
dpc-4515	216	10	pg	pg	PROPN
dpc-4515	216	11	,	,	PUNCT
dpc-4515	216	12	necessitating	necessitate	VERB
dpc-4515	216	13	a	a	DET
dpc-4515	216	14	multimodal	multimodal	NOUN
dpc-4515	216	15	,	,	PUNCT
dpc-4515	216	16	multidisciplinary	multidisciplinary	ADJ
dpc-4515	216	17	approach	approach	NOUN
dpc-4515	216	18	to	to	ADP
dpc-4515	216	19	management	management	NOUN
dpc-4515	216	20	.	.	PUNCT
dpc-4515	217	1	conclusion	conclusion	NOUN
dpc-4515	217	2	in	in	ADP
dpc-4515	217	3	our	our	PRON
dpc-4515	217	4	experience	experience	NOUN
dpc-4515	217	5	,	,	PUNCT
dpc-4515	217	6	the	the	DET
dpc-4515	217	7	renewal	renewal	NOUN
dpc-4515	217	8	of	of	ADP
dpc-4515	217	9	advanced	advanced	ADJ
dpc-4515	217	10	dressing	dressing	NOUN
dpc-4515	217	11	together	together	ADV
dpc-4515	217	12	with	with	ADP
dpc-4515	217	13	steroid	steroid	NOUN
dpc-4515	217	14	therapy	therapy	NOUN
dpc-4515	217	15	played	play	VERB
dpc-4515	217	16	a	a	DET
dpc-4515	217	17	key	key	ADJ
dpc-4515	217	18	role	role	NOUN
dpc-4515	217	19	in	in	ADP
dpc-4515	217	20	the	the	DET
dpc-4515	217	21	healing	healing	NOUN
dpc-4515	217	22	process	process	NOUN
dpc-4515	217	23	.	.	PUNCT
dpc-4515	218	1	moreover	moreover	ADV
dpc-4515	218	2	,	,	PUNCT
dpc-4515	218	3	we	we	PRON
dpc-4515	218	4	encourage	encourage	VERB
dpc-4515	218	5	the	the	DET
dpc-4515	218	6	use	use	NOUN
dpc-4515	218	7	of	of	ADP
dpc-4515	218	8	biological	biological	ADJ
dpc-4515	218	9	therapy	therapy	NOUN
dpc-4515	218	10	in	in	ADP
dpc-4515	218	11	patients	patient	NOUN
dpc-4515	218	12	affected	affect	VERB
dpc-4515	218	13	with	with	ADP
dpc-4515	218	14	moderate	moderate	ADJ
dpc-4515	218	15	-	-	PUNCT
dpc-4515	218	16	to	to	ADP
dpc-4515	218	17	-	-	PUNCT
dpc-4515	218	18	severe	severe	ADJ
dpc-4515	218	19	form	form	NOUN
dpc-4515	218	20	of	of	ADP
dpc-4515	218	21	pg	pg	PRON
dpc-4515	218	22	.	.	PUNCT
dpc-4515	219	1	in	in	ADP
dpc-4515	219	2	summary	summary	NOUN
dpc-4515	219	3	,	,	PUNCT
dpc-4515	219	4	our	our	PRON
dpc-4515	219	5	study	study	NOUN
dpc-4515	219	6	enriches	enrich	VERB
dpc-4515	219	7	the	the	DET
dpc-4515	219	8	understanding	understanding	NOUN
dpc-4515	219	9	of	of	ADP
dpc-4515	219	10	pg	pg	PROPN
dpc-4515	219	11	,	,	PUNCT
dpc-4515	219	12	reaffirming	reaffirm	VERB
dpc-4515	219	13	its	its	PRON
dpc-4515	219	14	association	association	NOUN
dpc-4515	219	15	with	with	ADP
dpc-4515	219	16	systemic	systemic	ADJ
dpc-4515	219	17	diseases	disease	NOUN
dpc-4515	219	18	and	and	CCONJ
dpc-4515	219	19	underscoring	underscore	VERB
dpc-4515	219	20	the	the	DET
dpc-4515	219	21	challenges	challenge	NOUN
dpc-4515	219	22	in	in	ADP
dpc-4515	219	23	diagnosis	diagnosis	NOUN
dpc-4515	219	24	and	and	CCONJ
dpc-4515	219	25	management	management	NOUN
dpc-4515	219	26	.	.	PUNCT
dpc-4515	220	1	further	further	ADJ
dpc-4515	220	2	prospective	prospective	ADJ
dpc-4515	220	3	studies	study	NOUN
dpc-4515	220	4	are	be	AUX
dpc-4515	220	5	essential	essential	ADJ
dpc-4515	220	6	to	to	PART
dpc-4515	220	7	unravel	unravel	VERB
dpc-4515	220	8	the	the	DET
dpc-4515	220	9	complexities	complexity	NOUN
dpc-4515	220	10	of	of	ADP
dpc-4515	220	11	pg	pg	PROPN
dpc-4515	220	12	,	,	PUNCT
dpc-4515	220	13	optimize	optimize	VERB
dpc-4515	220	14	treatment	treatment	NOUN
dpc-4515	220	15	strategies	strategy	NOUN
dpc-4515	220	16	,	,	PUNCT
dpc-4515	220	17	and	and	CCONJ
dpc-4515	220	18	ultimately	ultimately	ADV
dpc-4515	220	19	improve	improve	VERB
dpc-4515	220	20	patient	patient	ADJ
dpc-4515	220	21	outcomes	outcome	NOUN
dpc-4515	220	22	in	in	ADP
dpc-4515	220	23	this	this	DET
dpc-4515	220	24	challenging	challenging	ADJ
dpc-4515	220	25	condition	condition	NOUN
dpc-4515	220	26	.	.	PUNCT
dpc-4515	221	1	references	reference	NOUN
dpc-4515	221	2	1	1	NUM
dpc-4515	221	3	.	.	PUNCT
dpc-4515	221	4	maverakis	maverakis	PROPN
dpc-4515	221	5	e	e	PROPN
dpc-4515	221	6	,	,	PUNCT
dpc-4515	221	7	marzano	marzano	PROPN
dpc-4515	221	8	av	av	PROPN
dpc-4515	221	9	,	,	PUNCT
dpc-4515	221	10	le	le	PROPN
dpc-4515	221	11	st	st	PROPN
dpc-4515	221	12	,	,	PUNCT
dpc-4515	221	13	et	et	PROPN
dpc-4515	221	14	al	al	PROPN
dpc-4515	221	15	.	.	PUNCT
dpc-4515	221	16	pyoderma	pyoderma	PROPN
dpc-4515	221	17	gangrenosum	gangrenosum	NOUN
dpc-4515	221	18	.	.	PUNCT
dpc-4515	222	1	nat	nat	PROPN
dpc-4515	222	2	rev	rev	VERB
dpc-4515	222	3	dis	dis	PROPN
dpc-4515	222	4	primers	primer	NOUN
dpc-4515	222	5	.	.	PUNCT
dpc-4515	223	1	2020	2020	NUM
dpc-4515	223	2	oct	oct	PROPN
dpc-4515	223	3	8;6(1):81	8;6(1):81	NUM
dpc-4515	223	4	.	.	PUNCT
dpc-4515	224	1	doi	doi	NOUN
dpc-4515	224	2	:	:	PUNCT
dpc-4515	224	3	10.1038	10.1038	NUM
dpc-4515	224	4	/s41572	/s41572	SYM
dpc-4515	224	5	-	-	PUNCT
dpc-4515	224	6	020	020	NUM
dpc-4515	224	7	-	-	PUNCT
dpc-4515	224	8	0213	0213	NUM
dpc-4515	224	9	-	-	PUNCT
dpc-4515	224	10	x.	x.	NOUN
dpc-4515	224	11	pmid	pmid	PROPN
dpc-4515	224	12	:	:	PUNCT
dpc-4515	224	13	33033263	33033263	NUM
dpc-4515	224	14	.	.	PUNCT
dpc-4515	225	1	2	2	X
dpc-4515	225	2	.	.	X
dpc-4515	225	3	maverakis	maverakis	PROPN
dpc-4515	225	4	e	e	PROPN
dpc-4515	225	5	,	,	PUNCT
dpc-4515	225	6	ma	ma	PROPN
dpc-4515	225	7	c	c	PROPN
dpc-4515	225	8	,	,	PUNCT
dpc-4515	225	9	shinkai	shinkai	PROPN
dpc-4515	225	10	k	k	PROPN
dpc-4515	225	11	,	,	PUNCT
dpc-4515	225	12	et	et	PROPN
dpc-4515	225	13	al	al	PROPN
dpc-4515	225	14	.	.	PUNCT
dpc-4515	226	1	diagnostic	diagnostic	ADJ
dpc-4515	226	2	criteria	criterion	NOUN
dpc-4515	226	3	of	of	ADP
dpc-4515	226	4	ulcerative	ulcerative	ADJ
dpc-4515	226	5	pyoderma	pyoderma	NOUN
dpc-4515	226	6	gangrenosum	gangrenosum	NOUN
dpc-4515	226	7	:	:	PUNCT
dpc-4515	226	8	a	a	DET
dpc-4515	226	9	delphi	delphi	ADJ
dpc-4515	226	10	consensus	consensus	NOUN
dpc-4515	226	11	of	of	ADP
dpc-4515	226	12	international	international	ADJ
dpc-4515	226	13	experts	expert	NOUN
dpc-4515	226	14	.	.	PUNCT
dpc-4515	227	1	jama	jama	PROPN
dpc-4515	227	2	dermatol	dermatol	NOUN
dpc-4515	227	3	.	.	PUNCT
dpc-4515	228	1	2018;154(4):461	2018;154(4):461	NUM
dpc-4515	228	2	-	-	SYM
dpc-4515	228	3	466	466	NUM
dpc-4515	228	4	.	.	PUNCT
dpc-4515	229	1	doi:10.1001	doi:10.1001	PROPN
dpc-4515	229	2	/	/	SYM
dpc-4515	229	3	jamadermatol.2017.5880	jamadermatol.2017.5880	PROPN
dpc-4515	229	4	.	.	PUNCT
dpc-4515	230	1	6	6	NUM
dpc-4515	230	2	original	original	ADJ
dpc-4515	230	3	article	article	NOUN
dpc-4515	230	4	|	|	ADV
dpc-4515	230	5	dermatol	dermatol	ADJ
dpc-4515	230	6	pract	pract	NOUN
dpc-4515	230	7	concept	concept	NOUN
dpc-4515	230	8	.	.	PUNCT
dpc-4515	231	1	2024;14(4):e2024265	2024;14(4):e2024265	NUM
dpc-4515	231	2	disease	disease	NOUN
dpc-4515	231	3	.	.	PUNCT
dpc-4515	232	1	arch	arch	ADJ
dpc-4515	232	2	surg	surg	PROPN
dpc-4515	232	3	.	.	PUNCT
dpc-4515	233	1	1994	1994	NUM
dpc-4515	233	2	jul;129(7):769	jul;129(7):769	NOUN
dpc-4515	233	3	-	-	PUNCT
dpc-4515	233	4	72	72	NUM
dpc-4515	233	5	.	.	PUNCT
dpc-4515	234	1	doi	doi	NOUN
dpc-4515	234	2	:	:	PUNCT
dpc-4515	234	3	10.1001	10.1001	NUM
dpc-4515	234	4	/archsurg.1994.01420310101019	/archsurg.1994.01420310101019	NUM
dpc-4515	234	5	.	.	PUNCT
dpc-4515	235	1	pmid	pmid	NOUN
dpc-4515	235	2	:	:	PUNCT
dpc-4515	235	3	7912923	7912923	NUM
dpc-4515	235	4	.	.	PUNCT
dpc-4515	236	1	21	21	NUM
dpc-4515	236	2	.	.	PUNCT
dpc-4515	237	1	afifi	afifi	PROPN
dpc-4515	237	2	l	l	PROPN
dpc-4515	237	3	,	,	PUNCT
dpc-4515	237	4	sanchez	sanchez	PROPN
dpc-4515	238	1	i	i	PRON
dpc-4515	238	2	m	m	PROPN
dpc-4515	238	3	,	,	PUNCT
dpc-4515	238	4	wallace	wallace	PROPN
dpc-4515	238	5	mm	mm	PROPN
dpc-4515	238	6	,	,	PUNCT
dpc-4515	238	7	braswell	braswell	PROPN
dpc-4515	238	8	sf	sf	PROPN
dpc-4515	238	9	,	,	PUNCT
dpc-4515	238	10	ortega	ortega	PROPN
dpc-4515	238	11	-	-	PUNCT
dpc-4515	238	12	loayza	loayza	PROPN
dpc-4515	238	13	ag	ag	PROPN
dpc-4515	238	14	,	,	PUNCT
dpc-4515	238	15	shinkai	shinkai	PROPN
dpc-4515	238	16	k.	k.	PROPN
dpc-4515	238	17	diagnosis	diagnosis	PROPN
dpc-4515	238	18	and	and	CCONJ
dpc-4515	238	19	management	management	NOUN
dpc-4515	238	20	of	of	ADP
dpc-4515	238	21	peristomal	peristomal	ADJ
dpc-4515	238	22	pyoderma	pyoderma	NOUN
dpc-4515	238	23	gangrenosum	gangrenosum	NOUN
dpc-4515	238	24	:	:	PUNCT
dpc-4515	238	25	a	a	DET
dpc-4515	238	26	systematic	systematic	ADJ
dpc-4515	238	27	review	review	NOUN
dpc-4515	238	28	.	.	PUNCT
dpc-4515	239	1	j	j	PROPN
dpc-4515	239	2	am	be	AUX
dpc-4515	239	3	acad	acad	ADJ
dpc-4515	239	4	dermatol	dermatol	NOUN
dpc-4515	239	5	.	.	PUNCT
dpc-4515	240	1	2018	2018	NUM
dpc-4515	240	2	jun;78(6):1195	jun;78(6):1195	NOUN
dpc-4515	240	3	-	-	PUNCT
dpc-4515	240	4	1204.e1	1204.e1	PROPN
dpc-4515	240	5	.	.	PUNCT
dpc-4515	240	6	doi	doi	NOUN
dpc-4515	240	7	:	:	PUNCT
dpc-4515	240	8	10.1016	10.1016	NUM
dpc-4515	240	9	/	/	SYM
dpc-4515	240	10	j.jaad.2017.12.049	j.jaad.2017.12.049	PROPN
dpc-4515	240	11	.	.	PUNCT
dpc-4515	241	1	epub	epub	PROPN
dpc-4515	241	2	2017	2017	NUM
dpc-4515	241	3	dec	dec	PROPN
dpc-4515	241	4	27	27	NUM
dpc-4515	241	5	.	.	PUNCT
dpc-4515	242	1	pmid	pmid	NOUN
dpc-4515	242	2	:	:	PUNCT
dpc-4515	242	3	29288099	29288099	NUM
dpc-4515	242	4	.	.	PUNCT
dpc-4515	243	1	22	22	NUM
dpc-4515	243	2	.	.	PUNCT
dpc-4515	244	1	haag	haag	PROPN
dpc-4515	244	2	c	c	PROPN
dpc-4515	244	3	,	,	PUNCT
dpc-4515	244	4	hansen	hansen	PROPN
dpc-4515	244	5	t	t	PROPN
dpc-4515	244	6	,	,	PUNCT
dpc-4515	244	7	hajar	hajar	PROPN
dpc-4515	244	8	t	t	PROPN
dpc-4515	244	9	,	,	PUNCT
dpc-4515	244	10	latour	latour	PROPN
dpc-4515	244	11	e	e	PROPN
dpc-4515	244	12	,	,	PUNCT
dpc-4515	244	13	keller	keller	PROPN
dpc-4515	244	14	j	j	PROPN
dpc-4515	244	15	,	,	PUNCT
dpc-4515	244	16	shinkai	shinkai	PROPN
dpc-4515	244	17	k	k	PROPN
dpc-4515	244	18	,	,	PUNCT
dpc-4515	244	19	ortega	ortega	PROPN
dpc-4515	244	20	-	-	PUNCT
dpc-4515	244	21	loayza	loayza	PROPN
dpc-4515	244	22	ag	ag	PROPN
dpc-4515	244	23	.	.	PROPN
dpc-4515	244	24	comparison	comparison	NOUN
dpc-4515	244	25	of	of	ADP
dpc-4515	244	26	three	three	NUM
dpc-4515	244	27	diagnostic	diagnostic	ADJ
dpc-4515	244	28	frameworks	framework	NOUN
dpc-4515	244	29	for	for	ADP
dpc-4515	244	30	pyoderma	pyoderma	NOUN
dpc-4515	244	31	gangrenosum	gangrenosum	NOUN
dpc-4515	244	32	.	.	PUNCT
dpc-4515	245	1	j	j	PROPN
dpc-4515	245	2	invest	invest	VERB
dpc-4515	245	3	dermatol	dermatol	NOUN
dpc-4515	245	4	.	.	PUNCT
dpc-4515	246	1	2021	2021	NUM
dpc-4515	246	2	jan;141(1):59	jan;141(1):59	PROPN
dpc-4515	246	3	-	-	PUNCT
dpc-4515	246	4	63	63	NUM
dpc-4515	246	5	.	.	PUNCT
dpc-4515	247	1	doi	doi	NOUN
dpc-4515	247	2	:	:	PUNCT
dpc-4515	247	3	10.1016	10.1016	NUM
dpc-4515	247	4	/	/	SYM
dpc-4515	247	5	j.jid.2020.04.019	j.jid.2020.04.019	AUX
dpc-4515	247	6	.	.	PUNCT
dpc-4515	248	1	epub	epub	NOUN
dpc-4515	248	2	2020	2020	NUM
dpc-4515	248	3	may	may	AUX
dpc-4515	248	4	20	20	NUM
dpc-4515	248	5	.	.	PUNCT
dpc-4515	249	1	pmid	pmid	NOUN
dpc-4515	249	2	:	:	PUNCT
dpc-4515	249	3	32445742	32445742	NUM
dpc-4515	249	4	.	.	PUNCT
dpc-4515	250	1	17	17	NUM
dpc-4515	250	2	.	.	PUNCT
dpc-4515	251	1	riyaz	riyaz	PROPN
dpc-4515	251	2	n	n	PROPN
dpc-4515	251	3	,	,	PUNCT
dpc-4515	251	4	mary	mary	PROPN
dpc-4515	251	5	v	v	PROPN
dpc-4515	251	6	,	,	PUNCT
dpc-4515	251	7	sasidharanpillai	sasidharanpillai	PROPN
dpc-4515	251	8	s	s	PROPN
dpc-4515	251	9	,	,	PUNCT
dpc-4515	251	10	et	et	PROPN
dpc-4515	251	11	al	al	PROPN
dpc-4515	251	12	pyoderma	pyoderma	PROPN
dpc-4515	251	13	gangrenosum	gangrenosum	NOUN
dpc-4515	251	14	:	:	PUNCT
dpc-4515	251	15	a	a	DET
dpc-4515	251	16	clinico	clinico	NOUN
dpc-4515	251	17	-	-	PUNCT
dpc-4515	251	18	epidemiological	epidemiological	ADJ
dpc-4515	251	19	study	study	NOUN
dpc-4515	251	20	.	.	PUNCT
dpc-4515	252	1	indian	indian	PROPN
dpc-4515	252	2	j	j	PROPN
dpc-4515	252	3	dermatol	dermatol	PROPN
dpc-4515	252	4	venereol	venereol	ADJ
dpc-4515	252	5	leprol	leprol	PROPN
dpc-4515	252	6	.	.	PUNCT
dpc-4515	253	1	2017	2017	NUM
dpc-4515	253	2	jan	jan	PROPN
dpc-4515	253	3	-	-	PUNCT
dpc-4515	253	4	feb;83(1):33	feb;83(1):33	PROPN
dpc-4515	253	5	-	-	PUNCT
dpc-4515	253	6	39	39	NUM
dpc-4515	253	7	.	.	PUNCT
dpc-4515	254	1	doi	doi	NOUN
dpc-4515	254	2	:	:	PUNCT
dpc-4515	254	3	10.4103/0378	10.4103/0378	NUM
dpc-4515	254	4	-	-	SYM
dpc-4515	254	5	6323	6323	NUM
dpc-4515	254	6	.	.	PUNCT
dpc-4515	255	1	188654	188654	NUM
dpc-4515	255	2	.	.	PUNCT
dpc-4515	256	1	pmid	pmid	NOUN
dpc-4515	256	2	:	:	PUNCT
dpc-4515	256	3	27549869	27549869	NUM
dpc-4515	256	4	.	.	PUNCT
dpc-4515	257	1	18	18	NUM
dpc-4515	257	2	.	.	X
dpc-4515	258	1	bhat	bhat	PROPN
dpc-4515	258	2	rm	rm	PROPN
dpc-4515	258	3	.	.	PUNCT
dpc-4515	258	4	pyoderma	pyoderma	PROPN
dpc-4515	258	5	gangrenosum	gangrenosum	NOUN
dpc-4515	258	6	:	:	PUNCT
dpc-4515	258	7	an	an	DET
dpc-4515	258	8	update	update	NOUN
dpc-4515	258	9	.	.	PUNCT
dpc-4515	259	1	indian	indian	ADJ
dpc-4515	259	2	dermatol	dermatol	NOUN
dpc-4515	259	3	online	online	PROPN
dpc-4515	259	4	j.	j.	PROPN
dpc-4515	259	5	2012	2012	NUM
dpc-4515	259	6	jan;3(1):7	jan;3(1):7	PROPN
dpc-4515	259	7	-	-	SYM
dpc-4515	259	8	13	13	NUM
dpc-4515	259	9	.	.	PUNCT
dpc-4515	260	1	doi	doi	NOUN
dpc-4515	260	2	:	:	PUNCT
dpc-4515	260	3	10.4103/2229	10.4103/2229	NUM
dpc-4515	260	4	-	-	SYM
dpc-4515	260	5	5178.93482	5178.93482	NUM
dpc-4515	260	6	.	.	PUNCT
dpc-4515	261	1	pmid	pmid	NOUN
dpc-4515	261	2	:	:	PUNCT
dpc-4515	261	3	23130252	23130252	NUM
dpc-4515	261	4	;	;	PUNCT
dpc-4515	261	5	pmcid	pmcid	NOUN
dpc-4515	261	6	:	:	PUNCT
dpc-4515	261	7	pmc3481925	pmc3481925	PROPN
dpc-4515	261	8	.	.	PUNCT
dpc-4515	262	1	19	19	NUM
dpc-4515	262	2	.	.	NOUN
dpc-4515	262	3	bardazzi	bardazzi	PROPN
dpc-4515	262	4	f	f	PROPN
dpc-4515	262	5	,	,	PUNCT
dpc-4515	262	6	viviani	viviani	PROPN
dpc-4515	262	7	f	f	PROPN
dpc-4515	262	8	,	,	PUNCT
dpc-4515	262	9	filippi	filippi	PROPN
dpc-4515	262	10	f	f	PROPN
dpc-4515	262	11	,	,	PUNCT
dpc-4515	262	12	carpanese	carpanese	PROPN
dpc-4515	262	13	ma	ma	PROPN
dpc-4515	262	14	,	,	PUNCT
dpc-4515	262	15	piraccini	piraccini	PROPN
dpc-4515	262	16	bm	bm	PROPN
dpc-4515	262	17	,	,	PUNCT
dpc-4515	262	18	abbenante	abbenante	ADV
dpc-4515	262	19	d.	d.	PROPN
dpc-4515	262	20	the	the	DET
dpc-4515	262	21	legs	leg	NOUN
dpc-4515	262	22	:	:	PUNCT
dpc-4515	262	23	an	an	DET
dpc-4515	262	24	underestimated	underestimated	ADJ
dpc-4515	262	25	difficult	difficult	ADJ
dpc-4515	262	26	-	-	PUNCT
dpc-4515	262	27	to	to	ADP
dpc-4515	262	28	-	-	PUNCT
dpc-4515	262	29	treat	treat	VERB
dpc-4515	262	30	area	area	NOUN
dpc-4515	262	31	of	of	ADP
dpc-4515	262	32	psoriasis	psoriasis	NOUN
dpc-4515	262	33	.	.	PUNCT
dpc-4515	263	1	dermatol	dermatol	NOUN
dpc-4515	263	2	ther	ther	ADV
dpc-4515	263	3	.	.	PUNCT
dpc-4515	264	1	2022	2022	NUM
dpc-4515	264	2	jun;35(6):e15485	jun;35(6):e15485	PROPN
dpc-4515	264	3	.	.	PUNCT
dpc-4515	265	1	doi	doi	NOUN
dpc-4515	265	2	:	:	PUNCT
dpc-4515	265	3	10.1111	10.1111	NUM
dpc-4515	265	4	/	/	SYM
dpc-4515	265	5	dth.15485	dth.15485	PROPN
dpc-4515	265	6	.	.	PUNCT
dpc-4515	266	1	epub	epub	PROPN
dpc-4515	266	2	2022	2022	NUM
dpc-4515	266	3	apr	apr	NOUN
dpc-4515	266	4	7	7	NUM
dpc-4515	266	5	.	.	PUNCT
dpc-4515	266	6	pmid	pmid	NOUN
dpc-4515	266	7	:	:	PUNCT
dpc-4515	266	8	35383406	35383406	NUM
dpc-4515	266	9	.	.	PUNCT
dpc-4515	267	1	20	20	NUM
dpc-4515	267	2	.	.	PUNCT
dpc-4515	268	1	cairns	cairns	PROPN
dpc-4515	268	2	ba	ba	PROPN
dpc-4515	268	3	,	,	PUNCT
dpc-4515	268	4	herbst	herbst	PROPN
dpc-4515	268	5	ca	can	AUX
dpc-4515	268	6	,	,	PUNCT
dpc-4515	268	7	sartor	sartor	PROPN
dpc-4515	268	8	br	br	PROPN
dpc-4515	268	9	,	,	PUNCT
dpc-4515	268	10	briggaman	briggaman	PROPN
dpc-4515	268	11	ra	ra	PROPN
dpc-4515	268	12	,	,	PUNCT
dpc-4515	268	13	koruda	koruda	PROPN
dpc-4515	268	14	mj	mj	PROPN
dpc-4515	268	15	.	.	PROPN
dpc-4515	268	16	peristomal	peristomal	ADJ
dpc-4515	268	17	pyoderma	pyoderma	NOUN
dpc-4515	268	18	gangrenosum	gangrenosum	NOUN
dpc-4515	268	19	and	and	CCONJ
dpc-4515	268	20	inflammatory	inflammatory	ADJ
dpc-4515	268	21	bowel	bowel	NOUN